N,N－ニザハイコウキヲリヨウシタニッケルショクバイニヨルタンソ－スイソケツゴウカンノウキカニカンスルケンキュウ by アイハラ, ヨシノリ & 相原, 佳典
Osaka University
Title Studies on Nickel-Catalyzed C-H Bond FunctionalizationUtilizing N,N-Bidentate Directing Assistance
Author(s)相原, 佳典
Citation
Issue Date
Text VersionETD
URL http://hdl.handle.net/11094/55949
DOI
Rights
  
 
Doctoral Dissertation 
 
 
Studies on Nickel-Catalyzed 
C-H Bond Functionalization  
Utilizing N,N-Bidentate Directing Assistance 
 
 
 
 
 
Yoshinori Aihara 
 
January 2016 
 
Department of Applied Chemistry, 
Graduate School of Engineering, 
Osaka University 
ii 
 
  
iii 
 
Preface and Acknowledgements 
 
The findings presented in this thesis were carried out under the direction of Professor 
Naoto Chatani of the Department of Applied Chemistry, Faculty of Engineering, Osaka 
University between April 2010 and March 2016. The thesis is concerned with the 
development of the nickel(II)-catalyzed direct functionalization of aromatic and aliphatic C-H 
bonds utilizing an N,N-bidentate directing group. 
This thesis would not be possible without help, advice, and support from many people and 
I would like to express my sincerest appreciation to all of them. 
I would like to express my utmost gratitude to Professor Chatani for his guidance and 
suggestions throughout this work. His enthusiasm for chemistry has always motivated me. I 
also admire him for his wit and humor in daily life. He also arranged for me to be involved in 
research at The Scripps Research Institute in America for four months, and provided a 
financial support for this experience. I had one of the most exciting times in my life there.  
I would also like to thank Dr. Yoshiya Fukumoto and Dr. Mamoru Tobisu for their 
instructive and expert advice based on their extensive backgrounds in chemistry.  
I thank the secretaries in our laboratory, including Ms. Mayuko Nakamura, Ms. Yoshimi 
Shinomiya, and Ms. Junko Ohmagari for their kind assistance. 
I would like to express my special thanks to the senior members of the Chatani Group. 
Since I joined this group in 2010, I have been supported by many people: Dr. Takeshi Uemura, 
Dr. Satoshi Inoue, Dr. Yusuke Ano, Dr. Isao Hyodo, Dr. Masahiro Onoe, Mr. Keika Koh, Mr. 
Hirotaka Shiota, Mr. Takuya Tsuruta, Mr. Tomohiko Yasunaga, Mr. Ken Yamakawa, Dr. 
Hirotaka Kinuta, Mr. Shiratani Motohiro, Ms. Nao Hasegawa, Dr. Katsuaki Baba, Ms. Tian 
Xu, and Mr. Masato Daijo. I’m proud and grateful that I had the opportunity to learn many 
things from them. 
iv 
 
I also wish to thank my excellent classmates, including Mr. Akihiro Ohmae, Dr. Keisuke 
Nakamura, Mr. Jun-ya Hasegawa, Mr. Yasunori Soga and Mr. Masaki Yoneda (everyone 
calls him Yonepii). It has been a great pleasure for me to have worked with them and spend 
wonderful time, especially drinking parties. 
I would also wish to express my gratitude to the junior members of the Chatani group, 
including Ms. Miki Iyanaga, Mr. Kaname Shibata, Mr. Hiroto Shimizu, Mr. Takayuki 
Furukawa, Ms. Ayaka Yasutome, Ms. Aya Tashiro, Mr. Masaya Hirano, Mr. Toshifumi 
Morioka, Ms. Ayana Yokota, Mr. Motonobu Kamiya, Mr. Tsuyoshi Takahira, Mr. Yuto 
Tamura, Ms. Moe Noguchi, Mr. Yoshihiro Masuya, Mr. Takuya Igarashi, Mr. Teruhiko Kubo, 
Mr. Jiangning Zhao, Ms. Natsuki Okazaki, Mr. Yuta Seo, Mr. Kosuke Yasui, Mr. Takuma 
Yamaguchi, Ms. Mao Yamaguchi, Mr. Soudai Yamada, Mr. Yasuaki Iyori, Mr. Akihiro 
Nishizawa, Mr. Atsushi Obata, Ms. Satoko Natsui, and Mr. Kousuke Yanagisawa. 
Furthermore, I express my appreciation to Dr. Rebecca Reguillo Carmona, Dr. Valentine 
Charra, Ms. Yoonjoo Kim, Mr. Melih Kus, Dr. Guy Rouquet, Mr. Ho Jordan Sun, Dr. Jendrik 
Wuelbern. Dr. Luis Carlos Misal Castro, Dr. Yadagiri Komagara, and Dr. Akimichi Ohtsuki 
who performed research in the Chatani laboratory as visiting fellows or as postdoctoral 
fellows. 
I would like to express my special gratitude to the Chatani group members, who were 
involved in research on the nickel-catalyzed functionalization of C-H bonds utilizing 
bidentate directing groups, Dr. Luis Carlos Misal Castro, Mr. Hirotaka Shiota, Ms. Miki 
Iyanaga, Ms. Ayana Yokota, Mr. Teruhiko Kubo and Mr. Atsushi Obata. 
Professor Chatani also allowed me to spend a period of time doing research in the USA. 
Professor Phil Baran at The Scripps Research Institute in La Jolla, USA, accepted me in his 
group as an exchange graduate student from September to December 2014. During my stay in 
Baran’s group, he and Mr. Yi Yang See supported my stay and taught me experimental 
v 
 
techniques about total synthesis. I also acknowledge Ms. Patrece, who provided me with 
lodging, and all member of Baran’s Group, especially Dr. Yoshihiro Ishihara, Mr. Hai Dao, 
Dr. Quentin Michaudel, Dr. Chung-Mao Pan, Dr. Bart Roman, Dr. Yuki Yabe Mr. Daisuke 
Ogasawara and Dr. Syuhei Kawamura. They taught me many things about the culture, food, 
and life of Americans.  
I am grateful for and wish to acknowledge a JSPS Research Fellowship for Young 
Scientists.  
Finally, I would like to express my deepest gratitude to my parents, Mr. Yoshihisa Aihara 
and Ms. Masayo Aihara, my brother, Mr. Yuki Aihara, my sister, Ms. Saki Aihara and my 
fiancée, Ms. Sanae Kotani. 
 
Suita, Osaka 
January 2016 
 
Yoshinori Aihara 
  
vi 
 
 
vii 
 
Contents 
 
General Introduction 
   References 
 
Chapter 1  Nickel(II)-Catalyzed Direct Alkylation of C-H Bonds in Aromatic Amides 
Containing an 8-Aminoquinoline Moiety as the Directing Group 
   1.1  Introduction 
   1.2  Results and Discussion 
   1.3  Conclusion 
1.4  Experimental Section 
   1.5  References and Notes 
 
Chapter 2  Nickel(II)-Catalyzed Direct Arylation of C(sp3)-H Bonds in Aliphatic 
Amides via Bidentate-Chelation Assistance 
   2.1  Introduction 
   2.2  Results and Discussion 
   2.3  Conclusion 
   2.4  Experimental Section 
   2.5  References and Notes 
 
Chapter 3  Ni(II)-Catalyzed Oxidative Coupling between C(sp2)−H in Benzamides 
and C(sp3)−H in Toluene Derivatives 
   3.1  Introduction 
   3.2  Results and Discussion 
   3.3  Conclusion 
   3.4  Experimental Section 
   3.5  References and Notes 
 
Conclusion 
 
List of Publications / Supplementary List of Publications 
  
viii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
 
General Introduction 
 
The transition metal-catalyzed functionalization of C-H bonds has emerged as a powerful 
tool for the synthesis organic molecule in recent years.1 From the point of view of economy of 
steps and its environmentally friendly nature, the direct functionalization of C-H bonds has 
been developed as an alternative method for conventional cross coupling reactions. 
Palladium, rhodium and ruthenium are mainly used for functionalization of C-H bonds. On 
the other hand, there are only limited examples of the direct functionalization of C-H bonds 
using low-cost and more abundant metals, such as iron, copper and nickel, but this area of 
research has attracted recent attention. 
Focusing on C-H bond activation using a nickel complex, a pioneering example of 
activation of benzene C-H bond by chelation-assistant was achieved by utilizing a 
stoichiometric amount of a nickel complex and azobenzene (eq 1).3a Remarkably, this 
cyclometalation was published earlier than cyclometalation with palladium complex (eq 2),4 
although cyclopalladation has been widely used method for C-H bonds actication.5 
Cyclometalation via the cleavage of C-H bonds using nickel has been undeveloped even when 
a stoichiometric amount of nickel is used. Zargarian and co-workers recently reported on 
cylcometalation via the cleavage of benzene C-H bonds using a stoichiometric amount of a 
nickel complex prepared from phenol (eq 3).3b 
 
 
 
 
 
 Most of the known nickel-catalyzed transformations of C-H bonds are limited to acidic 
C-H bonds, such as activated C(sp2)-H bonds in azole, perfluorobenzene derivatives and 
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activated pyridine derivatives (Figure 1),2 although the use of nickel in cyclometalation has 
been reported (eq 1 and 3). The transformation of non-activated benzene or aliphatic C-H 
bonds with a nickel-catalyst represent undeveloped and challenging topics, due to the 
low-reactivity of nickel complexes. 
 
Figure1. Scope and Limitation of C-H bonds with Ni-catalyst 
 
 
Incidentally, one of the methods for the regioselective functionalization of C-H bonds, 
which are ubiquitous in organic molecules, is the use of directing groups. Murai and 
co-workers reported on a pioneering concept of the use of a directing group for activating 
C-H bonds in 1993, the reaction of acetophenone and vinylsilane in the presence of a 
Ru-catalyst gave the ortho-alkylation product via the formation of a metallacycle intermediate 
generated by the activation of aromatic C-H bonds (eq 4).6 
 
 
 
Directing groups, especially ketones or sp2 nitrogen-containing compounds, such as 
pyridine coordinated to a metal, can be used to selectively activate C-H bonds, and, after 
activation, the reaction proceeds via a metallacycle intermediate (Figure 2a). The driving 
force for the activation of inert C-H bonds in a directing group system is the formation of a 
metallacycle intermediate. Various types of directing groups for C-H functionalizations have 
been developed, since the appearance of Murai’s significant work.7 The transformation of 
C-H bonds using nickel-catalyst has been limited, even if conventional directing groups are 
used. The low interaction between the nickel(II) complex and directing group and the low 
affinity between nickel(II) and C-H bonds make the activation of C-H bonds with a 
nickel-catalyst difficult (Figure 2a). 
 
 
 
 
 3 
 
Figure 2. Working Hypothesis: Ni-Catalyzed Activation of C-H Bonds 
 
 
In this study, I hypothesized that the use of a strong coordinating directing group and more 
stabilized metallacycle would provide sufficient driving force to permit inert C-H bonds to be 
activated when a low reactive nickel-catalyst was used. On the basis of this hypothesis, many 
experiments that were intended to increase the reactivity of nickel were carried out. The 
combination of a nickel(II) complex and a bidentate directing group which has two 
coordinating atoms within the directing group has the potential to activate inert C-H bonds 
because the bidentate directing group can strongly coordinate to nickel(II) complexes and 
stabilize the metallacycle by coordinating two atoms within the bidentate directing group 
(Fiugre 2b). The successful pioneering example of the bidentate directing group assisted 
functionalization of C−H bonds was reported by Daugulis, who discovered the 
Pd(II)-catalyzed arylation of C−H bonds in aliphatic amides that contain a picolinamide and 
8-aminoquinoline moiety (eq 5 and 6).8 The transformation of C−H bonds using bidentate 
directing groups and a palladium catalyst has grown in popularity since this seminal discovery 
by Daugulis.9 The use of a bidentate directing group in conjunction with another transition 
metal catalyst in the transformation of C-H bonds had not still been developed before I started 
this study, except for our example of the direct Ru-catalyzed functionalization of C-H bonds 
utilizing a 2-aminopyridylmethylamine moiety as a bidentate directing group.9 
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Based on this working hypothesis, the activation of C-H bonds using a nickel(II)-catalyst 
and a bidentate directing group were examined. This thesis includes various types of 
transformations of C-H bonds utilizing a nickel(II)-catalyst and a bidentate directing group. 
This thesis is composed of the following three chapters.  
Chapter 1 discusses the nickel(II)-catalyzed direct alkylation of C(sp2)-H bonds 
containing an 8-aminoquinline moiety as a bidentate directing group with an alkyl halide. 
Chapter 2 deals with the nickel(II)-catalyzed direct arylation of aliphatic amide possessing 
a bidentate directing group with an aryl halide via cleavage of a C(sp3)-H bond. 
Chapter 3 is concerned with the nickel(II)-catalyzed oxidative coupling of C(sp2)-H bond 
in benzamides and benzylic C-H bond in toluene derivatives using hetafluoroisopropyl iodide 
as a mild oxidant. This reaction involves the catalytic cleavage of two different C-H bonds, 
C(sp2)-H and benzylic C-H bonds. 
Finally, the findings are summarized in the conclusion section of the thesis. 
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Chapter 1 
 
Nickel(II)-Catalyzed Direct Alkylation of C-H Bonds in Aromatic Amides 
 Containing an 8-Aminoquinoline Moiety as the Directing Group 
 
1.1  Introduction 
Transition metal-catalyzed direct arylation of C-H bonds with aryl halides or aryl metal 
reagents has been developed and emerged as a powerful method for the construction of 
organic molecules. Compared to these arylation reactions, examples of the direct alkylation of 
C-H bonds with alkyl halide remain limited, because of the unfavorable of alkyl halides 
toward oxidative addition and the fact that the resulting alkyl metal complexes are susceptible 
to β–hydride elimination.1 Conventional approaches to the synthesis of alkylated arenes rely 
on Friedel-Crafts type reactions or SEAr type reactions, both of which have some limitations 
including i) only electron rich arenes were applicable ii) a low functional group tolerance, ii) 
low regioselectivities, and iii) a mixture of normal and branched products are often produced.2 
Numerous efforts have been made to address these limitations, and transition metal-catalyzed 
direct alkylation with alkyl halides has emerged as an alternative method for the synthesis 
alkylated arenes. Due to those efforts, direct alkylation using alkyl halides as the alkylating 
reagent with Pd,3 Ru,4 Fe,5 and Co6 catalysts have been developed over the past few years, 
while a direct alkylation with nickel-catalyst has been undeveloped. 
Our group has focused on the use of 2-aminopyridylmethylamine as a bidentate directing 
groups in a catalytic functionalization of C-H bonds, such as the Ru-catalyzed carbonylation 
of aliphatic C-H bond utilizing 2-aminopyridylmethylamine (eq 1),7a and the Ru-catalyzed 
direct arylation of aromatic amides with aryl halides by talking advantage of 
2-aminopyridylmethylamine and 8-aminoquinoline (eq 2). 7b 
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Chapter 1 describes the Ni(II)-catalyzed direct alkylation of aromatic amides with alkyl 
halides by talking advantage of N,N-bidentate directing chelation system. This reaction 
represents the first example of Ni-catalyzed direct alkylation of aromatic C-H bonds. 
 
1.2.  Results and Discussion 
Motivated by previous our results and working hypothesis described in general 
introduction, various type of directing groups and additives were examined to find the new 
method for transformation of C-H bond with Ni(II)-catalyst. The arylation with aryl halide 
was examined as a preliminary experiment. The reaction of aromatic amide 1a containing an 
8-aminoqunoline moiety and iodobenzene in the presence of Ni(OTf)2 and sodium 
bicarbonate furnished direct ortho-arlyation product 2a in excellent yield (Scheme 1).8 This 
result represented that the cleavage of non-activated aromatic C-H bonds with low reactive 
nickel-catalyst was achieved. Screening of directing groups were examined. The reaction with 
amide without qunoline nitrogen, N-methylated amide and corresponding ester were resulted 
in no reaction (Scheme 1). These results indicated that both of NH and quinolone nitrogen 
atoms are necessary for the transformation of C-H bond. 
To expand the utility of the present chelation system, we examined the alkylation reaction 
using alkyl halides. When the amide 1a was reacted with butyl bromide under the arylation 
condition,8 the alkylation did not procced (entry 1 in Table 1). However, the addition of PPh3 
increased the alkylation product 3a yield to 41% NMR yield, along with 54% of unreacted 1a 
being recovered (entry 2). The yield was strongly depended on the choice of the base, and the 
sodium carbonate was chosen as a best base (entry 3). The use of PCy3 decreased 3a in 26% 
NMR yield (entry 6). The use of 2 equivalents of butyl bromide improved the yield of 3a in 
88% isolated yield (entry 7). 
 
Scheme 1. The Ni-Catalyzed Direct Arylation with Iodide Benzenea 
 
 a Isolated yields. 
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Table 1. The Nickel-Catalyzed Butylation of 1a with Butyl Bromide 
 
a NMR yields. The number in parenthesis is the isolated yield of 2a. b BuBr (0.6 mmol) was 
used. 
 
With the optimized reaction conditions in hand, we examined the scope of the substrate. 
Table 2 shows the results for reactions of various aromatic amides with butyl bromide under 
the standard reaction conditions. A variety of functional groups were found to be tolerated 
and, even the iodide was survived, as in 3h. The reaction of meta-substituted substrates 
resulted in selective alkylation at the less hindered C-H bonds, irrespective of the electronic 
nature of the substituent. In general, electron-withdrawing groups tended to give butylation 
products in higher yields. The addition of NaI was found to improve the product yields in the 
reaction with electron donating substituents, as in 3b and 3c. The C-H bonds in heterocyclic 
compounds could be alkylated, as in 8, 9 and 10. This C-H bond alkylation reaction was 
applicable to -unsaturated amides. The cyclic amides, 11, 12, and 13 gave the butylation 
products in good yields. 
Various of alkyl halides, such as benzyl, allyl and methyl halide, were also applicable to 
this reaction (Table 3). Octyl iodide and octyl bromide gave the octylation product 24 in high 
yield. While no reaction took place in the case of octyl chloride, the addition of sodium iodide 
(2 equivalents) dramatically improved the product 24 yield to 88% isolated yield, generating 
the alkyl iodide in situ. This effect of sodium iodide was also observed in the reaction with 
sterically demanding alkyl bromides or some functionalized alkyl bromides. The use of 
2-methylpropyl bromide and cyclopentylmethyl bromide without addition of sodium iodide 
resulted in almost no reaction, but the yields of 19 and 20 were dramatically improved to 44% 
and 45% yields when sodium iodide was added. While the reaction with methyl iodide gave 
the methylation product 29 and N-methylated product, the combination of methyl tosylate and 
sodium iodide gave the only methylation product 29 in excellent yields. The reaction of a 
cyclopentyl bromide under optimized reaction conditions gave only a trace amount of the 
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alkylation product 30. After screening of the reaction conditions, using IMesMe and PPh3 as 
the ligand improved the product 30 yield to 51%.9 
 
Table 2. The Ni-Catalyzed Butylation of C(sp2)-H Bondsa 
 
a Reaction conditions: amide (0.3 mmol), BuBr (0.6 mmol), Ni(OTf)2 (0.03 mmol), PPh3 
(0.06 mmol), Na2CO3 (0.6 mmol) in toluene (1 mL) at 140 °C for 24 h. 
b NaI (0.6 mmol) was 
used as an additive. c Run at 160 °C. d BuI (0.6 mmol) was used instead of BuBr. e BuBr (1.2 
mmol) was used. 
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Table 3. The Ni-Catalyzed Alkylation of C-H Bonds in Aromatic Amidesa 
 
a Reaction conditions: amide (0.3 mmol), Aklyl halide (0.6 mmol), Ni(OTf)2 (0.03 mmol), 
PPh3 (0.06 mmol), Na2CO3 (0.6 mmol) in toluene (1 mL) at 140 °C for 24 h. 
b NaI (0.6 mmol) 
was used as an additive. c.IMesMe•HCl (0.06 mmol) and NaOtBu (0.07 mmol) was added as a 
ligand. 
 
Several mechanistic studies were carried out to gain mechanistic information. We 
anticipated that under the reaction conditions, the alkylation takes place via the addition of the 
C−H bond with the alkene, which may generate from an alkyl halide via dehydrobromination. 
However, when 1a was reacted with octane resulted in no reaction (eq 3). A quaternary 
phosphonium bromide is also another candidate for alkylating reagent. However, the 
corresponding butylation product 3a was obtained in only 5% yield (eq 4). These results 
indicate that the alkyl halide itself functions as a coupling partner.  
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The deuterated amide 1a-d7 was reacted with BuBr for 8 h under the standard reaction 
condition (Scheme 2). A significant amount of H/D exchange at the ortho C-D bond (the 
d-content decreased from >98% to 51% (49%H)) and N-H on the amide nitrogen in the 
recovered amide was observed. A significant amount of H/D exchange occurred, even in the 
absence of BuBr, indicating that the cleavage of C-H bonds occurs before the reaction with an 
alkyl halide. It was also found that the presence of PPh3 had no effect on the H/D exchange 
reaction. These results indicate that the cleavage of C-H bonds is reversible and rapid step and 
not likely the rate determining step in the reaction.  
 
Scheme 2. Deuterium labeling experiments 
 
 
We next performed a competition experiment using a 1:1 mixture of 31a and 32a in a 
reaction with octyl bromide (Scheme 3). The findings indicate that 32a reacted to give 32b as 
the major product. This result indicates that the presence of an electronic withdrawing group 
on aromatic amides facilitates the reaction. 
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Scheme 3. Competition experiment 
 
 
To confirm the alkyl radical species, which were generated single electron transfer from 
nickel complex to alkyl halides were involved this reaction. The addition of radical 
scavengers were examined. The reaction in the presence of radical scavengers, such as 
TEMPO (2 equivalents) and GALVINOXYL (2equivalents), resulted in no reaction. The 
radical clock experiments were carried out to gain more information. The use of 
6-bromohex-1-ene gave the mixture of products, and the unrearranged alkylation product 33 
was the major product (Scheme 4). We next used cyclopropylmethyl bromide, since the 
cyclopropylmethyl radical is known to undergo ring-opening faster than the cyclization of the 
5-hexenyl radical.10 The reaction with cyclopropylmethyl bromide gave a mixture of the 
unrearranged product 35 and the rearranged product 36 in a total isolated yield of 81% in 
favor of the unrearranged product (Scheme 4). 
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Scheme 4. Radical clock experiments 
 
 
We next examined the effect of catalyst concentration on the ratio of products in the 
reaction of 1a with 6-bromohex-1-ene. If a radical chain mechanism were operative, then the 
33/34 ratio would increase at higher catalyst concentrations because the radical would have 
less time to rearrange before reacting with another nickel.11 In contrast, if a radical chain were 
not involved, the 33/34 ratio would be expected to be unchanged as a function of catalyst 
concentration. The ratio was found to be constant, irrespective of the catalyst concentration 
used (Scheme 5), suggesting that the radical chain mechanism is not operative. These results 
shown in Scheme 4 and 5 suggest that free radical species are not involved in the reaction. 
The possibility that the key intermediate has a radical character, but that a radical species is 
not free, but instead remains in the coordination sphere in a nickel center and rearrangement 
from alkyl nickel complex cannot be excluded. 
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Scheme 5. Dependence of the ratio of 33 and 34 on the concentration of nickel 
 
 
Scheme 6. Proposed reaction mechanism 
 
 
The alkylation of C-H bonds proceeds through a mechanism as shown in Scheme 6. Amide 
A coordinates to NiX2 followed by a ligand exchange, which is accelerated by sodium 
carbonate, to give the nickel complex B. Complex B then undergoes a reversible 
cyclometalation to give complex C via a concerted metalation deprotonation (CMD) 
mechanism, which is also accelerated by sodium carbonate. The oxidative addition of an alkyl 
halide to the complex C gives the nickel(IV) species D.12 Complex D undergoes a reductive 
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elimination to give E, which is then protonated to afford the alkylation product with the 
regeneration of the nickel(II) catalyst.  
 
1.3  Conclusion 
In summary, we have reported the development of a new catalytic system that takes 
advantage of chelation assistance by an 8-aminoquinoline moiety. This represents the first 
example of Ni(II)-catalyzed direct ortho-alkylation of benzamides and acrylamide derivatives 
with unactivated alkyl halides. Various groups, such as alkyl, allyl, benzyl, and methyl groups 
can be introduced at the ortho position. A variety of functional groups are tolerated in the 
reaction. The proposed mechanism involves a Ni(II)/Ni(IV) catalytic cycle, which is rare in 
nickel-catalyzed cross coupling reaction.13 The key intermediate appears to have a radical 
character, but the reaction probably does not proceed via a radical chain mechanism. 
 After this paper appeared, another groups have reported the Ni(II)-catalyzed direct 
alkylation with alkyl halides, such as the direct alkylation of C(sp3)-H bonds,14a alkylation 
with secondary alkyl halides,9 allyl halides14c and phosphates14b as alkylating reagents by 
utilizing the nickel(II)-catalyst and 8-aminoquinoline system.  
 
1.4  Experimental Section 
General Information. 
1H NMR and 13C NMR spectra were recorded on a JEOL ECS-400 spectrometer in CDCl3 
with tetramethylsilane as the internal standard. The data is reported as follows: chemical shift 
() in ppm, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad peak, and 
m = multiplet), coupling constant (Hz), and integration. Infrared spectra (IR) were obtained 
using a Horiba FT-700 spectrometer. Absorption is reported in reciprocal centimeters (cm-1) 
with the following relative intensities: s (strong), m (medium), or w (weak). Mass spectra 
were obtained on a Shimadzu GCMS-QP 2010 instrument. High resolution mass spectra 
(HRMS) were obtained using a JEOL JMS-DX303 spectrometer. Melting points were 
determined using a Yamato melting point apparatus. Column chromatography was performed 
with SiO2 (Silicycle SilicaFlash F60 (230-400 mesh)). Some compounds were purified by 
LC-908 HPLC (GPC). 
 
Materials. 
Na2CO3 (CAS 497-19-8) was purchased from Nacalai Tesque, Inc. Iodobenzene (CAS 
591-50-4), 1-bromobutane (CAS 109-65-9) and 8-Aminoquinoline (CAS 578-66-5), were 
purchased from Tokyo Kasei Kogyo Co., Ltd. PPh3 (CAS 603-35-01) and  toluene super 
dehydrated (CAS 68-12-2) was purchased from Wako Pure Chemicals. 
 
Synthesis of Nickel(II) Trifluoromethanesulfonate . 
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To a clear green solution of Ni(OAc)2 (0.519 g, 2.95 mmol) in MeCN (40 mL) 
trifluoromethanesulfonic acid (1.33 g, 8.84 mmol) was added dropwise; the color changed the 
blue. The mixture was evaporated under reduced pressure until 10 mL, diethyl ether (80 mL) 
was added, this resulted in precipitation of blue powder. The suspension was decanted, and 
the residual powder washed diethyl ether and hexane, and dried in vacuum at 70 °C; the color 
changed light green powder. Ni(OTf)2 was obtained in 72% (0.754 g). HRMS Calcd for 
C2F6O6S2Ni: 355.8394; Found: 355.8401. 
Synthesis of the Starting Amides. 
All amides containing an 8-aminoquinoline were prepared by the reaction of the 
corresponding acid chlorides and 8-aminoquinoline. All starting amides were synthesize 
following general procedure. All spectrum data of starting amides are cited in original 
paper.15 
  
General Procedure for the Preparation of Starting Amide. 
 
To an oven-dried 100 mL three-necked flask, 3-bromobenzoic acid (2.3 g, 15 mmol), DMF (5 
drops) and DCM (30 mL) were added under a N2 atmosphere. Oxalyl chloride (1.5 mL, 18 
mmol, 1.2 equiv.) was added dropwise at 0 °C resulting in vigorous bubbling. The mixture 
was stirred for 3 h at room temperature, and the solvent was then removed in vacuo. The 
resulting acid chloride was used immediately without further purification.  
To another oven-dried 100 mL three-necked flask, 8-aminoquinoline (2.9 g, 20 mmol, 1.3 
equiv.), Et3N (4.1 mL, 30 mmol, 2 equiv.) and DCM (30 mL) were added. A solution of the 
acid chloride in DCM (10 mL) was added dropwise to the solution at 0 °C, and the solution 
was then warmed to room temperature. After stirring overnight, the reaction system was 
quenched with sat. aq. NaHCO3 (30 mL) and the organic layer was separated. The aqueous 
layer was extracted with DCM (2 x 15 mL). The combined organic layers were washed with 1 
M HCl aq. (30 mL) and brine (30 mL), dried over MgSO4, filtered and evaporated in vacuo. 
The resulting crude amide was purified by column chromatography on silica gel (eluant: 
hexane/EtOAc = 5/1) to afford the desired amide. 
 
General Procedure for Direct Arylation: Ni-Catalyzed Reaction of Amide 1a with PhI.  
To an oven-dried 5 mL screw-capped vial, in a glove box 
2-methyl-N-(8-quinolinyl)benzamide 1a (79 mg, 0.3 mmol), iodobenzene (122 mg, 0.6 
mmol), Ni(OTf)2 (5 mg, 0.015 mmol), NaHCO3 (50 mg, 0.6 mmol) and toluene (1 mL) were 
added. The mixture was stirred for 20 h at 160 °C followed by cooling. The mixture was 
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filtered through a celite pad and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (eluent: hexane/EtOAc= 10/1) to afford the desired arylated 
product 2a (97 mg, 94%) as a colorless oil. 
 
General Procedure for Direct Alkylation: Ni-Catalyzed Alkylation of Amides 1a with 
BuBr 
To an oven-dried 5 mL screw-capped vial, in a glove box 
2-methyl-N-(8-quinolinyl)benzamide 1a (79 mg, 0.3 mmol), 1-bromobutane (82 mg, 0.6 
mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol), PPh3 (15.6 mg, 0.06 mmol), Na2CO3 (64 mg, 0.6 
mmol) and toluene (1 mL) were added. The mixture was stirred for 24 h at 140 °C followed 
by cooling. The resulting mixture was filtered through a celite pad and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (eluent: hexane/EtOAc= 
20/1) to afford the desired alkylated product 3a (84 mg, 88%) as a colorless oil. 
 
3-Methyl-N-(quinolin-8-yl)-[1,1'-biphenyl]-2-carboxamide (2a) [CAS 1436849-34-1]. 
 
Rf 0.23 (hexane/EtOAc = 5/1). Colorless oil. 
1H NMR (CDCl3, 400 MHz) 2.53 (s, 3H), 7.08 (t, 
J = 8.0 Hz, 1H), 7.19-7.24 (m, 2H), 7.28-7.33 (m, 3H), 7.38-7.54 (m, 5H), 8.04 (d, J = 8.4 Hz, 
1H), 8.59 (d, J = 4.0 Hz, 1H), 8.77 (d, J = 7.6 Hz, 1H), 9.64 (brs, 1H); 13C NMR (CDCl3, 400 
MHz) 19.94, 116.54, 121.57, 121.79, 127.34, 127.37, 127.74, 127.86, 128.29, 128.75, 129.32, 
129.61, 134.48, 135.94, 136.18, 136.96, 138.45, 139.77, 140.48, 148.08, 168.41; 
 
2-Butyl-6-methyl-N-(quinolin-8-yl)benzamide (3a). 
 
Rf 0.43 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.80 ( t, J = 
7.6 Hz, 3H), 1.25-1.34 (m, 2H), 1.64-1.70 (m, 2H), 2.43 (s, 3H), 2.71 (t, J = 8.0 Hz, 2H), 7.13 
(dd, J =12, 4.0 Hz, 2H), 7.28 (t, J = 7.6 Hz, 1H), 7.45 (dd, J = 8.0, 4.0 Hz, 1H), 7.56-7.64 (m, 
2H), 8.19 (dd, J = 8.0, 1.6 Hz, 1H), 8.74 (dd, J = 4.0, 1.6 Hz, 1H), 8.99 (dd, J = 7.2, 1.6 Hz, 
1H), 9.94 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.92, 20.94, 22.62, 32.66, 33.98, 
116.65, 121.67, 121.69, 127.48, 128.00, 130.26, 134.78, 135.52, 136.42, 138.16, 138.51, 
148.15, 168.69; IR (neat) 3347 w, 2954 w, 2864 w, 1675 m, 1518 s, 1481 s, 1423 m, 1384 m, 
1325 m, 1262 m, 1126 w, 897 w, 826 m; MS m/z (relative intensity, %) 318 (M+, 35), 176 
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(12), 175 (100), 174 (32), 146 (11), 145 (38 ), 144 (12), 105 (26); HRMS Calcd for 
C23H18N2O: 318.1732; Found: 318.1733. 
 
2-Butyl-5-methoxy-N-(quinolin-8-yl)benzamide (3b). 
 
Rf 0.31 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.85 (t, J = 
7.2 Hz, 3H), 1.28-1.38 (m, 2H), 1.61-1.69 (m, 2H), 2.84 (t, J = 8.0 Hz, 2H), 3.84 (s, 3H), 6.97 
(dd, J = 8.0, 2.8 Hz, 1H), 7.17 (d, J = 2.8 Hz, 1H), 7.24 (d, J = 8.0 Hz, 1H), 7.45 (dd, J = 8.0, 
4.0 Hz, 1H), 7.54-7.62 (m, 2H), 8.17 (dd, J = 8.0, 1.6 Hz, 1H), 8.77 (dd, J = 4.0, 1.2 Hz, 1H), 
8.94 (d, J = 7.2 Hz, 1H), 10.15 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.90, 22.55, 
32.24, 34.07, 55.45, 112.51, 115.98, 116.64, 121.64, 121.74, 127.40, 127.96, 131.41, 133.08, 
134.67, 136.32, 137.45, 138.52, 148.20, 157.51, 168.21; IR (neat) 3349 w, 2954 w, 2858 w, 
1675 m, 1607 w, 1575 w, 1520 s, 1481 s, 1423 m, 1384 m, 1325 m, 1285 m, 1107 m, 1040 m, 
825 m; MS m/z (relative intensity, %) 335 (11), 334 (M+, 45), 191 (25), 190 (37), 162 (17), 
161 (100), 149 (22), 144 (19), 121 (27); HRMS Calcd for C21H22N2O2: 334.1681; Found: 
334.1682. 
 
5-(Benzyloxy)-2-butyl-N-(quinolin-8-yl)benzamide (3c). 
 
Rf 0.23 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.85 (t, J = 
7.2 Hz, 3H), 1.28-1.38 (m, 2H), 1.61-1.69 (m, 2H), 2.84 (t, J = 7.6 Hz, 2H), 5.09 (s, 2H), 7.04 
(dd, J = 8.8 , 2.8 Hz, 1H), 7.23-7.27 (m, 2H), 7.30-7.53 (m, 6H), 8.16 (dd, J = 8.0, 1.6 Hz, 
8.76 (dd, J = 4.0, 1.6 Hz, 1H), 8.94 (d, J = 7.2 Hz, 1H), 10.15 (brs, 1H); 13C NMR (CDCl3, 
100.53 MHz)13.91, 22.56, 32.25, 34.04, 70.20, 113.51, 116.53, 116.77, 121.63, 121.77, 
127.37, 127.54, 127.93, 128.02, 128.59, 131.46, 133.47, 136.29, 136.70, 137.45, 138.52, 
148.21, 156.72, 168.10; IR (neat) 3348 w, 2954 w, 2860w, 1674 m, 1604 w, 1574 w, 1520 s, 
1481 s, 1423 m, 1383 m, 1352 m, 1325 m, 1285 m, 1024 w, 825 m; MS m/z (relative 
intensity, %) 410 (M+, 20), 319 (17), 267 (10), 266 (14), 237 (19), 144 (10), 91 (100); HRMS 
Calcd for C27H26N2O2: 410.1994; Found: 410.1994. 
 
2-Butyl-5-((tert-butyldimethylsilyl)oxy)-N-(quinolin-8-yl)benzamide (3d). 
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Rf 0.54 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.25 (s, 6H), 
0.86 (t, J = 7.2 Hz, 3H), 1.01 (s, 9H), 1.29-1.38 (m, 2H), 1.61-1.69 (m, 2H), 2.84 (t, J = 8.0 Hz, 
2H), 6.90 (dd, J = 8.0, 2.8 Hz, 1H), 7.13 (d, J = 2.8 Hz, 1H), 7.18 (d, J = 8.0 Hz, 1H), 7.44 (dd, 
J = 8.0, 4.0 Hz, 1H), 7.53-7.61 (m, 2 H), 8.16 (dd, J = 8.0, 1.6 Hz, 1H), 8.77 (dd, J = 4.0, 1.6 
Hz, 1H), 8.93 (d, J = 6.4 Hz, 1H), 10.17 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)-4.44, 
13.93, 18.17, 22.59, 25.66, 32.28, 34.03, 116.44, 118.70, 121.63, 121.68, 121.95, 127.94, 
131.44, 134.02, 134.72, 136.28, 137.32, 138.55, 148.18, 153.49, 168.06; IR (neat) 3350 w, 
2954w, 2858 w, 1678 m, 1603 w, 1522 s, 1482 s, 1424 m, 1385 m, 1326 m, 1290 m, 1257 m, 
973 m, 889 m, 837 s; MS m/z (relative intensity, %) 435 (21), 434 (M+, 63), 292 (13), 291 
(52), 262 (26), 261 (100), 249 (11), 234 (11), 233 (32), 215 (42), 205 (17), 174 (20), 171 (10), 
165 (19), 163 (20), 144 (22), 73 (66); HRMS Calcd for C23H18N2O: 434.2390; Found: 
434.2388. 
 
2-Butyl-5-methyl-N-(quinolin-8-yl)benzamide (3e). 
 
Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.85 (t, J = 
7.6 Hz, 3H), 1.29-1.38 (m, 2H), 1.62-1.70 (m, 2H), 2.39 (s, 3H), 2.87 (t, J = 7.6 Hz, 2H), 
7.20-7.25 (m, 2H), 7.44-7.47 (m, 2H), 7.54-7.62 (m, 2H), 8.18 (dd, J = 7.6, 1.6 Hz, 1H), 8.78 
(dd, J = 4.0, 1.6 Hz, 1H), 8.95 (d, J = 7.6 Hz, 1H), 10.13 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)13.92, 20.94, 22.62, 32.67, 33.98, 116.65, 121.61, 121.69, 127.48, 127.83, 128.00, 
130.26, 130.88, 134.78, 135.52, 136.42, 136.58, 138.16, 138.51, 148.15, 168.69; IR (neat) 
3351 w, 2955 w, 2860 w, 1673 m, 1596 w, 1518 s, 1481 s, 1423 m, 1383 m, 1325 m, 1262 w, 
824 m; MS m/z (relative intensity, %) 319 (13), 318 (M+, 54), 175 (45), 174 (22), 146 (17), 
145 (100), 144 (26), 133 (13), 105 (33); HRMS Calcd for C21H22N2O: 318.1732; Found: 
318.1734. 
 
4-Butyl-N-(quinolin-8-yl)-[1,1'-biphenyl]-3-carboxamide (3f). 
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Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.88 (t, J = 
7.2 Hz, 3H), 1.34-1.43 (m, 2H), 1.69-1.76 (m, 2H), 2.94 (t, J = 7.6 Hz 2H), 7.34-7.47 (m, 4H), 
7.55-7.68 (m, 5H), 7.85 (d, J = 2.0 Hz, 1H), 8.17 (dd, J = 8.0, 1.6 Hz, 1H), 8.75 (dd, J = 4.0, 
1.6 Hz, 1H), 8.98 (d, J = 7.2 Hz, 1H), 10.21 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)13.93, 22.66, 32.76, 33.87, 116.58, 121.17, 121.81, 125.86, 127.00, 127.40, 127.95, 
128.70, 128.84, 130.08, 134.69, 136.31, 137.19, 138.53, 138.89, 140.21, 140.29, 148.25, 
168.41; IR (neat) 3348 w, 2955 w, 2860 w, 1674 m, 1519 s, 1481 s, 1423 m, 1384 m, 1326 m, 
1244 w, 825 m; MS m/z (relative intensity, %) 381 (16), 380 (M+, 54), 237 (40), 236 (32), 208 
(24), 207 (100), 165 (12), 178 (12), 167 (33), 166 (11), 165 (21), 152 (10), 144 (18); HRMS 
Calcd for C26H24N2O: 380.1889; Found: 380.1890. 
 
2-Butyl-5-chloro-N-(quinolin-8-yl)benzamide (3g). 
 
Rf 0.37 (hexane/EtOAc = 5/1). White Solid. Mp = 79-80 °C. 1H NMR (CDCl3, 399.78 MHz) 
 0.86 (t, J = 7.6 Hz, 3H), 1.29-1.38 (m, 2H), 1.61-1.69 (m, 2H), 2.86 (t, J = 7.6 H, 1H), 7.27 
(d, J = 8.0 Hz, 1H), 7.38 (dd, J = 8.0, 2.4 Hz, 1H), 7.47 (dd, J = 8.0, 4.4 Hz, 1H), 7.56-7.63 (m, 
2H), 8.19 (dd, J = 8.0, 1.6 Hz, 1H), 8.79 (dd, J = 4.4, 1.6 Hz, 1H),8.91 (dd, J = 7.6, 1.6 Hz, 
1H), 10.13 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.87, 22.54, 32.51, 33.74, 116.72, 
121.74, 122.07, 127.19, 127.37, 127.95, 130.14, 131.54, 131.75, 134.38, 136.42, 138.04, 
138.43, 139.77, 148.31, 166.92; IR (neat) 3343 w, 2956 w, 2867 w, 1677 m, 1521 s, 1482 s, 
1424 m, 1385 m, 1326 m, 1259 w, 1120 w, 824 m; MS m/z (relative intensity, %) 338 (17), 
339 (12), 338 (M+, 49), 311 (11), 309 (32), 195 (13), 167 (32), 166 (12), 165 (100), 153 (13), 
144 (66), 142 (11), 130 (11), 125 (28), 116 (11), 89 (12); HRMS Calcd for C20H19ClN2O: 
338.1186; Found: 338.1186. 
 
2-Butyl-5-iodo-N-(quinolin-8-yl)benzamide (3h). 
 
Rf 0.37 (hexane/EtOAc = 5/1). White Solid. Mp = 101 °C. 1H NMR (CDCl3, 399.78 MHz)  
0.85 (t, J = 7.6 Hz, 3H), 1.28-1.38 (m, 2H), 1.61-1.68 (m, 2H), 2.83 (t, J = 7.6 Hz, 2H), 7.08 
(d, J = 8.0 Hz, 1H), 7.47 (dd, J = 8.0, 4.0 Hz, 1H), 7.56-7.62 (m, 2H), 7.72 (dd, J = 8.0, 1.6 Hz, 
1H), 7.93 (d, J = 1.2 Hz, 1H), 8.19 (dd, J = 8.0, 1.6 Hz, 1H), 8.79 (dd, J = 4.0, 1.6 Hz, 1H), 
8.90 (dd, J = 7.6, 1.6 Hz, 1H), 10.10 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.86, 
22.53, 32.66, 33.62, 90.43, 116.71, 121.73, 122.06, 127.35, 127.93, 132.21, 134.35, 135.75, 
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136.39, 138.40, 138.76, 138.99, 140.82, 148.30, 166.62; IR (neat) 3342 w, 2955 w, 2865 w, 
1675 m, 1521 s, 1483 s, 1423 m, 1384 m, 1326 m, 1259 m, 905 w, 825 m; MS m/z (relative 
intensity, %) 431 (17), 430 (M+, 78), 401 (29), 287 (17), 286 (13), 258 (12), 257 (100), 245 
(10), 217 (13), 194 (11), 145 (11), 144 (63), 142 (15), 130 (15), 117 (14), 116 (22), 115 (10), 
102 (10), 90 (18), 89 (14); HRMS Calcd for C20H19IN2O: 430.0542; Found: 430.0539. 
 
5-Acetyl-2-butyl-N-(quinolin-8-yl)benzamide (3i). 
 
Rf 0.11 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 88-90 °C. 1H NMR (CDCl3, 399.78 MHz) 
 0.87 (t, J = 7.6 Hz, 3H), 1.32-1.41 (m, 2H), 1.66-1.74 (m, 2H), 2.64 (s, 3H), 2.96 (t, J = 7.6 
Hz, 2H), 7.43-7.48 (m, 2H), 7.57-7.64 (m, 2H), 8.01 (dd, J = 8.0, 1.6 Hz, 1H), 8.19 (dd, J = 
8.0, 1.6 Hz, 1H), 8.23 (d, J = 2.0 Hz, 1H), 8.78 (dd, J = 4.0, 1.6 Hz, 1H), 8.93 (dd, J = 7.6, 1.6 
Hz, 1H), 10.19 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.83, 22.60, 26.60, 33.22, 33.52, 
116.69, 121.73, 122.08, 127.33, 127.94, 129.76, 130.66, 134.39, 134.92, 136.37, 137.01, 
138.44, 146.91, 148.31, 167.46, 197.10; IR (neat) 3346 w, 2956 w, 2867 w, 1677 s, 1600 w, 
1521 s, 1482 m, 1424 m, 1385 w, 1326 m, 1226 m, 826 m; MS m/z (relative intensity, %) 347 
(15), 346 (M+, 62), 317 (23), 203 (21), 174 (15), 173 (100), 145 (10), 144 (42); HRMS Calcd 
for C22H22N2O2: 346.1681; Found: 346.1684. 
 
2-Butyl-N-(quinolin-8-yl)-5-(trifluoromethyl)benzamide (3j). 
 
Rf 0.40 (hexane/EtOAc = 5/1). White Solid. Mp = 94-95 °C. 1H NMR (CDCl3, 399.78 MHz) 
0.87 (t, J = 7.2 Hz, 3H), 1.29-1.40 (m, 2H), 1.68-1.74 (m, 2H), 2.95 (t, J = 7.6 Hz, 2H), 
7.45-7.549 (m, 2H), 7.58-7.88 (m, 3H), 7.88 (s, 1H), 8.20 (dd, J = 8.0, 2.0 Hz, 1H), 8.79 (dd, J 
= 4.0, 1.6 Hz, 1H), 8.92 (dd, J = 7.2, 1.6 Hz, 1H), 10.17 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)13.82, 22.59, 29.69, 33.01, 33.59, 116.86, 121.77, 122.21, 124.7 (d, J = 3.9 Hz), 
123.89 (q, J = 271 Hz), 126.74 (d, J = 2.8 Hz), 127.38, 127.99, 128.68 (q, 33.4 Hz), 130.83, 
134.31, 145.35, 148.37, 166.98; IR (neat) 3343 w, 2958 w, 2870 w, 1678 m, 1523 s, 1484 m, 
1424 w, 1386 w, 1327 s, 1215 w, 1169 m, 1123 s, 1079 m, 826 m; MS m/z (relative 
intensity, %) 373 (14), 372 (M+, 64), 344 (11), 343 (54), 200 (16), 199 (94), 171 (12), 159 
(22), 145 (14), 144 (100); HRMS Calcd for C21H19F3N2O: 372.1449; Found: 372.1452. 
 
2,6-Dibutyl-4-methoxy-N-(quinolin-8-yl)benzamide (4). 
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Rf 0.34 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.81 (t, J = 
7.6 Hz, 6H), 1.24-1.33 (m, 4H), 1.62-1.70 (m, 4H), 2.69 (t, J = 8.0 Hz, 4H), 3.88 (s, 3H), 6.68 
(s, 2H), 7.43 (dd, J = 8.0, 4.0 Hz, 1H), 7.54-7.62 (m, 2H), 8.17 (dd, J = 8.0, 1.6 Hz, 1H), 8.72 
(dd, J = 4.0, 1.6 Hz, 1H), 8.97 (dd, J = 8.0, 1.2 Hz, 1h), 9.90 (brs, 1H); 13C NMR (CDCl3, 
100.53 MHz)13.82, 22.62, 33.39, 33.69, 55.17, 111.98, 116.57, 121.58, 121.70, 127.95, 
130.59, 134.50, 136.24, 138.45, 141.37, 148.13, 159.73, 168.92; IR (neat) 3352 w, 2954 w, 
1673 m, 1600 m, 1517 s, 1480 s, 1423 m, 1383 m, 1323 s, 1155 s, 826 m; MS m/z (relative 
intensity, %) 390 (M+, 7), 249 (17), 248 (100); HRMS Calcd for C25H30N2O2: 390.2304; 
Found: 390.2307. 
 
4-Butyl-2-methyl-3-(quinolin-8-ylcarbamoyl)phenyl acetate (5). 
 
Rf 0.20 (hexane/EtOAc = 5/1). White Solid. Mp = 122-123 °C.. 1H NMR (CDCl3, 399.78 
MHz)  0.79 (t, J = 7.6 Hz, 3H), 1.24-1.33 (m, 2H), 1.61-1.69 (m, 2H), 2.24 (s, 3H), 2.34 (s, 
3H), 2.69 (t, J = 8.0 Hz, 2H), 7.05 (d, J = 8.0 Hz, 1H), 7.17 (d, J = 7.2 Hz, 1H), 7.44 (dd, J = 
8.0, 4.0 Hz, 1H), 7.56-7.63 (m, 2H), 8.17 (dd, J = 8.0, 1.6 Hz, 1H), 8.75 (dd, J = 4.0, 1.6 Hz, 
1H), 8.97 (dd, J = 8.0, 1.6 Hz, 1H), 9.96 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.22, 
13.79, 20.82, 22.55, 32.83, 33.65, 116.77, 121.70122.06, 122.63, 126.75, 127.30, 127.93, 
134.22, 136.24, 137.25, 138.45, 139.06, 147.27, 148.31, 167.76, 169.44; IR (neat) 3346 w, 
2956 w, 2867 w, 1763 w, 1675 m, 1598 w, 1519 s, 1482 s, 1424 m, 1384 m, 1325 m, 1262 w, 
1204 w, 1138 w, 826 w; MS m/z (relative intensity, %) 377 (15), 376 (M+, 60), 235 (15), 233 
(100), 232 (52), 203 (43), 191 (54), 190 (29), 162 (10), 161 (36), 149 (14), 145 (10), 144 (29), 
121 (25), 91 (11);. HRMS Calcd for C23H24N2O3: 376.1787; Found: 376.1786. 
 
2-Butyl-4,5-dimethoxy-N-(quinolin-8-yl)benzamide (6). 
 
Rf 0.11 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.88 (t, J = 
7.6 Hz, 3H), 1.32-1.40 (m, 2H), 1.67-1.74 (m, 2H), 2.89 (t, J = 8.0 Hz, 2H), 3.92 (s, 3H), 3.95 
(s, 3H), 6.800 (s, 1H), 7.19 (s, 1H), 7.45 (dd, J = 8.0, 4.0 Hz, 1H), 7.53-7.62 (m, 2H), 8.17 (dd, 
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J = 8.0, 1.6 Hz, 1H), 8.78 (dd, J = 4.0, 1.6 Hz, 1H), 8.93 (dd, J = 7.6, 1.2 Hz, 1H), 10.16 (brs, 
1H); 13C NMR (CDCl3, 100.53 MHz)13.26, 22.62, 32.95, 34.26, 55.90, 56.06, 110.85, 
112.91, 116.37, 121.56, 121.57, 127.38, 127.92, 128.46, 134.60, 134.76, 136.38, 138.52, 
146.77, 148.14, 150.29, 160.99; IR (neat) 3353 w, 2955 w, 1669 m, 1604 w, 1511 s, 1481 s, 
1462 s, 1423 m, 1382 m, 1325 m, 1261 s, 1210 s, 1153 s, 824 m; MS m/z (relative 
intensity, %) 364 (M+, 27), 222(14), 221 (100), 220 (25), 192 (12), 191 (65), 179 (15), 151 
(13); HRMS Calcd for C22H24N2O3: 364.1787; Found: 364.1789. 
 
2-Butyl-4-fluoro-6-methyl-N-(quinolin-8-yl)benzamide (7). 
 
Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.80 (t, J = 
7.6 Hz, 3H), 1.24-1.33 (m, 2H), 1.61-1.69 (m, 2H), 2.42 (s, 3H), 2.71 (t, J = 7.6 Hz, 2H), 6.83 
(t, J = 10.8 Hz, 2H), 7.45 (dd, J = 8.4, 4.0 Hz, 1H), 7.56-7.63 (m, 2H), 8.18 (dd, J = 8.4, 2.0 
Hz, 1H), 8.74 (dd, J = 4.8, 2.0 Hz, 1H), 8.97 (dd, J = 8.0, 2.0 Hz, 1H), 9.91 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz)13.78, 19.59, 22.46, 33.07, 33.39, 113.24 (d, J = 21 Hz), 
114.44 (d, J = 21.0 Hz), 116.73 , 121.68, 122.02, 127.35, 127.96, 133.91 (d, J = 2.8 Hz), 
134.23, 136.32, 13137.33 (d, J = 8.6 Hz), 138.42, 142.142.33 (d, J = 7.6 Hz), 148.28, 162.64 
(d, J = 246 Hz), 168.11; IR (neat) 3343 w, 2955 w, 2866 w, 1761 m, 1676 m, 1519 s, 1481 s, 
1424 m, 1384 m, 1325 m, 1200 s, 898 m, 827 m; MS m/z (relative intensity, %) 337 (10), 336 
(M+, 40), 194 (13), 193 (100), 192 (26), 164 (11), 163 (11), 144 (14), 137 (13), 123 (17); 
HRMS Calcd for C21H21FN2O: 336.1638; Found: 336.1636. 
 
2-Butyl-N-(quinolin-8-yl)-1-naphthamide (8). 
 
Rf 0.34 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.82 (t, J = 
7.6 Hz, 3H), 1.31-1.37 (m, 2H), 1.74-1.78 (m, 2H), 2.89 (t, J = 8.0 Hz, 2H), 7.38-7.49 (m, 4H), 
7.58 (dd, J = 8.0, 1.6 Hz, 1H), 7.65 (t, J = 8.0 Hz, 1H), 7.83-7.88 (m, 2H), 7.98-8.00 (m, 1H), 
8.16 (dd, J = 8.0, 2.0 Hz, 1H), 8.65 (dd, J = 4.0, 2.0 Hz, 1H9, 9.13 (d, J = 7.6 Hz, 1H), 10.13 
(brs, 1H); 13C NMR (CDCl3, 100.53 MHz)13.87, 22.68, 33.60, 33.81, 116.81, 121.65, 
122.02, 124.90, 125.56, 126.93, 127.41, 127.51, 127.92, 127.98, 129.21, 130.27, 131.81, 
133.91, 134.49, 136.26, 137.19, 138.44, 148.20, 168.41; IR (neat) 3343 w, 2954 m, 2862 m, 
1672 s, 1596 w, 1517 s, 1481 s, 1423 m, 1383 m, 1325 m, 1257 w, 1212 w, 892 w, 823 m; 
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MS m/z (relative intensity, %) 354 (M+, 34), 212 (17), 211 (100), 210 (35), 182 (13), 181 (42), 
141 (42); HRMS Calcd for C24H22N2O: 354.1732; Found: 354.1732. 
 
2-butyl-9-methyl-N-(quinolin-8-yl)-9H-carbazole-3-carboxamide (9). 
 
Rf 0.29 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 69 °C. 
1H NMR (CDCl3, 399.78 MHz) 
0.91 (t, J = 7.2 Hz, 3H), 1.38-1.47 (m, 2H), 1.75-1.83 (m, 2H), 3.16 (t, J = 8.0 Hz, 2H), 3.87 (s, 
3H), 7.33-7.30 (m, 2H), 7.40-7.56 (m, 4H), 7.63 (t, J = 7.6 Hz, 1H), 8.19 (d, J = 7.6 Hz, 1H), 
8.18 (dd, J = 8.0, 2.0 Hz, 1H), 8.42 (s, 1H), 8.78 (dd, J = 4.0, 2.0 Hz, 1H), 9.01 (d, J = 7.6 Hz, 
1H), 10.33 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 14.03, 22.79, 29.17, 34.12, 34.48, 
108.63, 109.69, 116.43, 119.33, 120.06, 120.23, 120.34, 121.42, 121.57, 122.71, 125.81, 
127.51, 127.98 (two overlapping peaks), 135.12, 136.39, 138.54, 140.12, 141.48, 142.05, 
148.11, 169.25.; IR (neat) 3356 w, 2954 w, 1667 m, 1600 m, 1517 s, 1478 s, 1382 m, 1324 s, 
1252 s, 746 s; MS m/z (relative intensity, %) 407 (M+, 15), 265 (20), 264 (100), 263 (24), 194 
(17); HRMS Calcd for C27H25N2O: 407.1998; Found: 407.1995. 
 
2-Butyl-5-methyl-N-(quinolin-8-yl)thiophene-3-carboxamide (10). 
 
Rf 0.51 (hexane/EtOAc = 5/1). White Solid. Mp = 54-55 °C. 1H NMR (CDCl3, 399.78 MHz) 
 0.95(t, J = 7.2 Hz, 3H), 1.41-1.50 (m, 2H), 1.72-1.79 (m, 2H), 2.50 (s, 3H), 3.23 (t, J = 7.2 
Hz, 2H), 7.12 (s, 1H), 7.46-7.60 (m, 3H), 8.19 (dd, J = 8.4, 2.0 Hz, 1H), 8.84 (dd, J = 4.0, 2.0 
Hz, 1H), 8.88 (dd, J = 7.6, 1.6 Hz, 1H), 1.031 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)113.90, 15.17, 22.49, 28.97, 34.02, 116.29, 121.28, 121.57, 124.48, 127.44, 127.95, 
131.75, 134.80, 136.16, 136.32, 138.57, 148.11, 149.84, 162.67; IR (neat) 3360 w, 2955 w, 
2859 w, 1666 m, 1522 s, 1484 s, 1424 m, 1383 m, 1327 m, 1245 w, 1165 w, 824 m; MS m/z 
(relative intensity, %) 325 (21), 324 (M+, 91), 182 (16), 181 (98), 180 (92), 152 (11), 151 
(100), 144 (16), 141 (10), 139 (54), 111 (15), 110 (14); HRMS Calcd for C19H20N2OS: 
324.1296; Found: 324.1297. 
 
2-Butyl-N-(quinolin-8-yl)cyclohex-1-enecarboxamide (11). 
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Rf 0.37 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.82 (t, J = 
6.8 Hz, 3H), 1.21-1.30 (m, 2H), 1.50-1.58 (m,2H), 1.67-1.75 (m, 4 H), 2.13-2.14 (m, 2H), 
2.26 (t, J = 8.0, 2H), 2.43 (m, 2H), 7..45 (dd, J = 8.4, 4.0 Hz, 1H), 7.49-7.57 (m, 2H), 8.16 (dd, 
J = 8.0, 2.0 Hz, 1H), 8.80 (dd, J = 4.0, 2.0, 1H), 8.87 (d, J = 7.6 Hz, 1H), 9.83 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz)13.98, 22.41, 22.80, 27.13, 28.95, 30.72, 34.88, 116.42, 121.31, 
121.52, 127.44, 127.94, 129.92, 134.70, 136.29, 138.49, 139.81, 148.02, 170.46; IR (neat) 
3326 w, 2930 m, 2870 w, 1738 w, 1666 m, 1597 m, 1520 s, 1483 s, 1423 m, 1382 m, 1325 m, 
1261 m, 1114 m, 1087 w, 825 w; MS m/z (relative intensity, %) 308 (M+, 33), 165 (55), 164 
(24), 145 (13), 144 (100), 135 (32), 95 (24), 81 (18); HRMS Calcd for C20H24N2O: 308.1889; 
Found: 308.1887. 
 
2-Btyl-N-(quinolin-8-yl)cyclopent-1-enecarboxamide (12). 
 
Rf 0.51 (hexane/EtOAc = 5/1). White Solid. Mp = 63-64 °C. 1H NMR (CDCl3, 399.78 MHz) 
 0.93 (t, J = 7.6 Hz, 3H), 1.36-1.45 (m, 2H), 1.51-1.59 (m, 2H), 1.96 (f, J = 7.6 Hz, 2H), 2.58 
(t, J = 7.2 Hz, 2H), 2.72 (t, J = 8.0 Hz, 2H), 2.91 (t, J = 7.2 Hz, 2H), 7.44-7.57 (m, 3 H), 8.16 
(dd, J = 8.0, 1.6 Hz, 1H), 8.80 (dd, J = 4.0, 1.6 Hz, 1H), 8.86 (dd, J = 18.0, 1.6 Hz, 1H), 10.02 
(brs, 1H); 13C NMR (CDCl3, 100.53 MHz)14.07, 21.67, 22.95, 29.81, 30.41, 34.09, 37.99, 
116.29, 121.09, 121.48, 127.46, 127.92, 129.98, 134.83, 136.28, 138.57, 148.03, 156.08, 
165.28; IR (neat) 3357 w, 2954 w, 2858 w, 1739 w, 1665 m, 1520 s, 1483 s, 1423 m, 1382 m, 
1325 m, 1259 w, 1202 w, 1123 w, 824 m; MS m/z (relative intensity, %) 294 (M+, 29), 151 
(48), 150 (13), 145 (12), 144 (100), 121 (14), 81 (12); HRMS Calcd for C19H22N2O: 
294.1732; Found: 294.1731.  
 
6-Butyl-N-(quinolin-8-yl)-3,4-dihydro-2H-pyran-5-carboxamide (13). 
 
Rf 0.49 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.90 (t, J = 
7.6 Hz, 3H), 1.32-1.41 (m, 2H), 1.63-1.71 (m, 2H), 1.97 (f, J = 6.4 Hz, 2H), 2.56 (t, J = 6.4 Hz, 
2H), 2.64 (t, J = 7.2 Hz, 2H), 4.08 (t, J = 5.2 Hz, 2H), 7.43-7.49 (m, 2H), 7.54 (t, J = 7.6 Hz, 
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1H), 8.15 (dd, J = 7.6, 1.2 Hz, 1H), 8.79 (dd, J = 4.0, 1.6 Hz, 1H), 8.83 (dd, J = 7.6, 1.2 Hz, 
1H), 9.99 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)14.01, 21.92, 22.30, 22.68, 30.03, 
32.71, 66.05, 105.14, 116.12, 120.85, 121.46, 127.51, 127.95, 135.08, 136.31, 138.63, 147.93, 
163.15, 168.03; IR (neat) 3359 w, 2927 m, 2858 w, 1669 m, 1517 s, 1481 s, 1422 m, 1383 m, 
1324 m, 1244 m, 1107 w, 899 w, 825 m; MS m/z (relative intensity, %) 310 (M+, 18), 168 
(11), 167 (100), 166 (14), 85 (12); HRMS Calcd for C19H22N2O2: 310.1681; Found: 310.1680. 
 
2-Methyl-6-octyl-N-(quinolin-8-yl)benzamide (14). 
 
Rf 0.37 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.79 (t, J = 
7.6 Hz, 3H), 1.09-1.18 (m, 8H), 1.22-1.29 (m, 2H), 1.63-1.71 (m, 2H), 2.43 (s, 3H), 2.71 (t, J 
= 7.6 Hz, 2H);7.10-7.15 (m, 2H), 7.27 (t, J = 7.6 Hz, 1H), 7.43 (dd, J = 7.6, 4.0 Hz, 1H), 
7.55-7.63 (m,2H), 8.17 (dd, J = 7.6, 2.0 Hz, 1H), 8.72 (dd, J = 4.0, 2.0 Hz, 1H), 9.00 (dd, J = 
7.6, 1.6 Hz, 1H), 9.93 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)14.04, 19.48, 22.52, 29.05, 
29.26, 29.51, 31.67, 31.75, 33.42, 116.71, 121.61, 121.86, 126.74, 127.39, 127.66, 127.97, 
128.93, 134.39, 134.47, 136.28, 137.72, 138.48, 139.51, 148.20, 168.89; IR (neat) 3348 w, 
2924 w, 2854 w, 1677 m, 1518 s, 1481 s, 1423 m, 1384 m, 1325 m, 1262 w, 1126 w, 897 w, 
825 m; MS m/z (relative intensity, %) 375 (12), 374 (M+, 42), 232 (16), 231 (100), 230 (34), 
146 (20), 145 (71), 144 (29), 143 (13), 131 (14), 29 (105); HRMS Calcd for C25H30N2O: 
374.2358; Found: 374.2361. 
 
2-Benzyl-6-methyl-N-(quinolin-8-yl)benzamide (15). 
 
Rf 0.23 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  2.45 (s, 3H), 
4.10 (s, 2H), 7.00 (t, J = 8.0 Hz, 1H), 7.05-7.11 (m, 3H), 7.13-7.17 (m, 3H), 7.26 (t, J = 7.6 Hz, 
1H), 7.40 (dd, J = 8.0, 4.0 Hz, 1H), 7.53-7.61 (m, 2H), 8.14 (dd, J = 8.0, 1.6 Hz, 1H), 8.65 (dd, 
J = 4.0, 1.6 Hz, 1H), 8.96 (dd, J= 8.0, 1.6 Hz, 1H), 9.82 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)19.51, 39.10, 116.67, 121.55, 121.90, 125.88, 127.30, 127.56, 127.86, 128.25 (two 
overlapping peaks), 129.01, 129.09, 134.24, 134.66, 136.18, 137.83, 137.92, 138.39, 140.32, 
148.10,168.60; IR (neat) 2924 w, 1674 s, 1518 s, 1481 s, 1423 m, 1384 m, 1325 m, 1262 w, 
1125 w, 897 w, 825 m; MS m/z (relative intensity, %) 352 (M+, 33), 209 (69), 208 (100), 194 
(31), 166 (11), 165 (29); HRMS Calcd for C24H20N2O: 352.1576; Found: 352.1574. 
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2-(4-Cyanobutyl)-6-methyl-N-(quinolin-8-yl)benzamide (16). 
 
Rf 0.09 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  1.61-1.68 (m, 
2H), 1.80-1.88 (m, 2H), 2.25 (t, J = 7.6 Hz, 2H), 2.44 (s, 3H), 2.76 (t, J = 7.6 Hz, 2H), 
7.13-7.16 (m, 2H), 7.29 (t, J = 8.0 Hz, 1H), 7.46 (dd, J = 8.0, 4.0 Hz, 1H), 7.57-7.64 (m, 2H), 
8.19 (dd, J = 8.0, 1.2 Hz, 1H), 8.75 (dd, J = 4.4, 1.6 Hz, 1H), 8.97 (dd, J = 7.6, 1.6 Hz, 1H), 
9.93 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)16.88, 19.48, 24.93, 30.33, 32.36, 116.73, 
119.60, 121.74, 122.10, 126.62, 127.35, 127.99, 128.19, 129.16, 134.16, 134.67, 136.37, 
137.77, 137.86, 138.41, 148.37, 168.62; IR (neat) 3346 w, 2945 w, 2866 w, 1673 m, 1595 w, 
1518 s, 1481 s, 1423 m, 1385 m, 1325 m, 1263 m, 1127 w, 897 w, 827 m; MS m/z (relative 
intensity, %) 343 (M+, 35), 201 (13), 200 (100), 199 (16), 171 (48), 145 (17), 144 (16), 131 
(19), 105 (11); HRMS Calcd for C22H21N3O: 343.1685; Found: 343.1686. 
 
2-(3-Methoxypropyl)-6-methyl-N-(quinolin-8-yl)benzamide (17). 
 
Rf 0.11 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  1.92-1.99 (m, 
2H), 2.43 (s, 3H), 2.80 (t, J = 8.0 Hz, 2H), 3.23 (s, 3H), 3.34 (t, J = 6.4 Hz, 2H), 7.12-7.18 (m, 
2H), 7.29 (t, J = 8.0 Hz, 1H), 7.44 (dd, J = 8.4, 4.0 Hz, 1H), 7.56-7.63 (m, 2H), 8.18 (dd, J = 
8.4, 1.6 Hz, 1H), 8.73 (dd, J = 4.0, 1.6 Hz, 1H), 8.99 (dd, J = 8.0, 1.6 Hz, 1H), 9.93 (brs, 1H); 
13C NMR (CDCl3, 100.53 MHz)19.48, 29.83, 31.21, 58.29, 71.87 116.74, 121.64, 121.92, 
126.87, 127.36, 127.91, 127.95, 129.02, 134.33, 134.54, 136.31, 137.82, 138.45, 138.60, 
148.24, 168.73; IR (neat) 3347 w, 2923 w, 2869 w, 1675 m, 1595 w, 1518 s, 1480 s, 1423 m, 
1385 m, 1325 m, 1263 w, 1117 m, 897 w, 826 m; MS m/z (relative intensity, %) 335, (10), 
334 (M+, 44), 190 (28), 145 (33), 144 (19), 132 (16), 131 (100), 117 (12), 105 (21), 61 (19); 
HRMS Calcd for C21H22N2O2: 334.1681; Found: 334.1684.  
 
2-Allyl-6-methyl-N-(quinolin-8-yl)benzamide (18). 
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Rf 0.37 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  2.44(s, 3H), 
3.51 (d, J = 6.8 Hz, 2H), 4.97-5.04 (m, 2H), 5.94-6.04 (m, 1H), 7.15 (d, J = 8.0, 2H), 7.30 (t, J 
= 7.2 Hz, 1H), 7.44 (dd, J = 8.4, 4.0 Hz, 1H), 7.56-7.63 (m, 2H), 8.17 (d, J = 8.4 Hz, 1H), 
8.73 (d, J = 4.0 Hz, 1H), 8.99 (d, J = 7.2 Hz, 1H), 9.95 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)19.49, 37.71, 116.22, 116.74, 121.64, 121.95, 121.01, 127.35, 127.95, 128.23, 129.12, 
134.27, 134.71, 136.29, 136.62, 136.86, 137.70, 138.41, 148.21, 168.53; IR (neat) 3345 w, 
2921 w, 1675 m, 1595 w, 1519 s, 1482 s, 1424 m, 1385 m, 1326 m, 1264 w, 1127 w, 902 w, 
826 w; MS m/z (relative intensity, %) 303 (13), 302 (M+, 59), 301 (28), 160 (10), 159 (89), 
158 (100), 157 (11), 144 (41), 131 (47), 130 (13), 129 (18), 128 (12), 116 (32), 115 (30), 91 
(26); HRMS Calcd for C20H18N2O: 302.1419; Found: 302.1420. 
 
2-Isobutyl-6-methyl-N-(quinolin-8-yl)benzamide (19). 
 
Rf 0.37 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.87 (d, J = 
7.2 Hz, 6H), 1.97-2.04 (m, 1H), 2.43 (s, 3H), 2.61 (d, J = 7.2 Hz, 2H), 7.12 (d, J = 7.6 Hz, 2H), 
7.28 (t, J = 87.6 Hz, 1H), 7.45 (dd, J = 8.0, 4.0 , 1H), 7.56-7.64 (m, 2H), 8.18 (dd, J = 8.0, 1.6 
Hz, 1H), 8.73 (dd, J = 4.0, 1.6 Hz, 1H), 8.99 (dd, J = 7.6, 1.6 Hz, 1H), 9.90 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz)19.67, 22.68, 30.01, 31.07, 42.65, 116.82, 121.76, 121.98, 
127.51, 127.54, 127.88, 128.11, 128.80, 134.52, 134.58, 136.41, 138.27, 138.43, 138.62, 
148.37, 169.02; IR (neat) 3347 w, 2954 w, 2867 w, 1676 m, 1595 w, 1519 s, 1481 s, 1423m, 
1384 m, 1325 m, 1263 w, 1126 w, 899 w, 826 w; MS m/z (relative intensity, %) 318 (M+, 66), 
176 (12), 175 (97), 174 (58), 159 (56), 158 (14), 157 (100), 145 (14), 144 (53), 132 (16), 131 
(11), 129 (11), 116 (11), 105 (24), 104 (13), 103 (12), 91 (11); HRMS Calcd for C21H22N2O: 
318.1735; Found: 318.1732. 
 
2-(cyclopentylmethyl)-6-methyl-N-(quinolin-8-yl)benzamide (20 and 34). 
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Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil, 
1H NMR (CDCl3, 399.78 MHz) 1.11-1.20 (m, 
2H), 1.41-1.58 (m, 4H), 1.64-1.69 (m, 2H), 2.21 (se, J = 3.6 Hz, 1H), 2.43 (s, 3H), 2.73 (d, J = 
7.6 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 7.16 (d, J = 8.0 Hz, 1H), 7.27 (t, J = 7.6 Hz, 1H), 7.44 
(dd, J = 4.0, 2.0 Hz, 1H), 7.56-7.64 (m, 2H), 8.18 (dd, J = 8.0, 2.0 Hz, 1H), 8.73 (dd, J = 4.0, 
1.6 Hz, 1H), 8.99 (dd, J = 7.6, 1.6 Hz, 1H), 9.92 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
19.54, 24.72, 32.59, 39.07, 41.60, 116.71, 121.64, 121.86, 127.08, 127.40, 127.65, 127.95, 
128.75, 134.37, 134.42, 136.29, 137.88, 138.47, 138.86, 148.20, 168.93; IR (neat) 3347 w, 
2949 m, 1676 m, 1520 s, 1482 s, 1424 m, 1326 m, 1126 w; MS m/z (relative intensity, %) 345 
(11), 344 (M+, 46), 201 (36), 200 (49), 184 (15), 200 (49), 184 (15), 183 (100), 182 (16), 168 
(10), 159 (10), 157 (15), 155 (25), 149 (13), 145 (15), 144 (70), 143 (10), 142 (10), 132 (14), 
129 (14), 129 (14), 128 (10), 105 (31), 104 (11); 144 (42); HRMS Calcd for C23H24N2O2: 
344.1889; Found: 344.1891. 
 
2-(2-(Benzyloxy)ethyl)-6-methyl-N-(quinolin-8-yl)benzamide (21). 
 
Rf 0.20 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  2.44, 3.05 (t, 
J = 7.2 Hz, 2H), 3.74 (t, J = 7.2 Hz, 2H), 4.45 (s, 2H), 7.15-7.20 (m, 7H), 7.29 (t, J = 7.6 Hz, 
1H), 7.44 (dd, J = 8.0, 4.0 Hz, 1H), 7.57-7.65 (m, 2H), 8.20 (dd, J = 8.4, 1.6 Hz, 1H), 8.69 (dd, 
J = 4.4, 1.6 Hz, 1H), 9.00 (dd, J = 7.6, 1.6 Hz, 1H), 10.05 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)19.53, 33.79, 70.97, 72.70, 116.87, 121.60, 121.98, 127.29, 127.37, 127.39, 127.98, 
128.12, 128.31, 128.98, 134.35, 134.58, 135.50, 136.28, 138.28 (two overlapping peaks), 
138.49, 148.19, 168.66; IR (neat) 3344 w, 2925 w, 2858 w, 1673 m, 1595 w, 1519 s, 1481 s, 
1424 m, 1385 m, 1325 m, 1264 m, 1095 m, 898 w, 826 m; MS m/z (relative intensity, %) 396 
(M+, 7), 289 (11), 288 (7), 287 (17), 234 (13), 233 (14), 145 (12), 144 (38), 129 (12), 91 
(100); HRMS Calcd for C26H24N2O2: 396.1836; Found: 396.1838. 
 
2-Methyl-6-phenethyl-N-(quinolin-8-yl)benzamide (22). 
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Rf 0.29 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  2.45 (s, 3H), 
2.96-3.05 (m,4H), 7.05-7.09 (m,3H), 7.12-7.16 (m, 4H), 7.28 (t, J = 8.0 Hz, 1H), 7.44 (dd, J = 
8.0, 4.0 Hz, 1H), 7.56-7.65 (m, 2H), 8.18 (dd, J = 8.4, 1.6 Hz, 1H), 8.72 (dd, J = 4.0, 1.6 Hz, 
1H), 9.01 (dd, J = 8.0, 1.6 Hz, 1H), 9.95 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)19.53, 
35.83, 38.14, 116.82, 121.66, 121.98, 125.78, 126.95, 127.42, 127.99, 128.09, 128.21, 128.37, 
129.05, 134.30, 134.59, 136.36, 137.79, 138.42, 141.66, 148.26, 168.70; IR (neat) 3345 w, 
3025 w, 2927 w, 1738 w, 1674 m, 1595 w, 1518 s, 1481 s, 1423 m, 1384 m, 1325 m, 1262 w, 
1126 w, 897 w, 826 m; MS m/z (relative intensity, %) 366 (M+, 17), 224 (10), 223 (61), 222 
(46), 179 (12), 178 (13), 165 (12), 145 (37), 144 (100), 132 z811), 117 (27), 103 (11), 91 
(20); HRMS Calcd for C25H22N2O:366.1732; Found: 366.1730. 
 
2-Isopentyl-6-methyl-N-(quinolin-8-yl)benzamide (23). 
 
Rf 0.26 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.77 (d, J = 
6.4 Hz, 6H), 1.47-1.60 (m, 3H), 2.43 (s, 3H), 2.70 (t, J = 8.0 Hz, 2H), 7.10-7.15 (m, 2H), 7.27 
(t, J = 7.6 Hz, 1H), 7.45 (dd, J = 8.4, 4.0 Hz, 1H), 7.56-7.64 (m, 2H), 8.18 (dd, J = 8.4, 1.6 Hz, 
1H), 8.74 (dd, J = 4.4, 1.6 Hz, 1H), 8.99 (dd, J = 8.4, 1.6 Hz, 1H), 9.93 (brs, 1H); 13C NMR 
(CDCl3, 100.53 MHz)19.49, 22.33, 27.95, 31.39, 41.17, 116.79, 121.63, 121.87, 126.77, 
127.44, 127.65, 127.98, 128.98, 134.37, 134.55, 136.35, 137.69, 138.44, 139.73, 148.19, 
168.87; IR (neat) 3348 w, 2953 w, 2868 w, 1677 m, 1595 w, 1519 s, 1481 s, 1424 m, 1385 m, 
1325 m, 1263 w, 1126 w, 898 w, 826 w; MS m/z (relative intensity, %) 333 (13), 332 (M+, 
52), 289 (14), 189 (55), 188 (31), 171 (13), 147 (12), 146 (13), 145 (100), 144 (25), 132 (11), 
131 (42), 105 (32), 59 (32); HRMS Calcd for C22H24N2O: 332.1889; Found: 332.1890. 
 
2-(But-3-en-1-yl)-6-methyl-N-(quinolin-8-yl)benzamide (24). 
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Rf 0.29 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  2.41-2.47 
(m,5H), 2.2.80-2.84 (m, 2H), 4.86-4.95 (m, 2H), 5.75-5.82 (m, 1H), 7.14 (t, J = 8.0 Hz, 2H), 
7.27 (t, J = 8.0 Hz, 1H), 7.44 (dd, J = 8.0, 4.0 Hz, 1H), 7.56-7.63 (m, 2H), 8.17 (dd, J= 8.4, 16 
Hz, 1H), 8.73 (dd, J = 4.0, 1.6 Hz, 1H), 8.99 (dd, J = 8.0, 1.6 Hz, 1H), 9.93 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz)19.49, 32.87, 35.54, 115.05, 116.74, 121.65, 121.93, 126.80, 
127.38, 127.93, 127.96, 128.96, 134.31, 134.50, 136.31, 137.82, 137.89, 138.38, 138.46, 
148.24, 168.72; IR (neat) 3345 w, 2924 w, 1674 m, 1595 w, 1518 s, 1481 s, 1423 m, 1385 m, 
1325 m, 1263 w, 1127 w, 899 w, 826 m; MS m/z (relative intensity, %) 316 (M+, 32), 173 
(67), 172 (58), 171 (17), 157 (18), 146 (10), 145 (82), 144 (100), 143 (10), 132 (11), 131 (14), 
130 (21), 129 (19), 128 (15), 115 (1), 105 (18), 104 (11); HRMS Calcd for 
C21H20N2O:316.1576; Found: 316.1576. 
 
2-Methyl-N-(quinolin-8-yl)-6-(6-(triisopropylsilyl)hex-5-yn-1-yl)benzamide (25). 
 
Rf 0.34 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.95-1.17 (m, 
21H), 1.49-1.57 (m, 2H), 1.79-1.86 (m, 2H), 2.19 (t, J = 7.2 Hz, 2H), 2.43 (s, 3H), 2.74 (t, J = 
7.6 Hz, 2H), 7.11-7.16 (m, 2H), 7.28 (t, J = 7.6 Hz, 1H), 7.45 (dd, J = 8.0,. 4.0 Hz, 1H), 
7.56-7.64 (m, 2H), 8.19 (d, J = 7.6 Hz, 1H), 8.73 (d, J = 3.6 Hz, 1H), 8.98 (d, J = 7.6 Hz, 1H), 
9.92 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)111.20, 18.59, 19.50, 19.63, 28.65, 30.50, 
32.71, 80.04, 108.90, 116.81, 121.66, 121.94, 126.58, 127.41, 127.80, 127.99, 129.00, 134.31, 
134.48, 136.35, 137.74, 138.43, 138.94, 148.21, 168.80; IR (neat) 3349 w, 2941 m, 2863 m, 
2170 w, 1679 m, 1520 s, 1482 s, 1463 m, 1424 m, 1385 m, 1325 m, 1263 w, 1126 w, 883 m, 
826 m; MS m/z (relative intensity, %) 498 (M+, 2), 457 (10), 456 (37), 455 (100); HRMS 
Calcd for C32H42N2OSi: 498.3066; Found: 498.3062. 
 
Methyl 5-(3-methyl-2-(quinolin-8-ylcarbamoyl)phenyl)pentanoate (26). 
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Rf 0.11 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  1.60-1.76 
(m,4H), 2.24 (t, J = 7.6 Hz, 2H), 2.43 (s, 3H), 2.74 (t, J = 7.6 Hz, 2H), 3.56 (s, 3H), 7.13 (t, J 
= 7.2 Hz, 2H), 7.28 (t, J = 7.6 Hz, 1H), 7.45 (dd, J = 8.4, 4.0 Hz, 1H), 7.56-7.64 (m, 2H), 8.18 
(dd, J = 8.4, 1.6 Hz, 1H), 8.73 (dd, J = 4.0, 1.6 Hz, 1H), 8.98 (dd, J = 8.0, 1.6 Hz, 1H), 9.92 
(brs, 1H); 13C NMR (CDCl3, 100.53 MHz)19.47, 24.72, 31.00, 33.04, 33.78, 51.33, 116.75, 
121.65, 121.95, 126.70, 127.37, 127.90, 127.97, 129.01, 134.28, 134.54, 136.31, 137.71, 
138.45, 138.70, 148.26, 168.72, 173.95; IR (neat) 3347 w, 2948 w, 2864 w, 1734 m, 1675 m, 
1595 w, 1518 s, 1481 s, 1424 m, 1384 m, 1325 m, 1262 m, 1127 m, 896 w, 827 m; MS m/z 
(relative intensity, %) 377 (19), 376 (M+, 72), 245 (20), 234 (14), 233 (99), 232 (100), 201 
(14), 200 (13), 173 (24), 163 (20), 159 (21), 158 (13), 157 (13), 155 (10), 146 (14), 145 (84), 
144 (39), 143 (10), 119 (12), 117 (12), 116 (14), 115 (15), 105 (21), 91 (14); HRMS Calcd for 
C23H18N2O: 376.1787; Found: 376.1789. 
 
2-Methyl-6-(2-methylpropen-3-yl)-N-(quinolin-8-yl)benzamide (27). 
 
Rf: 0.31 (hexane/EtOAc = 5/1). Yellow oil. 
1H NMR (CDCl3, 399.78 MHz) 1.63 (s, 3H), 2.43 
(s, 3H), 3.44 (s, 2H), 4.65 (s, 1H), 4.76 (s, 1H), 7.13-7.15 (m, 2H), 7.26-7.62 (m, 4H), 8.17 
(dd, J = 2.0, 8.4 Hz, 1H), 8.71 (dd, J = 2.0, 4.4 Hz, 1H), 8.97 (dd, J = 1.2, 7.2 Hz, 1H), 9.92 (s, 
1H); 13C NMR (CDCl3, 100.53 MHz) 19.66, 22.48, 41.67, 112.85, 116.83, 121.76, 122.01, 
127.41, 127.51, 128.08, 128.38, 129.05, 134.49, 134.88, 136.32, 136.38, 138.24, 138.61, 
144.62, 148.31, 168.72; IR (neat): 3345 w, 3066 w, 2969 w, 2916 w, 1737 w, 1674 s, 1595 w, 
1578 w, 1517 s, 1481 s, 1423 m, 1384 m, 1325 s, 1263 m, 1170 w, 1126 m, 1088 w, 1071 w, 
1042 w, 977 w, 894 m, 825 m, 790 m, 760 m, 685 m; MS m/z (relative intensity, %): 326 (M+, 
29), 315 (20), 173 (18), 172 (21), 157 (14), 145 (65), 144 (100), 130 (16), 129 (21), 128 (17), 
115 (12), 105 (14); HRMS Calcd for C18H13F3N2O: 316.1576; Found: 316.1571. 
 
2-methyl-N-(quinolin-8-yl)-6-(2,2,2-trifluoroethyl)benzamide (28). 
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Rf 0.37 (hexane/EtOAc = 5/1). White Solid. Mp = 148 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.48 (s, 2H), 3.59 (q, J = 10.8 Hz, 2H), 7.30 (t, J = 8.0 Hz, 2H), 7.37 (t, J = 8.0 Hz, 1H), 7.45 
(dd, J = 8.4, 4.4 Hz, 1H), 7.58-7.64 (m, 2H), 8.18 (dd, J = 8.0, 2.0 Hz, 1H), 8.74 (dd, J = 4.4, 
1.6 Hz, 1H), 8.97 (dd, J = 7.6, 1.6 Hz, 1H), 10.05 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
19.78, 37.08 (q, J = 29.6 Hz), 116.82, 121.50, 121.73, 122.28, 125.64 (q, J = 275.5 Hz), 
127.15 (d, J = 3 Hz), 127.27, 127.97, 128.25, 128.61, 129.01, 129.28, 130.37, 134.02, 135.15, 
136.30, 138.45, 139.05, 148.38, 167.64; IR (neat) 3343 w, 1671 m, 1520 s, 1483 s, 1326 m, 
1260 m, 1134 m, 792 m; MS m/z (relative intensity, %)344 (M+, 41), 202 (24), 201 (100), 200 
(19), 181 (16), 144 (21), 123 (25); HRMS Calcd for C19H15F3N2O: 344.1136; Found: 
344.1134. 
 
2,6-Dimethyl-N-(quinolin-8-yl)benzamide (29). 
 
Rf: 0.37 (hexane/EtOAc = 5/1). White Solid. Mp = 125 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.44 (s, 6H), 7.12 (d, J = 7.2 Hz, 2H), 7.25 (t, J = 7.6 Hz, 1H), 7.45 (dd, J = 8.0, 4.4 Hz, 1H), 
7.56-7.64 (m, 2H), 8.19 (d, J = 8.0 Hz, 1H), 8.74 (d, J = 4.0 Hz, 1H), 9.00 (d, J = 7.2 Hz, 1H), 
9.95 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.45, 116.82, 121.65, 121.94, 127.43, 
127.89, 127.99, 128.95, 134.34, 134.53, 136.42, 137.99, 138.42, 148.21, 168.89; IR (neat) 
3345 w, 1673 m, 1518 s, 1481 s, 1424 m, 1385 m, 1325 m, 1127 w; MS m/z (relative 
intensity, %): 276 (M+, 29), 259 (12), 133 (100), 132 (21), 105 (26); HRMS Calcd for 
C18H16N2O: 276.1263; Found: 276.1261. 
 
2-cyclopentyl-N-(quinolin-8-yl)benzamide (30). 
 
Rf 0.49 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 1.62-1.82 (m, 
6H), 2.14-2.22 (m, 2H), 3.48-3.54 (m, 1H), 7.27-7.31 (m, 1H), 7.43-7.47 (m, 3H), 7.54-7.63 
(m, 3H), 8.18 (dd, J = 8.4, 1.2 Hz, 1H), 8.76 (dd, J = 4.0, 1.6 Hz, 1H), 8.97 (dd, J = 7.6, 1.6 
Hz, 1H), 10.14 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 25.85, 35.44, 41.95, 116.60, 
121.63, 121.79, 125. 71, 126.91, 126.93, 127.41, 127.96, 130.28, 134.68, 136.40, 137.17, 
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138.40, 144.83, 148.15, 168.91; IR (neat) 3347 w, 2952 w, 1672 m, 1519 s, 1482 s, 1424 m, 
1385 m, 1326 m, 1260 w; MS m/z (relative intensity, %) 316 (M+, 41), 173 (29), 172 (100), 
171 (17), 155 (41), 154 (16), 153 (14), 145 (16), 144 (92), 131 (15), 130 (18), 129 (33), 128 
(15), 117 (10), 116 (12), 115 (19), 91 (15); HRMS Calcd for C21H20N2O: 316.1576; Found: 
316.1576. 
 
5-Methoxy-2-octyl-N-(quinolin-8-yl)benzamide (31b). 
 
Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.80 (t, J = 
7.2 Hz, 3H), 1.11-1.29 (m, 10H), 1.66 (t, J = 7.6 Hz, 2H), 2.83 (t, J = 7.6 Hz, 2H), 3.84 (s, 
3H), 6.97 (dd, J = 8.0, 1.6 Hz, 1H), 7.17 (d, J = 2.4 Hz, 1H), 7.25 (d, J = 8.0 Hz, 1H), 7.45 (dd, 
J = 8.4, 4.4 Hz, 1H), 7.54-7.62 (m, 2H), 8.17 (dd, J = 8.0, 1.6 Hz, 1H), 8.76 (dd, J = 4.0, 1.6 
Hz, 1H), 8.94 (dd, J = 7.6, 1.2 Hz, 1H), 10.15 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)14.04, 22.55, 39.16, 29.34, 29.45, 31.77, 31.89, 32.47, 55.42, 112.45, 115.93, 116.52, 
121.63, 121.76, 127.37, 127.76, 131.40, 133.08, 134.64, 136.29, 137.46, 138.51, 148.20, 
157.48, 168.22; IR (neat) 3349 w, 2924 w, 2853 w, 1676 m, 1607 w, 1520 s, 1481 s, 1423 m, 
1384 m, 1325 m, 1285 m, 1109 w, 1040 m, 824 m; MS m/z (relative intensity, %) 391 (14), 
390 (M+, 50), 305 (10), 247 (15), 246 (35), 217 (15), 176 (11), 161 (100), 149 (23), 147 (13), 
146 (12), 144 (34), 121 (30). HRMS Calcd for C25H30N2O2: 390.2307; Found: 390.2306. 
 
2-Octyl-N-(quinolin-8-yl)-5-(trifluoromethyl)benzamide (32b). 
 
Rf 0.51 (hexane/EtOAc = 5/1). Colorless Oil. 1H NMR (CDCl3, 399.78 MHz)  0.80 (t, J = 
7.2 Hz, 3H), 1.11-1.35 (m, 10H), 1.67-1.74 (m, 2H), 2.94 (t, J = 8.0 Hz, 2H), 7.45-7.49 (m, 
2H), 7.57-7.68 (m, 3H), 7.88 (s, 1H), 8.19 (dd, J = 8.0, 4.0, 1H), 8.78 (dd, J = 4.0, 1.6 Hz, 1H), 
8.93 (dd, J = 7.6, 4.0 Hz, 1H), 10.17 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)14.02, 
22.54, 29.09, 29.25, 29.44, 31.45, 31.74, 33.28, 116.76, 121.76, 122.19, 123.88 (q, J = 271 
Hz), 124.21 (d, J = 2.9 Hz), 126.71 (d, J = 3.8 Hz), 127.73, 127.95, 128.35 (q, J = 33Hz), 
130.82, 134.28, 136.38, 137.23, 138.44, 145.35, 148.37, 166.97; IR (neat) 3344 w, 2926 w, 
2855 w, 1678 m, 1522 s, 1483 s, 1424 m, 1385 m, 1326 s, 1258 m, 1169 m, 1125 s, 1080 w, 
910 w, 826 m; MS m/z (relative intensity, %) 429 (11), 428 (M+, 41), 344 (11), 343 (52), 213 
(11), 200 (12), 199 (59), 145 (13), 144 (100); HRMS Calcd forC25H27F3N2O: 428.2075; 
Found: 428.2073. 
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2-(hex-5-en-1-yl)-6-methyl-N-(quinolin-8-yl)benzamide (33). 
 
Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 1.37 (f, J = 7.6 
Hz, 2H), 1.66-1.73 (m, 2H), 1.96 (q, J = 7.6 Hz, 2H), 2.43 (s, 3H), 2.72 (t, J = 8.0 Hz, 2H),  
4.78 (dd, J = 10.4, 1.6 Hz, 1H), 4.86 (dd, J = 17.2, 1.6 Hz, 1H), 5.62-5.72 (m, 1H), 7.13 (t, J = 
8.0 Hz), 7.28 (t, J = 7.6 Hz, 1H), 7.45 (dd, J = 8.0, 4.0 Hz, 1H), 7.56-7.64 (m, 2H), 8.19 (dd, J 
= 8.0, 1.2 Hz, 1H), 8.74 (dd, J = 4.0, 1.2 Hz, 1H) 9.00 (dd, J = 7.2, 1.6 Hz, 1H), 9.93 (brs, 
1H); 13C NMR (CDCl3, 100.53 MHz) 19.50, 28.73, 31.09, 33.27, 33.48, 114.21, 116.80, 
121.64, 121.92, 126.73, 127.44, 127.74, 127.99, 128.97, 134.34, 134.51, 136.39, 137.72, 
138.41, 138.74, 139.24, 148.20, 168.87; IR (neat) 3347 w, 1676 m, 1519 s, 1481 s, 1423 m, 
1385 m, 1325 m, 1126 w; MS m/z (relative intensity, %) 344 (M+, 13), 201 (32), 200 (22), 
159 (47), 145 (30), 144 (100), 131 (20), 130 (11), 116 (10), 105 (28); HRMS Calcd for 
C22H22N2O2: 344.1889; Found: 344.1890. 
 
2-(cyclopropylmethyl)-6-methyl-N-(quinolin-8-yl)benzamide (35). 
 
Rf 0.41 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 0.18 (q, J = 5.2 
Hz, 2H), 0.47 (q, J = 5.6 Hz, 2H), 1.03-1.09 (m, 1H), 2.44 (s, 3H), 2.67 (d, J = 6.8 Hz, 2H), 
7.15 (d, J = 8.4 Hz, 1H), 7.29-7.34 (m, 2H), 7.44 (dd, J = 4.4, 2.4 Hz, 1H), 7.56-7.63 m, 2H), 
8.17 (d, J = 8.0 Hz, 1H), 8.73 (dd, J = 4.0, 1.6 Hz, 1H), 9.00 (d, J = 6.8 Hz, 1H), 9.96 (brs, 
1H); 13C NMR (CDCl3, 100.53 MHz) 4.95, 11.72, 19.49, 37.59, 116.77, 121.64, 126.51, 
127.39, 127.92, 127.97, 129.00, 134.31, 134.33, 136.34, 137.58, 138.39, 138.86, 148.20, 
168.89; IR (neat) 3346 w, 1676 m, 1520 s, 1482 s, 1424 m, 1385 m, 1326 m, 1263 w; MS m/z 
(relative intensity, %)316 (M+, 21), 315 (11), 173 (17), 172 (37), 171 (15), 157 (14), 146 (11), 
145 (89), 144 (100), 130 (19), 129 (21), 128 (17), 115 (17), 105 (15); HRMS Calcd for 
C21H20N2O: 316.1576; Found: 316.1573. 
 
2-(but-3-en-1-yl)-6-methyl-N-(quinolin-8-yl)benzamide (36). 
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Rf 0.41 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 2.41-2.47 (m, 
5H), 2.82 (t, J = 8.0 Hz, 2H), 4.86-4.95 (m, 2H), 5.74-5.84 (m, 1H), 7.14 (t, J = 8.4 Hz, 2H), 
7.29 (t, J = 7.2 Hz, 1H), 7.45 (dd, J = 8.0, 4.0 Hz, 1H), 7.56-7.64 (m, 2H), 8.19 (dd, J = 8.4, 
1.6 Hz, 1H), 8.74 (dd, J = 4.0, 2.0 Hz, 1H), 8.99 (dd, J = 7.2, 1.2 Hz, 1H), 9.94 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz) 19.52, 32.88, 35.56, 115.05, 116.90, 121.65, 121.97, 126.80, 
127.46, 127.94, 128.01, 128.98, 134.27, 134.52, 136.48, 137.80, 137.92, 138.34, 138.39, 
148.18, 168.77; IR (neat) 3346 w, 1675 m, 1519 s, 1481 s, 1424 m, 1385 m, 1325 m, 1263 w, 
826 w; MS m/z (relative intensity, %) 316 (M+, 32), 173 (64), 172 (56), 171 (18), 157 (19), 
146 (11), 145 (86), 144 (100), 143 (11), 132 (12), 131 (14), 130 (22), 129 (22), 128 (18), 115 
(14), 105 (21), 104 (11), 103 (11); HRMS Calcd for C21H20N2O: 316.1576; Found: 316.1574. 
 
Deuterium Labeling Experiments (Scheme 2). 
To an oven-dried 5 mL screw-capped vial in a glove box, 
2-methyl-N-(8-quinolinyl)benzamide 1a-d7 (79 mg, 0.3 mmol), 1-bromobutane (82 mg, 0.6 
mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol), PPh3 (15.6 mg, 0.06 mmol), Na2CO3 (64 mg, 0.6 
mmol) and toluene (1 mL) were added. The mixture was stirred for 8 h at 140 °C followed by 
cooling. The resulting mixture was filtered through a celite pad and concentrated in vacuo. 
The ratio of deuterium was determined by 1H-NMR. 
 
Competition Experiment (Scheme. 3). 
To an oven-dried 5 mL screw-capped vial, N-(8-Quinolinyl)-3-(trifluoromethyl)benzamide 
32a (158 mg, 0.5 mmol), 3-Methoxy-N-(quinolin-8-yl)benzamide 31a (139 mg, 0.5 mmol), 
1-bromooctane (79 mg, 0.4 mmol), Ni(OTf)2, (7.1 mg, 0.02 mmol), PPh3 (10 mg, 0.04 mmol), 
Na2CO3 (42 mg, 0.4 mmol) and toluene (1 mL) were added in a glove box. The mixture was 
stirred for 36 h at 160 °C followed by cooling. The mixture was filtered through a celite pad 
and concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(eluant: hexane/EtOAc= 20/1) to afford the desired alkylated product 32b (115 mg, 67% 
based on Oct-Br) as a colorless oil and alkylated prduct 31b (7 mg 5% based on Oct-Br) as a 
colorless oil. N-(8-Quinolinyl)-3-(trifluoromethyl)benzamide 32a and 
3-Methoxy-N-(quinolin-8-yl)benzamide 31a was recovered 41% and 90%. 
 
Radical Trapping Experiment. 
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To an oven-dried 5 mL screw-capped vial in a glove box, 
2-methyl-N-(8-quinolinyl)benzamide 1a-d7 (79 mg, 0.3 mmol), 1-bromobutane (82 mg, 0.6 
mmol), TEMPO or GALVINOXYL (0.6 mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol), PPh3 (15.6 
mg, 0.06 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene (1 mL) were added. The mixture 
was stirred for 24 h at 140 °C followed by cooling. The resulting mixture was filtered through 
a celite pad and concentrated in vacuo. The yield of product was determined by 1H-NMR. 
 
Radical Clock Experiments (Scheme. 4 and 5). 
To an oven-dried 5 mL screw-capped vial in a glove box, 
2-methyl-N-(8-quinolinyl)benzamide  1a (79 mg, 0.3 mmol), 6-bromohex-1-ene (97 mg, 0.6 
mmol) or (bromomethyl)cyclopropane (80 mg, 0.6 mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol), 
PPh3 (15.6 mg, 0.06 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene (1 mL) were added. The 
mixture was stirred for 24 h at 140 °C followed by cooling. The resulting mixture was filtered 
through a celite pad and concentrated in vacuo. The ratio of products was determined by 
1H-NMR. 
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Chapter 2 
 
Nickel(II)-Catalyzed Direct Arylation of C(sp3)-H Bonds in Aliphatic Amides 
via Bidentate-Chelation Assistance 
 
2.1  Introduction 
As described in general introduction and chapter 1, the transition metal-catalyzed 
functionalization of C(sp2)-H bonds has emerged as a powerful tool for the formation of C-C 
and C-heteroatom bonds in recent years.1 Compare to those functionalization of  C(sp2)-H 
bonds, the functionalization of C(sp3)-H bonds has been limited and continues to be a 
challenging issue.2 However, most of the functionalization reactions of C(sp3)-H bonds 
reported so thus have involved the use of palladium complexes as catalysts. One of the 
method for the functionalization of C(sp3)-H bonds is the utilization of a bidentate directing 
group discovery by Daugulis,3 and various types of functionalization of C(sp3)-H bonds have 
been achieved using the bidentate-chelation system in conjunction with Pd(II) catalysts.4 
Another method for functionalization of C(sp3)-H bond with Pd-catalyst is the use of electron 
deficient directing groups, which is reported by Yu.5 The Functionalization of C-H bonds 
using transition metal complexes other than palladium complexes have been limited.6 To the 
best of our knowledge, Ni-catalyzed transformation of C(sp3)-H bonds have been restricted to 
only one example, i.e., the Ni(0)-catalyzed cycloaddition of formamide with alkynes.7 
Chapter 2 deals the Ni(II)-catalyzed direct arylation of aliphatic amide containing an 
8-aminoquinoline moiety with aryl iodides via a cleavage of C(sp3)-H bond. This reaction 
represents the first general method for functionalization of C(sp3)-H bond with 
nickel-catalyst. 
 
2.2  Result and Discussion 
The reaction of amide 1a (0.3 mmol) with 4-iodoanisole (0.6 mmol) in the presence of 
Ni(OTf)2 (0.03 mmol) as a catalyst and Na2CO3 (0.6 mmol) as a base in DMA (0.6 mL) at 
140 °C for 24 h gave the -arylation product 1b in 40% NMR yield along with the recovery 
of 44% of the unreacted 1a, and no evidence of any biarylated product or any other products 
produced by reaction at the methylene or -benzene C-H bonds was found (entry 1 in Table 1). 
The addition of benzoic acid as a ligand improved the yield of 1a to 70% (entry 2). Further 
investigation revealed that the addition of a sterically bulky carboxylic acid, such as 
2,4,6-trimethylbenzoic acid (MesCOOH) or [1,1':3',1''-terphenyl]-2'-carboxylic acid 
(2,6-Ph2C6H3COOH), also improved the product yield (entries 3-7). The efficiency of the 
reaction was also significantly affected by the choice of the base used. Na2CO3 was 
determined to be the best base for this reaction (entries 8-11). Among the solvents examined, 
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DMF was the solvent of choice. Curiously, not only a Ni(II) complex but also a Ni(0) 
complex showed a high catalytic activity, resulting in high yields of the -arylation product 
(entries 15-17).  
We next examined the effect of directing groups (Figure 1). The reaction did not proceed at 
all when the corresponding N-2-naphthylbenzamaide 2 or the ester 3 was used. The use of 
other bidentate directing groups, such as 2-pyridinylmethylamine 4 or 2-(methylthio)aniline 5, 
also resulted in no reaction. 
 
Figure 1. Ineffective Directing Groups 
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Table 1. Optimaization of the Nickel-Catalyzed Direct Arylation of Aliphatic Amide 1a 
with 4-Iodoanisolea 
 
a Reaction conditions: amide 1a (0.3 mmol), 4-iodoanisole (0.6 mmol), catalyst (0.03 
mmol), ligand (0.06 mmol), base (0.6 mmol) in solvent (0.6 mL) at 140 °C for 24 h. b NMR 
yields. The number in parenthesis is the isolated yield.  
 
Table 2 shows the scope of the substrates under the standard reaction conditions. Aliphatic 
amides possessing three substituents at the -position reacted efficiently. The reactions 
proceeded exclusively at the methyl group in a highly regioselective manner, as in the cases 
of 6, 7, 8, and 9, and methylene and benzene C-H bonds were not arylated. Although the 
reaction of 1-methylcyclohexanecarboxamide 10a resulted in selective mono arylation only at 
the methyl group, 1-methylcycloheptanecarboxamide 11a gave a mixture of monoarylated 
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11b and biarylated products 11c, the latter involving the arylation at the cyclic methylene C-H 
bonds.8 When 1-phenylcyclobutanecarboxamide 12a and 1-phenylcyclopentanecarboxamide 
13a were used, the cleavage of -methlyene C-H bonds was the predominant reaction and 
-benzenes C(sp2)-H bonds reacted to a lesser extent. The structure of 12c was confirmed 
from X-ray crystallography, which show that the introduced aryl groups are located syn to the 
directing group. This also indicates the importance of the directing group. The presence of 
two substituents on the -carbon, as in 14a resulted in a low conversion and the arylation 
product 14b was obtained in 30% yield.  
Phenyl bromides and triflates did not give arylation products (Table 3). The scope of aryl 
iodides with various substituents at the para position was examined using 1a as the substrate 
(Table 3). The results showed that common functional groups, including esters, iodide, 
bromides, chlorides and amines, were compatible in the present reaction. Electron rich aryl 
iodides tended to give the products in slightly higher yields than electron poor aryl iodides. 
Ortho-substituted aryl iodides resulted in no reaction. The heterocyclic aryl iodide, such as 
thiophene and indole gave the arylated product. 
A gram scale reaction of 6a was successfully performed in a 30-mL two-necked flask 
under the 5 mol% of nickel catalyst (eq 1).  
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Table 2. The Nickel-Catalyzed Direct Arylation of Aliphatic Amides with 4-Iodoanisolea 
 
a Reaction conditions: amide (0.3 mmol), aryl iodides (0.6 mmol), Ni(OTf)2 (0.03 mmol), 
MesCOOH (0.06 mmol), Na2CO3 (0.6 mmol) in DMF (0.6 mL) at 140 °C for 24 h. Isolated 
yields by column chromatogrphy. The number in parenthesis is the yield of the recovered 
starting amide. b [1,1':3',1''-terphenyl]-2'-carboxylic acid (2,6-Ph2C6H3COOH) was used 
instead of MesCOOH and 4-iodoanisole (0.9 mol) was used. 
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Table 3. Scope of Aryl Halides in Ni-Catalyzed Direct Arylation of C(sp3)-H Bondsa 
 
a Reaction conditions: amide (0.3 mmol), aryl iodides (0.6 mmol), Ni(OTf)2 (0.03 mmol), 
MesCOOH (0.06 mmol), Na2CO3 (0.6 mmol) in DMF (0.6 mL) at 140 °C for 24 h. The 
number in parentheses is the yield of recovered starting amides. b NMR yields. c Purified by 
GPC. 
 
To gain additional insights into the mechanism for the reaction, deuterium labeling 
experiments were carried out (Scheme 1). The deuterated amides 1a-d3 were reacted with 
4-iodoanisole for 3h under standard conditions (Scheme 1). A significant amount of H/D 
exchange between the methyl C-D bond and N-H bond was detected. Thus, the D content in 
the recovered amide decreased from >99% to 76%, and the D content of the amide nitrogen 
increased from 0% to 23%. A significant amount of H/D exchange was observed, even in the 
absence of 4-iodoanisole. These results suggest that the cleavage of C-H bonds is rapid and 
reversible, and the cleavage of C-H bonds occurs before the reaction with the aryl iodide.  
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Scheme 1. Deuterium Labeling Experiments 
 
 
Scheme 2. Product Distributiona  
 
a The yields were determined by GC and 1H-NNMR. 
 
Product distribution was examined in detail, in order to develop a better understanding of 
the difference between Ni(0) and Ni(II)-catalyzed reactions (Scheme 2). In the reaction of 1a 
with 1-butyl-4-iodobenzene in the presence of 30 mol% Ni(cod)2, the arylation product 1o 
was obtained in 67% NMR yield with 32% of the starting amide 1a being recovered. When 
Ni(0) was used, butylbenzene was produced in 86% yield/Ni(0) and no biaryl derivative was 
formed. In sharp contrast, when Ni(OTf)2 was used as the catalyst, neither butylbenzene nor 
biaryl were detected. The arylation product 1o was obtained in 65% NMR yield with 36% of 
the starting amide being recovered, along with the corresponding amount of 4-iodo-biphenyl. 
It is known that Ni(0) complexes react with Ar-X to give homocoupling products Ar-Ar with 
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the generation of a Ni(II) complex,9 however the results in Scheme 2 indicate that such a 
reaction did not take place. Instead, the results suggest that the Ni(0) complex was oxidized 
by 1-butyl-4-iodobenzene with the generation of butylbenzene.10 The source of hydrogen is 
probably the N-H bonds of the amide. The results of the above analyses indicate that the 
catalytic active species in this reaction is not Ni(0)-complex but rather, the Ni(II) complex. 
 
Scheme 3. Deuterium Labeling Experiments with Ni(0)-Catalyst 
 
To gain more information, deuterium labeling experiment using nickel(0)-catalyst was 
examined. The deuterated amides 1a-d3 were reacted with Ni(0)-catalyst for 3h under 
standard conditions (Scheme 3). As the result with Ni(II)-catalyst, the H/D exchange at 
methyl group was observed (Scheme 1). Contrast to the Ni(II)-catalyst, the H/D exchange did 
not take place in the case of the absence of 4-iodoanisole, suggesting that the presence of an 
aryl iodide is required for the cleavage of C-H bonds with Ni(0)-catalyst to take place. These 
results also indicate that Ni(0)-complex was not catalytic active species and Ni(0)-complex 
was oxidized by the aryl iodide to generate Ni(II)-complex. 
 
A proposed mechanism for the reaction is shown in Scheme 4. Coordination of the amide 
to the Ni center followed by ligand exchange with the concomitant generation of HX gives 
the Ni complex 15, which undergoes reversible cyclometalation to give 16 probably via a 
concerted-metalation−deprotonation mechanism. The oxidative addition of iodobenzene gives 
the high-valent Ni(IV) complex 17 which is stabilized by the N,N-bidentate directing group. 
The Ni(IV) complex 17 underwent reductive elimination to give 18, which, on protonation, 
affords the desired arylation product with the regeneration of Ni(II). In the case of the 
Ni(0)-catalyst, the reaction of the Ni(0) complex and iodobenzene gives the aryl-nickel 
species, following protonation or ligand exchange with amide N-H and protonation to give the 
Ni(II) complex 15 with the generation of benzene.10 In order to gain additional insight into the 
mechanism, we performed some radical trapping experiments. The addition of 
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2,2,6,6-tetramethyl-1-piperidinoxyl (TEMPO) did not inhibit the reaction and the arylation 
product was obtained in moderate yield (53%). This suggests that a single electron transfer 
(SET) was not involved in this reaction. 
 
Scheme 4. Proposed Mechanism 
 
 
Not only aryl iodide but also diaryliodonium salt is applicable as an arylated reagent (eq 
2).11 Although the addition of a sterically bulky carboxylic acid was required for the reaction 
with aryl iodides, the arylated product was obtained in the absence of a carboxylic acid. A 
Ni(II)/Ni(IV) cycle is also operative in this reaction. 
 
 
2.3  Conclusion 
In summary, we report on the first example of the nickel-catalyzed direct arylation of 
unactivated C(sp3)-H bonds in aliphatic amides having 8-aminoquinoline moiety as a 
bidentate directing group with aryl halides and diaryliodonium salts. Some mechanistic 
experiments revealed that the reaction proceeded via not Ni(0)/Ni(II) or Ni(I)/Ni(III) cycle but 
Ni(Ii)/Ni(IV) cycle, which is not common for nickel-catalyzed cross coupling reaction. After 
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published this paper, about 10 reports about the Ni(II)-catalyzed functionalization of C(sp3)-H 
bonds using a combination of nickel(II)-catalyst and bidentate directing group were reported 
by another researchers.12 
 
2.4  Experimental Section 
General Information. 
1H NMR and 13C NMR spectra were recorded on a JEOL ECS-400 spectrometer in CDCl3 
with tetramethylsilane as the internal standard. The data is reported as follows: chemical shift 
() in ppm, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad peak, and 
m = multiplet), coupling constant (Hz), and integration. Infrared spectra (IR) were obtained 
using a Horiba FT-700 spectrometer. Absorption is reported in reciprocal centimeters (cm-1) 
with the following relative intensities: s (strong), m (medium), or w (weak). Mass spectra 
were obtained on a Shimadzu GCMS-QP 2010 instrument. High resolution mass spectra 
(HRMS) were obtained using a JEOL JMS-DX303 spectrometer. Melting points were 
determined using a SRS MPA 100 instrument. Column chromatography was performed with 
SiO2 (Silicycle SilicaFlash F60 (230-400 mesh)). Some compounds were purified by LC-908 
HPLC (GPC). X-Ray crystallographic structure analysis performed on Rigaku R-AXIS 
RAPID imaging plate diffract meter with graphite monochromated Cu Κα radiation (λ= 
1.54187 Å). 
 
Materials.  
Na2CO3 (CAS 497-19-8) was purchased from Nacalai Tesque, Inc. 4-Iodoanisole (CAS 
696-62-8) and 8-Aminoquinoline (CAS 578-66-5), 2,4,6-Trimethylbenzoic Acid (CAS 
480-63-7) and methyl 2-methylbenzoate (CAS 89-71-4 ) were purchased from Tokyo Kasei 
Kogyo Co., Ltd. N,N-dimethylformamide, super dehydrated (CAS 68-12-2) was purchased 
from Wako Pure Chemicals. Ni(OTf)2 ( CAS 60871-84-3) was prepared by chapter 1 
procedure. 
 
Synthesis of the Starting Amides. 
All amides bearing an 8-aminoquinoline moiety were prepared by the reaction of the 
corresponding acid chlorides with 8-aminoquinoline. 1-Phenylcyclobutanecarboxylic acid 
(SM for 12a) was synthesized by a literature procedure.13 2-Phenylheptanoic acid (SM for 
1a-d3 ) was synthesized by a literature procedure.
14 
1-Methyl-N-(quinolin-8-yl)cyclohexanecarboxamide 10a (CAS 1429896-59-2) and 
2-methyl-2-phenyl-N-(quinolin-8-yl)propanamide 9a (CAS 1327475-16-0) were prepared by 
a literature procedure.15 All spectrum data of starting amides are cited in original paper.16 
 
General Procedure for the Preparation of the Starting Carboxylic Acid. 
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A solution of n-buthyllithium in hexane (1.6M, 15 mL, 24 mmol) was added dropwise to a 
solution of diisopropylamine (2.4 g, 24 mmol) in 30 mL of THF at -78 °C. The solution was 
stirred for 1h and a solution of methyl 2-phenylpropanoate (3.3 g, 20 mmol) in 10 ml of THF 
was added dropwise to the LDA solution. The solution was stirred for 1h at -78 °C and 
1-bromopentane (6.0 g, 40 mmol) was added dropwise to the solution. The solution was 
stirred for 1 h at -78 °C and then 4h at r.t.  The reaction mixture was quenched with water 
and the organic layer was separated. The aqueous layer was extracted with ether (2 x 15 mL). 
The combined organic layers were washed with brine (30 mL), dried over MgSO4, filtered 
and evaporated in vacuo to give the desired methyl 2-methyl-2-phenylheptanoate (4.5 g, 
96%).  
The ester was hydrolyzed in 30 mL of 4N NaOH aq. and MeOH at 100 °C for 1day. After 
cooling the solution, the aqueous layer was extracted with DCM (2 x 15 mL). The aqueous 
layer was acidified with aqueous HCl and the aqueous layer was extracted with DCM (2 x 15 
mL) and brine (30 mL), dried over MgSO4, filtered and evaporated in vacuo to give the 
desired carboxylic acid (2.9 g, 70%). 
2-Butyl-2-methylhexanoic acid (SM for 7a) was synthesized by the reaction of methyl 
2-butylhexanoate with methyl iodide. 2-Benzyl-2-methylbutanoic acid (SM for 8a) was 
synthesized by the reaction of methyl 2-methyl-3-phenylpropanoate with ethyl iodide. 
1-Methylcycloheptanecarboxylic acid (SM for 11a) was synthesized by the reaction of methyl 
cycloheptanecarboxylate with methyl iodide. 2-Cyclohexylpropanoic acid (SM for 14a) was 
synthesized by the reaction of methyl 2-cyclohexylacetate with methyl iodide. 
2-methyl-d3-2-phenylheptanoic acid (SM for 1a-d3) was synthesized by the reaction of methyl 
2-phenylheptanoate with metyl iodide-d3. 
 
General Procedure for the Preparation of Starting Amide. 
 
To an oven-dried 100 mL three-necked flask, 2-methyl-2-phenylheptanoic acid (3.3 g, 15 
mmol), DMF (5 drops) and DCM (30 mL) were added under a N2 atmosphere. Oxalyl 
chloride (1.5 mL, 18 mmol, 1.2 equiv.) was added dropwise at 0 °C resulting in vigorous 
bubbling. The mixture was stirred for 3 h at room temperature, and the solvent was then 
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removed in vacuo. The resulting acid chloride was used immediately without further 
purification.  
To another oven-dried 100 mL three-necked flask, 8-aminoquinoline (2.9 g, 20 mmol, 1.3 
equiv.), Et3N (4.1 mL, 30 mmol, 2 equiv.) and DCM (30 mL) were added. A solution of the 
acid chloride in DCM (10 mL) was added dropwise to the solution at 0 °C, and the solution 
was then warmed to room temperature. After stirring overnight, the reaction system was 
quenched with sat. aq. NaHCO3 (30 mL) and the organic layer was separated. The aqueous 
layer was extracted with DCM (2 x 15 mL). The combined organic layers were washed with 1 
M HCl aq. (30 mL) and brine (30 mL), dried over MgSO4, filtered and evaporated in vacuo. 
The resulting crude amide was purified by column chromatography on silica gel (eluant: 
hexane/EtOAc = 5/1) to afford the desired amide as a white solid (4.6 g, 90%). 
 
General Procedure for Direct Arylation: Ni-Catalyzed Arylation of Amides 1a with 
4-iodoanisole. 
To an oven-dried 5 mL screw-capped vial, in a glove box 
2-methyl-2-phenyl-N-(quinolin-8-yl)heptanamide 1a  (104 mg, 0.3 mmol), 4-iodoanisole 
(140 mg, 0.6 mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol), MesCOOH (9.8 mg, 0.06 mmol), 
Na2CO3 (64 mg, 0.6 mmol) and DMF (0.6 mL) were added. The mixture was stirred for 24 h 
at 140 °C followed by cooling. 30 mL of water was added to the reaction mixture and the 
aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were washed with and brine (20 mL), dried over MgSO4, filtered and evaporated in vacuo. 
The residue was purified by column chromatography on silica gel (eluent: hexane/EtOAc= 
20/1) to afford the desired arylated product 1b (112 mg, 83%) as a white solid. 
 
2-(4-methoxybenzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1b). 
 
Rf 0.34 (hexane/EtOAc = 5/1). White Solid. Mp = 144 °C. 
1H NMR (CDCl3, 399.78 MHz)  
0.83 (t, J = 6.4 Hz, 3H), 1.26-1.55 (m, 6H), 2.01 (t, J = 8.0, 2H), 3.35 (d, J = 14.0 Hz, 1H), 
3.51 (d, J = 13.6 Hz, 1H), 3.72 (s, 3H), 6.64 (s, 4H), 7.25-7.36 (m, 6H), 7.46 (d, J = 8.0, 1H), 
7.54 (t, J = 8.4 Hz, 1H), 8.08 (d, J = 8.4 Hz, 1H), 8.58 (dd, J = 4.0, 1.2 Hz, 1H), 8.78 (d, J = 
7.6 Hz, 1H), 9.80 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 14.03, 22.42, 24.06, 32.31, 
33.99, 40.79, 55.05,  56.60, 113.00, 116.02, 21.012, 121.40, 126.96, 127.32, 127.66, 127.84, 
128.39, 129.30, 131.24, 134.65, 138.62, 142.99, 148.11, 158.01, 174.67; IR (neat) 3343 w, 
2934 w, 1712 m, 1683 m, 1522 s, 1424 m, 1325 m, 1247 m, 1036 w, 825 m, 754 m; MS m/z 
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(relative intensity, %) 452 (M+, 23), 264 (26), 167 (67), 144 (34), 119 (100), 13 (13); HRMS 
Calcd for C30H32N2O2: 452.2464; Found: 452.2469. 
 
3-(4-methoxyphenyl)-2,2-diphenyl-N-(quinolin-8-yl)propanamide (6b). 
 
Rf 0.20 (hexane/EtOAc = 5/1). White Solid. Mp =164 °C. 
1H NMR (CDCl3, 399.78 MHz)  
3.68 (s, 3H), 3.85 (s, 2H), 6.56 (d, J = 8.8 Hz, 2H), 6.73 (d, J = 8.8 Hz, 2H), 7.54-7.32 (m, 
7H), 7.36-7.38 (m, 4H), 7.42 (d, J = 8.0 Hz, 1H), 7.50 (t, J = 8.0 Hz, 1H), 8.04 (d, J = 8.4 Hz, 
1H), 8.52 (dd, J = 4.0, 1.2 Hz, 1H),  8.78 (dd, J = 8.0, 1.2 Hz, 1H), 10.23 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz) 43.59, 55.02, 64.45, 112.75, 115.98, 121.29, 121.40, 126.97, 
127.24, 127.78, 128.02, 129.70, 129.79, 132.15, 134.65, 135.96, 138.66, 142.35, 148.07, 
157.88, 172.18; IR (neat) 3330 w, 1679 m, 1512 s, 1484 m, 1384 m, 1326 m, 1250 m, 1178 w, 
1036 w, 825 m, 753 s, 700 m; MS m/z (relative intensity, %) 458 (M+, 12), 337 (29), 265 (10), 
264 (51), 171 (40), 165 (13), 144 (17), 121 (100); HRMS Calcd for C31H26N2O2: 458.1994; 
Found: 458.1995. 
 
2-butyl-2-(4-methoxybenzyl)-N-(quinolin-8-yl)hexanamide (7b). 
 
Rf 0.31 (hexane/EtOAc = 5/1). Pale Brown Solid. Mp =97-98 °C. 
1H NMR (CDCl3, 399.78 
MHz) 0.92 (t, J = 6.8 Hz, 6H), 1.32-1.38 (m, 8H), 1.59-1.80 (m, 4H), 3.01 (s, 2H), 3.69 (s, 
3H), 6.70 (d, J = 8.8 Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 7.42 (dd, J = 8.4, 4.0, 1H), 7.48-7.57 
(m, 2H), 8.14 (dd, J = 8.4, 1.6 Hz, 1H), 8.74 (dd, J = 4.4, 1.6 Hz, 1H), 8.82 (dd, J = 8.0, 1.6 
Hz, 1H), 10.15 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 14.05, 23.24, 26.25, 34.27, 40.18, 
51.64, 55.04, 113.35, 116.23, 11.12, 121.45, 127.44, 127.87, 129.80, 130.92, 134.45, 136.16, 
138.75, 148.11, 157.98, 175.39; IR (neat) 3361 w, 2931 w, 1672 m, 1524 s, 1466 m, 1423 m, 
1384 m, 1325 m, 1249 m, 1178 w, 1038 w, 825 m, 792 m; MS m/z (relative intensity, %) 418 
(M+, 23), 361 (10), 297 (10), 246 (14), 217 (31), 171 (47), 145 (10), 144 (67), 121 (100); 
HRMS Calcd for C27H34N2O2: 418.2620; Found: 418.2617. 
 
2-benzyl-2-(4-methoxybenzyl)-N-(quinolin-8-yl)butanamide (8b). 
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Rf 0.29 (hexane/EtOAc = 5/1). Pale Brown Solid. Mp =97-98 °C. 
1H NMR (CDCl3, 399.78 
MHz) 1.18 (t, J = 7.2 Hz, 3H), 1.75 (q, J = 7.2 Hz, 2H), 2.95 (dd, J = 20.8, 13.6 Hz, 2H), 3.29 
(dd, J = 25.6, 14.0 Hz, 2H), 3.64 (s, 3H), 6.66 (d, J = 8.0 Hz, 2H), 7.07-7.21 (m, 7H), 7.36 (dd, 
J = 8.4, 4.0 Hz, 1H), 7.47 (d, J = 8.4 Hz, 1H), 7.55 (t, J = 8.0 Hz, 1H), 8.09 (d, J = 8.4 Hz, 1H), 
8.60 (dd, J = 4.0, 1.2 Hz, 1H), 8.86 (dd, J = 8.0, 1.2 Hz, 1H), 9.95 (brs, 1H); 13C NMR (CDCl3, 
100.53 MHz) 8.68, 23.84, 40.93, 41.54, 53.25, 55.00, 113.37, 116.25, 121.26, 121.36, 126.24, 
127.34, 127.75, 128.00, 129.50, 130.11, 131.03, 134.21, 136.02, 137.69, 138.62, 147.96, 
158.00, 174.57; IR (neat) 3359 w, 2931 w, 1671 m, 1526 s, 1325 w, 1248 m, 1179 w, 1036 w, 
826 w; MS m/z (relative intensity, %) 424 (M+, 8), 334 (14), 333 (60), 190 (12), 189 (100), 
171 (31), 144 (25), 121 (73) 91 (26); HRMS Calcd for C28H28N2O2: 424.2151; Found: 
424.2145 
 
3-(4-methoxyphenyl)-2-methyl-2-phenyl-N-(quinolin-8-yl)propanamide (9b). 
 
Rf 0.23 (hexane/EtOAc = 5/1). White Solid. Mp =136 °C. 
1H NMR (CDCl3, 399.78 MHz) 
1.68 (s, 3H), 3.34 (d, J = 13.6 Hz, 1H), 3.56 (d, J = 13.6 Hz, 1H), 3.71 (s, 3H), 6.66 (d, J = 8.8 
Hz, 2H), 6.79 (d, J = 8.8 Hz, 2H), 7.27-7.38 (m, 4H), 7.43-7.45 (m, 3H), 7.52 (t, J = 8.4 Hz, 
1H), 8.06 (dd, J = 8.4, 1.6 Hz, 1H), 8.57 (dd, J = 4.0, 1.6 Hz, 1H), 8.80 (d, J = 8.0 Hz, 1H), 
9.89 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 22.80, 44.34, 52.89, 55.05, 113.06, 116.00, 
121.24, 121.40, 127.08, 127.22, 127.29, 127.79, 128.53, 129.47, 131.53, 134.60, 136.04, 
138.58, 143.16, 148.09, 158.05, 175.12; IR (neat) 3351 w, 1679 m, 1523 s, 1484 m, 1384 m, 
1326 m, 1245 m, 1034 w, 824 m, 755 m; MS m/z (relative intensity, %) 396 (M+, 9), 171 (40), 
144 (23), 121 (100), 103 (16); HRMS Calcd for C26H24N2O2: 396.1838; Found: 396.1838. 
 
2-(4-methoxybenzyl)-3-(4-methoxyphenyl)-2-phenyl-N-(quinolin-8-yl)propanamide (9c). 
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Rf 0.11 (hexane/EtOAc = 5/1). White Solid. Mp =157 °C. 
1H NMR (CDCl3, 399.78 MHz) 
3.43 (q, J = 10.8 Hz, 4H), 3.69 (s, 6H), 6.64 (d, J = 8.8 Hz, 4H), 6.87 (d, J = 8.8 Hz, 4H), 
7.27-7.37 (m, 6H), 7.44 (d, J = 8.4 Hz, 1H), 7.52 (t, J = 8.4 Hz, 1H), 8.06 (dd, J = 8.0, 1.2 Hz, 
1H), 8.52 (dd, J = 4.0, 1.2 Hz, 1H), 8.73 (d, J = 7.2 Hz, 1H), 9.87 (brs, 1H); 13C NMR (CDCl3, 
100.53 MHz) 40.93, 55.01, 58.20, 113.12, 116.04, 121.15, 121.36, 127.16, 127.30, 127.78, 
128.15, 128.38, 129.11, 131.55, 134.44, 135.94, 138.53, 142.40, 148.06, 158.03, 173.84; IR 
(neat) 3338 w, 1685 m, 1610 w, 1512 s, 1484 m, 1325 w, 1248 m, 1179 m, 1035 m, 824 m, 
754 m; MS m/z (relative intensity, %) 502 (M+, 2), 382 (19), 381 (69), 264 (13), 237 (50), 209 
(17), 171 (46), 144 (10), 121 (100); HRMS Calcd for C33H30N2O3: 502.2249; Found: 
502.2256. 
 
1-(4-methoxybenzyl)-N-(quinolin-8-yl)cyclohexanecarboxamide (10b). 
 
Rf 0.31 (hexane/EtOAc = 5/1). Colorless oil. 
1H NMR (CDCl3, 399.78 MHz) 1.32-1.75 (m, 
8H), 2.22-2.25 (m, 2H), 2.90 (s, 2H), 3.61 (s, 3H), 6.61 (d, J = 8.4 Hz, 2H), 7.01 (d, J = 8.4 
Hz, 2H), 7.40 (dd, J = 8.4, 4.0 Hz, 1H), 7.47 (dd, J = 8.0, 4.0, 1H), 7.54 (t, J = 8.4 Hz, 1H), 
8.12 (dd, J = 8.4, 2.0 Hz, 1H), 8.69 (dd, J = 4.0, 2.0 Hz, 1H), 8.80 (dd, J = 8.0, 1.6 Hz, 1H), 
10.01 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 23.11, 25.92, 34.12, 46.40, 49.61, 54.99, 
113.20, 116.22, 121.09, 121.36, 127.39, 127.81, 129.13, 130.99, 134.47, 136.09, 138.70, 
148.02, 158.08, 174.69; IR (neat) 3359 w, 2928 w, 1672 m, 1512 s, 1468 m, 1324 m, 1245 s, 
1178 m, 1035 m, 792 m, 753 s; MS m/z (relative intensity, %) 374 (M+, 17), 253 (14), 202 
(13), 171 (44), 145 (10), 144 (68), 121 (100), 109 (10); HRMS Calcd for C24H26N2O2: 
374.1990; Found: 374.1994. 
 
1-(4-methoxybenzyl)-N-(quinolin-8-yl)cycloheptanecarboxamide (11b). 
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Rf 0.34 (hexane/EtOAc = 5/1). Pale yellow oil 
1H NMR (CDCl3, 399.78 MHz) 1.58-1.78 (m, 
10 H), 2.22-2.28 (m, 2H), 2.93 (s, 2H), 3.63 (s, 3H), 6.63 (d, J = 8.8 Hz, 2H), 7.03 (d, J = 8.4 
Hz, 2H), 7.41 (dd, J = 8.4, 4.0 Hz, 1H), 7.48 (dd, J = 8.4, 1.6 Hz, 1H), 7.54 (t, J = 8.0 Hz, 1H), 
8.13 (dd, J = 8.0, 1.6 Hz, 1H), 8.71 (dd, J = 4.0, 1.6 Hz, 1H), 8.82 (dd, J = 8.0, 1.2 Hz, 1H), 
10.02 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 23.46, 30.02, 36.10, 46.90, 52.45, 55.00, 
113.23, 116.18, 121.08, 121.39, 127.43, 127.83, 129.71, 131.01, 134.59, 136.13, 138.69, 
148.03, 158.05, 175.87; IR (neat) 3359 w, 2924 w, 1672 m, 1523 s, 1465 m, 1324 m, 1246 s, 
1178 m, 1036 m, 825 m, 753 s; MS m/z (relative intensity, %) 388 (M+, 26), 267 (20), 216 
(14), 171 (56), 145 (13), 144 (93), 121 (100); HRMS Calcd for C25H28N2O2: 388.2152; 
Found: 388.2152. 
 
1-(4-methoxybenzyl)-2-(4-methoxyphenyl)-N-(quinolin-8-yl)cycloheptanecarboxamide 
(11c). 
 
Rf 0.23 (hexane/EtOAc = 5/1). White Solid. Mp =79-80 °C. 
1H NMR (CDCl3, 399.78 MHz) 
1.44-1.68 (m, 5H), 1.92-1.95 (m, 3H), 2.31-2.49 (m, 3H), 2.79 (t, J = 10.0 Hz, 1H), 2.98 (d, J 
= 13.6 Hz, 1H), 3.11 (d, J = 14.0 Hz, 1H), 3.64 (s, 3H), 3.82 (s, 3H), 6.60 (d, J = 8.0 Hz, 1H), 
6.86 (d, J = 8.4 Hz, 1H), 6.99 (d, J = 8.4 Hz, 1H), 7.16 (d, J = 8.4 Hz, 1H), 7.41 (dd, J = 8.0, 
4.0 Hz, 1H), 7.48-7.56 (m, 2H), 8.13 (d, J = 8.4 Hz, 1H), 8.72 (d, J = 4.4 Hz, 1H), 8.80 (d, J = 
7.2 Hz, 1H), 10.12 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 23.76, 31.07, 35.74, 40.07, 
40.74, 43.83, 45.85, 51.88, 55.02, 55.25, 113.37, 113.80, 116.26, 121.19, 121.45, 127.42 (two 
overlapping peaks), 127.85, 129.50, 131.01, 134.56, 136.18, 142.01, 148.14, 157.58, 158.07, 
175.92; .18, IR (neat) 3358 w, 2924 w, 1670 m, 1611 m, 1511 s, 1484 m, 1325 m, 1245 s, 
1178 m, 1035 m, 824 m, 752 s; MS m/z (relative intensity, %) 495 (18), 494 (M+, 43), 373 
(18), 172 (10), 171 (68), 145 (11), 144 (63), 122 (10), 121 (100); HRMS Calcd for 
C32H34N2O3: 494.2569; Found: 494.2568. 
 
2-(4-methoxyphenyl)-1-phenyl-N-(quinolin-8-yl)cyclobutanecarboxamide (12b). 
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Rf 0.31 (hexane/EtOAc = 5/1). White Solid. Mp =128 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.26-2.37 (m, 2H), 2.70-2.78 (m, 1H), 3.27 (t, J = 7.6 Hz, 1H), 3.47 (s, 3H), 4.28 (t, J = 7.6 Hz, 
1H), 6.57 (d, J = 2H), 7.23 (dd, J = 8.4, 4.0 Hz, 1H), 7.29-7.46 (m, 7H), 7.53 (d, J = 8.0 Hz, 
2H), 7.96 (dd, J = 8.4, 1.6 Hz, 1H), 8.37 (dd, J = 4.0, 1.6 Hz, 1H), 8.57 (dd, J = 8.0, 1.6 Hz, 
1H), 9.27 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 24.57, 29.03, 49.81, 54.94, 61.41, 
113.50, 115.60, 120.88, 121.02, 126.33, 126.87, 127.03, 128.94, 129.20, 132.58, 134.51, 
135.55, 138.45, 145.98, 147.57, 158.36, 171.53; IR (neat) 3324 w, 2944 w, 1674 m, 1524 s, 
1485 m, 1327 w, 1251 m, 1178 w, 1035 w, 756 m; MS m/z (relative intensity, %) 409 (11), 
408 (M+, 36), 275 (20), 274 (95), 273 (12), 246 (11), 231 (12), 172 (12), 171 (100), 145 (10), 
144 (69), 134 (69), 130 (17), 119 (17), 103 (42), 91 (10), 77 ( 10); HRMS Calcd for 
C27H24N2O2: 408.1838; Found: 408.1835. 
 
2,4-bis(4-methoxyphenyl)-1-phenyl-N-(quinolin-8-yl)cyclobutanecarboxamide (12c). 
 
Rf 0.20 (hexane/EtOAc = 5/1). White Solid. Mp =87 °C. 
1H NMR (CDCl3, 399.78 MHz) 2.72 
(q, 8.0 Hz, 1H), 3.49 (q, J = 10.4 Hz, 1H), 3.69 (s, 6H), 4.09 (dd, J = 10.8, 8.0 Hz, 1H), 6.78 
(d, J = 8.8 Hz, 4H), 7.20 (dd, J = 8.0, 4.0 Hz, 1H), 7.27-7.34 (m, 2H), 7.43-7.48 (m, 5H), 7.34 
(t, J = 7.6 Hz, 2H), 7.68 (d, J = 8.4 Hz, 2H), 7.92 (dd, J = 8.0, 1.6 Hz, 1H), 8.31 (dd, J = 4.4, 
1.6 Hz, 1H), 8.44 (dd, J = 7.6, 1.6 Hz, 1H), 9.38 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
30.83, 47.16, 55.11, 67.56, 113.38, 115.90, 120.87, 121.01, 127.06, 127.33, 127.45, 129.08, 
129.57, 132.57, 134.32, 135.64, 138.51, 145.12, 147.58, 158.14, 169.56; IR (neat) 3318 w, 
1674 m, 1610 w, 1512 s, 1483 m, 1326 w, 1248 s, 1178 m, 1035 m, 825 m, 755 m; MS m/z 
(relative intensity, %) 514 (M+, 9), 381 (12), 380 (41), 525 (12), 251 (67), 238 (17), 237 (100), 
210 (14), 209 (80), 171 (13), 165 (14), 144 (21); HRMS Calcd for C34H30N2O3: 514.2256; 
Found: 514.2253. 
 
2-(4-methoxyphenyl)-1-phenyl-N-(quinolin-8-yl)cyclopentanecarboxamide (13b). 
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Rf 0.23 (hexane/EtOAc = 5/1). White Solid. Mp =130 °C. 
1H NMR (CDCl3, 399.78 MHz) 
1.74-1.81 (m, 1H), 2.14-2.33 (m, 4H), 3.40-3.11 (m, 1H), 3.53 (s, 3H), 3.92 (t, J = 8.0 Hz, 
1H), 6.54 (d, J = 8.8 Hz, 2H), 7.23-7.31 (m, 4H), 7.33-7.44 (m, 4H), 7.62 (d, J = 8.8 Hz, 2H), 
7.97 (dd, J = 8.0, 1.6 Hz, 1H), 8.39 (dd, J = 4.4, 1.6 Hz, 1H), 8.56 (dd, J = 8.0, 1.6 Hz, 1H), 
9.35 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 22.42, 33.28, 38.24, 52.76, 54.90, 64.91, 
113.25, 115.63, 120.87, 121.10, 126.89, 127.10, 127.51, 128.63, 129.92, 134.07, 134.49, 
138.40, 144.08, 147.65, 157.92, 173.31; IR (neat) 3326 w, 2952 w, 1672 m, 1520 s, 1484 s, 
1384 m, 1247 s, 1180 m, 1035 m, 826 m, 755 m; MS m/z (relative intensity, %) 423 (13), 422 
(M+, 40), 276 (20), 275 (100), 257 (16), 250 (26), 172 (10), 171 (70), 147 (12), 145 (10), 144 
(76), 117 (18), 103 (30), 91 (10); HRMS Calcd for C28H26N2O2: 422.1994; Found: 422.1992. 
 
2,5-bis(4-methoxyphenyl)-1-phenyl-N-(quinolin-8-yl)cyclopentanecarboxamide (13c). 
 
Rf 0.23 (hexane/EtOAc = 5/1). White Solid. Mp =130 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.31-2.38 (m, 2H), 2.81-2.86 (m, 2H), 3.57 (s, 6H), 3.74-3.78 (m, 2H), 6.57 (d, J = 8.8 Hz, 
4H), 7.16 (dd, J = 8.4, 4.0 Hz, 1H), 7.23 (d, J = 8.4 Hz, 4H), 7.26-7.33 (m, 5H), 7.37 (dd, J = 
8.0, 1.6 Hz, 1H), 7.95 (dd, J = 8.0, 1.6 Hz, 1H), 8.16 (dd, J = 4.0, 1.6 Hz, 1H), 8.76 (dd, J = 
7.2, 1.6 Hz, 1H), 9.15 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 30.71, 54.94, 56.84, 69.23, 
113.02, 115.78, 120.93, 120.98, 127.03, 127.11, 127.50, 127.96, 129.26, 130.79, 132.30, 
134.53, 135.44, 138.46, 140.53, 147.51, 158.08, 171.52; IR (neat) 3325 w, 2933 w, 1672 m, 
1513 s, 1483 m, 1246 s, 1179 m, 1036 m, 826 m; MS m/z (relative intensity, %) 529 (12), 528 
(M+, 28), 395 (10), 394 (34), 381 (29), 356 (12), 250 (16), 238 (17), 237 (94), 223 (14), 210 
(12), 209 (58), 171 (33), 145 (14), 144 (100), 121 (15), 115 (10) 91 (10); HRMS Calcd for 
C35H32N2O3: 528.2413; Found: 528.2414. 
 
2-cyclohexyl-3-(4-methoxyphenyl)-N-(quinolin-8-yl)propanamide (14b). 
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Rf 0.23 (hexane/EtOAc = 5/1). Pale wellow oil. 
1H NMR (CDCl3, 399.78 MHz) 1.34-1.31 (m, 
5H), 1.64-1.87 (m, 5H), 2.04 (d, J = 8.4 Hz, 1H), 2.46-2.52 (m, 1H), 2.92-3.04 m, 2H), 3.62 (s, 
3H), 6.69 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 7.36 (dd, J = 8.4, 4.0 Hz, 1H), 
7.41-7.50 (m, 2H), 8.07 (dd, J = 8.4, 1.2 Hz, 1H), 8.70 (dd, J = 4.0, 2.0 Hz, 1H), 8.76 (d, J = 
8.0 Hz, 1H), 9.53 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 26.33 (t, J = 5.7 Hz), 30.89, 
31.05, 35.09, 40.63, 54.99, 58.02, 113.67, 116.28, 121.18, 121.36, 127.25, 127.74, 129.73, 
132.26, 134.19, 136.11, 138.19, 147.90, 157.73, 173.34; IR (neat) 2925 w, 1683 m, 1523 s, 
1484 m, 1324 m, 1246 m, 1037 w, 825 w; MS m/z (relative intensity, %) 388 (M+, 29), 306 
(15), 305 (49), 171 (30), 161 (56), 145 (16), 144 (100), 121 (54); HRMS Calcd for 
C25H28N2O2: 388.2151; Found: 388.2153. 
 
2-phenyl-N-(quinolin-8-yl)-2-(4-(trifluoromethyl)benzyl)heptanamide (1d). 
 
Rf 0.51 (hexane/EtOAc = 5/1). Pale Brown Solid. Mp =136 °C. 
1H NMR (CDCl3, 399.78 
MHz) 0.83 (t, J = 6.8 Hz, 3H), 1.27-1.57 (m, 6H), 1.94-2.07 (m, 2H), 3.45 (d, J = 13.6 Hz, 
1H), 3.59 (d, J = 14.0 Hz, 1H), 6.79 (d, J = 7.6 Hz, 2H), 7.27-7.36 (m, 8H), 7.46 (d, J = 8.4 Hz, 
1H), 7.54 (t, J = 8.4 Hz, 1H), 8.08 (dd, J = 8.0, 1.6 Hz, 1H), 8.56 (dd, J = 4.0, 1.6 Hz, 1H), 
8.77 (d, J = 7.6 Hz, 1H), 9.79 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 14.11, 22.50, 24.23, 
32.35, 34.27, 41.83, 56.63, 116.16, 120.33, 121.43, 121.58, 124.40 (q, J = 270 Hz), 124.52 (d, 
J = 3.8 Hz), 127.41 (d, J = 3.8 Hz), 127.72, 127.96, 128.69, 130.73, 134.59, 136.16, 138.69, 
141.89, 142.37, 148.27, 147.23; IR (neat) 3340 w, 2934 w, 1682 m, 1523 s, 1485 m, 1323 s, 
1163 m, 1119 s, 1067 m, 825 m, 700 m; MS m/z (relative intensity, %) 490 (M+, 6), 172 (12), 
171 (100), 144 (16); HRMS Calcd for C30H29N2O: 490.2232; Found: 490.2228. 
 
Methyl 4-(2-phenyl-2-(quinolin-8-ylcarbamoyl)heptyl)benzoate (1e). 
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Rf 0.26 (hexane/EtOAc = 5/1). Off white solid. Mp =122 °C. 
1H NMR (CDCl3, 399.78 MHz) 
0.83 (t, J = 7.6 Hz, 3H), 1.26-1.60 (m, 6H), 1.93-2.03 (m, 2H), 3.43 (d, J = 14.0 Hz, 1H), 3.60 
(d, J = 13.2 Hz, 1H), 3.86 (s, 3H), 6.76 (d, J = 8.4 Hz, 2H), 7.28-7.36 (m, 6H), 7.47 (d, J = 8.4 
Hz, 1H), 7.54 (t, J = 8.0 Hz, 1H), 7.76 (d, J = 8.4 Hz, 2H), 8.09 (d, J = 8.4 Hz, 1H), 8.56 (dd, J 
= 4.4, 1.2 Hz, 1H), 8.78 (d, J = 8.0 Hz, 1H), 9.79 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
14.02, 22.39, 24.09, 32.24, 34.08, 41.84, 51.94, 56.54, 116.05, 121.28, 121.44, 127.26, 127.30, 
127.57, 127.84, 128.10, 128.53, 130.39, 134.49, 136.06, 138.56, 142.37, 143.20, 148.14, 
167.14, 174.20; IR (neat) 3341 w, 2951 w, 1719 s, 1682 m, 1522 s, 1484 m, 1325 m, 1278 s, 
1183 w, 1108 m, 754 m; MS m/z (relative intensity, %) 480 (M+, 5), 172 (11), 171 (100), 144 
(16); HRMS Calcd for C31H32N2O3: 480.2413; Found: 480.2414. 
 
2-(4-Iodobenzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide(1f). 
 
Rf 0.51 (hexane/EtOAc = 5/1). Off white Solid. Mp =121 °C. 
1H NMR (CDCl3, 399.78 MHz) 
0.82 (t, J = 6.8 Hz, 3H), 1.25-1.54 (m, 6H), 1.93-2.05 (m, 2H), 3.33 (d, J = 13.6 Hz, 1H), 3.48 
(d, J = 13.6 Hz, 1H), 6.43 (d, J = 8.4 Hz, 2H), 7.26-7.35 (m, 6H), 7.39 (d, J = 8.4 Hz, 2H), 
7.44 (d, J = 8.4 Hz, 1H), 7.53 (t, J = 8.4 Hz, 1H), 8.06 (dd, J = 8.4, 1.6 Hz, 1H), 8.56 (dd, J = 
4.0, 1.6 Hz, 1H), 8.77 (d, J = 8.0 Hz, 1H), 9.78 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
14.01, 22.38, 24.07, 32.24, 34.03, 41.33, 56.40, 91.84, 116.01, 121.24, 121.42, 127.19, 127.26, 
127.60, 127.81, 128.51, 132.36, 134.48, 136.01, 136.60, 137.11, 138.55, 142.42, 148.13, 
174.23; IR (neat) 3334 w, 2933 w, 1739 s, 1673 s, 1524 s, 1485 s, 1378 m, 1326 m, 1216 m, 
822 m, 792 m; MS m/z (relative intensity, %) 548 (M+, 15), 172 (12), 171 (100), 144 (24); 
HRMS Calcd for C29H29N2OI: 548.1325; Found: 548.1323. 
 
2-(4-chlorobenzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1g). 
 
Rf 0.51 (hexane/EtOAc = 5/1). White Solid. Mp =109 °C. 
1H NMR (CDCl3, 399.78 MHz) 
0.82 (t, J = 6.8 z, 3H), 1.26-1.55 (m, 6H), 1.94-2.07 (m, 2H),  3.36 (d, J = 13.6 Hz, 1H), 3.52 
(d, J = 13.6 Hz, 1H), 6.62 (d, J = 8.4 Hz, 2H), 7.04 (d, J = 8.8 Hz, 2H), 7.25-7.35 (m, 6H), 
7.45 (dd, J = 8.4, 1.2 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 8.07 (dd, J = 8.4, 1.2 Hz, 1H), 8.56 (dd, 
J = 4.4, 1.2 Hz, 1H), 8.77 (d, J = 8.0 Hz, 1H), 9.79 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
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14.01, 22.38, 24.06, 32.24, 34.03, 41.15, 56.45, 116.02, 121.24, 121.42, 127.18, 127.27, 
127.60, 127.68, 127.81, 131.61, 132.07, 134.49, 135.91, 136.01, 138.55, 142.46, 148.12, 
174.26; IR (neat) 3342 w, 2932 w, 1683 m, 1522 s, 1485 m, 1326 m, 824 m, 754 m; MS m/z 
(relative intensity, %) 456 (M+,7),172 (12), 171 (100), 144 (20); HRMS Calcd for 
C29H29ClN2O: 456.1968; Found: 456.1970. 
 
2-(4-methylbenzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1h). 
 
Rf 0.51 (hexane/EtOAc = 5/1). White Solid. Mp =101 °C. 
1H NMR (CDCl3, 399.78 MHz) 
0.82 (t, J = 7.2 Hz, 3H), 1.26-1.55 (m, 6H), 2.302 (t, J = 8.4 Hz, 2H), 2.23 (s, 3H), 3.36 (d, J = 
13.2 Hz, 1H), 3.54 (d, J = 13.6 Hz, 1H), 6.61 (d, J = 8.0 Hz, 2H), 6.89 (d, J = 8.0 Hz, 2H), 
7.26-7.33 (m, 6H), 7.43 (d, J = 8.4 Hz, 1H), 7.52 (t, J = 8.0 Hz, 1H), 8.04 (dd, J = 8.0, 1.2 Hz, 
1H), 8.55 (dd, J = 4.0, 1.2 Hz, 1H), 8.79 (dd, J = 8.0, 1.2 Hz, 1H), 9.81 (brs, 1H); 13C NMR 
(CDCl3, 100.53 MHz) 14.02, 20.98, 22.41, 24.05, 32.27, 33.92, 41.14, 56.49, 115.97, 121.09, 
121.36, 126.94, 127.29, 127.60, 127.80, 128.31, 128.37, 130.17, 134.13, 134.63, 135.62, 
135.97, 138.57, 143.01, 148.06, 174.63; IR (neat) 3342 w, 2931 w, 1638 m, 1521 s, 1484 m, 
1383 m, 1325 m, 791 m, 753 m; MS m/z (relative intensity, %) 436 (M+, 17), 172 (12), 171 
(100), 144 (34), 105 (24), 91 (11); HRMS Calcd for C30H32N2O: 436.2513; Found: 436.2515. 
 
2-(4-aminobenzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1j). 
 
Rf 0.22 (hexane/EtOAc = 5/1). Pale yellow Solid. Mp =121 °C. 
1H NMR (CDCl3, 399.78 
MHz) 0.82 (t, J = 7.2 Hz, 3H), 1.25-1.45 (m, 6H), 1.99-2.04 (m, 2H), 3.29 (d, J = 13.6 Hz, 
1H), 3.45-3.49 (m, 3H), 6.42 (d, J = 7.6 Hz, 2H), 6.51 (d, J = 8.4 Hz, 2H), 7.23-7.34 (m, 6H), 
7.44 (dd, J = 8.4, 1.6 Hz, 1H), 7.52 (t, J = 8.4 Hz, 1H), 8.07 (dd, J = 8.0, 1.6 Hz, 1H), 8.57 (dd, 
J = 4.0, 1.6 Hz, 1H), 8.78 (dd, J = 8.0, 1.6 Hz, 1H), 9.80 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz) 14.04, 22.41, 24.03, 32.30, 33.89, 40.77, 56.59, 114.56, 115.96, 121.05, 121.37, 126.85, 
127.15, 127.30, 127.65, 127.81, 128.32, 131.07, 134.66, 135.98, 138.58, 143.15, 144.49, 
148.08, 174.80; IR (neat) 3352 w, 2931 w, 1680 m, 1622 w, 1521 s, 1484 m, 1326 m, 826 w, 
755 m; MS m/z (relative intensity, %) 437 (M+, 6), 332 (18), 171 (11), 144 (28), 106 (100); 
HRMS Calcd for C29H31N3O: 437.2467; Found: 437.2465. 
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2-(4-(dimethylamino)benzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1k). 
 
Rf 0.29 (hexane/EtOAc = 5/1). Pale yellow Solid. Mp =125 °C. 
1H NMR (CDCl3, 399.78 
MHz) 0.82 (t, J = 6.8 Hz, 3H), 1.26-1.51 (m, 6H), 2.02 (t, J = 8.4 Hz, 1H), 2.84 (s, 6H), 3.32 
(d, J = 13.6 Hz, 1H), 3.50 (d, J =14.0 Hz, 1H), 6.49 (d, J = 8.4 Hz, 2H), 6.60 (d, J = 8.4 Hz, 
2H), 7.24-7.36 (m, 6H), 7.43 (dd, J = 8.0, 1.2 Hz, 1H), 7.52 (t, J = 8.4 Hz, 1H), 8.06 (dd, J = 
8.0, 1.2 Hz, 1H), 8.56 (dd, J = 4.4, 1.2 Hz, 1H), 8.79 (dd, J = 7.6, 1.2 Hz, 1H), 9.81 (brs, 1H); 
13C NMR (CDCl3, 100.53 MHz) 14.20, 22.58, 24.20, 32.47, 34.07, 40.78, 56.79, 112.23, 
116.09, 121.16, 121.50, 125.26, 126.95, 127.45, 127.80, 127.96, 128.46, 131.11, 134.85, 
136.11, 138.74, 143.44, 148.21, 149.13, 175.01; IR (neat) 3343 w, 2931 w, 1682 m, 1614 w, 
1520 s, 1483 m, 1326 m, 791 m, 751 s, 699 m; MS m/z (relative intensity, %) 465 (M+, 4), 
135 (10), 134 (100); HRMS Calcd for C31H35N3O: 465.2780; Found: 465.2778. 
 
2-((1H-indol-5-yl)methyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1m). 
 
Rf 0.11 (hexane/EtOAc = 5/1). Off white Solid. Mp =90 °C. 
1H NMR (CDCl3, 399.78 MHz) 
0.82(t,  = 7.2 Hz, 3H), 1.26-1.61 (m, 6H), 1.99-2.11 (m, 2H), 3.50 (d, J = 14.0 Hz, 1H), 
3.69 (d, J = 14.0 Hz, 1H), 6.34 (t, J = 2.0 Hz, 1H), 6.49 (dd, J = 4.4, 1.2 Hz, 1H), 7.05 (t, J = 
4.4 Hz, 3H), 7.23-7.33 (m, 6H), 7.43 (dd, J = 8.8, 1.2 Hz, 1H), 7.52 (t, J = 8.0 Hz, 1H), 8.05 
(dd, J = 8.0, 1.6 Hz, 1H), 8.11 (brs, 1H), 8.55 (dd, J = 4.0, 1.6 Hz, 1H), 8.81 (dd, J = 7.6, 1.2 
Hz, 1H), 9.85 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 14.21, 22.55, 24.23, 32.45, 34.78, 
41.78, 56.99, 102.33, 110.16, 116.15, 121.53, 122.32, 124.15, 124.82, 126.99, 127.46, 
127.66, 127.88, 127.97, 128.38, 128.47, 134.72, 134.85, 136.13, 138.77, 143.51, 148.24, 
175.23; IR (neat) 3335 w, 2952 w, 1671 m, 1522 s, 1484 m, 1423 m, 1326 m, 825 w, 753 s; 
MS m/z (relative intensity, %) 461 (M+, 13), 273 (18), 171 )20), 144 (18), 131 (11), 130 
(100); HRMS Calcd for C31H31N3O: 461.2471; Found: 461.2471. 
 
2-Phenyl-N-(quinolin-8-yl)-2-(thiophen-2-ylmethyl)heptanamide (1n). 
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Rf 0.51 (hexane/EtOAc = 5/1). Colorless oil. 
1H NMR (CDCl3, 399.78 MHz) 0.82 (t, J = 6.8 
Hz, 3H), 1.27-1.59 (m, 6H), 2.06-2.18 (m, 2H), 3.64 (d, J = 14.8 Hz, 1H), 3.83 (d, J = 15.2 Hz, 
1H), 6.45 (d, 3.2 Hz, 1H), 6.79 (t, J = 4.0 Hz, 1H), 7.01 (d, J = 5.2 Hz, 1H), 7.25-7.54 (m, 8H), 
8.07 (d, J = 7.2 Hz, 1H), 8.58 (d, J = 4.0 Hz, 1H), 8.77 (d, J = 7.6 Hz, 1H), 9.82 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz) 14.05, 22.39, 23.99, 32.25, 34.12, 36.00, 56.13, 116.03, 121.21, 
121.41, 123.93, 126.12, 127.00, 127.28, 127.51, 127.80, 128.60, 134.53, 136.03, 138.55, 
139.07, 142.43, 148.11, 174.10; IR (neat) 3342 w, 2931 w, 1681 m, 1523 s, 1484 s, 1384 m, 
1326 m, 791 m; MS m/z (relative intensity, %) 429 (12), 428 (M+, 38), 357 (14), 331 (20), 172 
(13), 171 (100), 145 (11), 144 (59), 117 (13), 97 (19), 91 (11); HRMS Calcd for C27H28N2OS: 
428.1922; Found: 428.1924. 
 
2-(4-Butylbenzyl)-2-phenyl-N-(quinolin-8-yl)heptanamide (1o). 
 
Rf 0.50 (hexane/EtOAc = 5/1). White Solid. Mp =125 °C. 
1H NMR (CDCl3, 399.78 MHz)  
0.82 (t, J = 6.8 Hz, 3H), 0.88 (t, J = 7.6 Hz, 3H), 1.24-1.55 (m, 10H), 2.03 (t, J = 8.0 Hz, 2H), 
2.49 (t, J = 7.2 Hz, 2H), 3.8 (d, J = 14.0 Hz, 1H), 3.55 (d, J = 13.6 Hz, 1H), 6.65 (d, J = 7.6 Hz, 
2H), 6.90 (d, J = 8.0 Hz, 2H), 7.22-7.34 (m, 6H), 7.42 (dd, J = 8.0, 1.2 Hz, 1H), 7.51 (t, J = 
8.4 Hz, 1H), 8.03 (dd, J = 8.0, 2.0 Hz, 1H), 8.54 (dd, J = 4.4, 1.6 Hz, 1H), 8.79 (dd, J = 7.6, 
1.2 Hz, 1H), 9.82 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 13.90, 14.00, 22.29, 22.38, 
24.03, 32.25, 33.44, 34.01, 35.12, 41.20, 56.53, 115.96, 121.06, 121.33, 126.90, 127.26, 
127.59 (two overlapping peaks), 127.77, 128.33, 130.13, 134.34, 134.61, 135.93, 138.56, 
140.63, 143.02, 148.03, 174.62; IR (neat) 3337 w, 2932 w, 1683 s, 1522 s, 1484 m, 1385 m, 
1326 m, 1145 w, 822 m, 753 s, 703 m; MS m/z (relative intensity, %) 478 (M+, 20), 331 (12), 
172 (12), 171 (100), 144 (40), 14 (91); HRMS Calcd for C33H38N2O: 478.2984; Found: 
478.2989. 
 
Deuterium Labeling Experiment (Scheme. 1 and 3). 
 To an oven-dried 5 mL screw-capped vial, in a glove box 
2-methyl-2-phenyl-N-(quinolin-8-yl)heptanamide 1a-d3 (104 mg, 0.3 mmol), 4-iodoanisole 
(140 mg, 0.6 mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol) or Ni(cod)2 (6.5 mg, 0.03 mmol),  
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MesCOOH (9.8 mg, 0.06 mmol), Na2CO3 (64 mg, 0.6 mmol) and DMF (0.6 mL) were added. 
The mixture was stirred for 3 h at 140 °C followed by cooling. 30 mL of water was added to 
the reaction mixture and the aqueous layer was extracted with ethyl acetate (3 x 10 mL). The 
combined organic layers were washed with and brine (20 mL), dried over MgSO4, filtered and 
evaporated in vacuo. The residue was purified by column chromatography on silica gel 
(eluent: hexane/EtOAc= 20/1) to afford the desired arylated product. The ratio of deuterium 
was determined by 1H-NMR. 
 
Product Distribution (Scheme. 2). 
To an oven-dried 5 mL screw-capped vial, in a glove box 
2-methyl-2-phenyl-N-(quinolin-8-yl)heptanamide 1a  (104 mg, 0.3 mmol), 
1-butyl-4-iodobenzene (156 mg, 0.6 mmol), Ni(OTf)2 (10.6 mg, 0.03 mmol) or Ni(cod)2 (6.5 
mg, 0.03 mmol), MesCOOH (29 mg, 0.18 mmol), Na2CO3 (64 mg, 0.6 mmol) and DMF (0.6 
mL) were added. The mixture was stirred for 24 h at 140 °C followed by cooling. The yields 
of buthylbenzene, 1-butyl-4-iodobenzene, and 4,4'-dibutyl-1,1'-biphenyl were determined by 
GC. After determined GC yields, 30 mL of water was added to the reaction mixture and the 
aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were washed with and brine (20 mL), dried over MgSO4, filtered and evaporated in vacuo. 
The yield of product 1o was determined by 1H-NMR. 
 
Radical Trapping Experiment. 
To an oven-dried 5 mL screw-capped vial, in a glove box 
2-methyl-2-phenyl-N-(quinolin-8-yl)heptanamide 1a  (52 mg, 0.15 mmol), 4-iodoanisole (70 
mg, 0.3 mmol), TEMPO (47 mg, 0.3 mmol), Ni(OTf)2 (5.3 mg, 0.015 mmol), MesCOOH (4.8 
mg, 0.03 mmol), Na2CO3 (32 mg, 0.3 mmol) and DMF (0.6 mL) were added. The mixture 
was stirred for 24 h at 140 °C followed by cooling. 30 mL of water was added to the reaction 
mixture and the aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined 
organic layers were washed with and brine (20 mL), dried over MgSO4, filtered and 
evaporated in vacuo.  The yield of product 1b was determined by 1H-NMR. 
 
General Procesure for Direct Arylation: Ni-Catalyzed Arylation of Amides with 
Diaryliodonium salt (eq 1). 
To an oven-dried 5 mL screw-capped vial, in a glove box 
2,2-diphenyl-N-(quinolin-8-yl)propanamide 6a (106 mg, 0.3 mmol), 
4-methoxyphenyl(mesityl)iodonium trifluoromethanesulfonate (181 mg, 0.36 mmol), 
Ni(OTf)2 (10.6 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol) and 4-methyltetrahydropyrane (1 
mL) were added. The mixture was stirred for 24 h at 140 °C followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
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purified by column chromatography on silica gel (eluent: hexane/EtOAc= 10/1) to afford the 
desired arylated product 6b (99 mg, 72%) as a white solid. 
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Chapter 3 
 
Ni(II)-Catalyzed Oxidative Coupling between C(sp2)−H in Benzamides 
and C(sp3)−H in Toluene Derivatives 
 
3.1  Introduction 
The direct functionalization of C-H bonds has been developed, and most of them were 
divided into the reaction of C-H bonds and C-X bonds, such as halogen and organometallic 
reagents, as dealt in Chapter 1 and 2 (Figure 1). In contrast, oxidative coupling between C-H 
bonds and C-H bonds is an ideal and environmentally attractive strategy because the reaction 
does not require functionalized compounds for coupling and stoichiometric amounts of 
halogenated and organometallic byproducts are not generated (Figure 1). In a pioneering 
study, Fagnou reported on such a reaction: the Pd-catalyzed reaction of indole derivatives 
with benzene derivatives gave the arylation products.1 Following this pioneering example, a 
number of reactions involving oxidative C-H/C-H coupling have been reported.2 However, 
most of these examples involve the coupling of C(sp2)-H/C(sp2)-H bonds. The oxidative 
coupling of C(sp2)-H/C(sp3)-H bonds represent the next targeted reaction (Figure 1). To the 
best of our knowledge, only one example of the oxidative coupling between C(sp2)-H bonds 
and C(sp3)-H bonds is available. 
 
Figure 1. Oxidative Cross Coupling of C-H/C-H bond. 
 
In fact, Li reported on the Ru(II)-catalyzed oxidative coupling between C(sp2)-H bonds in 
2-arylpyridines and with C(sp3)-H bonds in cycloalkanes, as the solvent, in the presence of a 
strong oxidant, such as di-tert-butyl peroxide(eq 1).3 The role of di-tert-butyl peroxide is used 
to generate radical species from the cycloalkanes. The scope of cycloalkane is quite narrow, 
only cyclohexane, cycloheptane and cyclooctane were applicable, and functional group 
compatibility is low, due to the use a strong oxidant. The oxidative coupling of 
C(sp2)-H/C(sp3)-H bonds without the use of such strong oxidants and the high functional 
groups compatibility continues to be a challenging issue in the field of organic synthesis. 
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In this chapter, we report here on the Ni(II)-catalyzed oxidative coupling between ortho 
C-H bonds in aromatic amides and benzylic C-H bonds in toluene derivatives. Various 
functionalized benzyl groups can be introduced by using mild oxidant. 
 
3.2  Results and discussion 
Based on the result from chapter 1, we hypothesize that use of alkyl radical which is 
generated from alkane by hydrogen atom transfer instead of alkyl halide achieves oxidative 
coupling. Inspired by Fu work: tert-alkyl radical act as a hydrogen atom abstraction reagent in 
Ni-catalyzed cross coupling reaction.4 Various alkyl halides were examined as alky radical 
sources, but all efforts were in vain. However, the benzylation of ortho C-H bonds proceeded, 
when iC3F7I was used as an alkyl halide. The reaction of amide 1a (0.3 mmol) with 
iC3F7I (0.6 
mmol) in the presence of Ni(OTf)2 (0.03 mmol) as the catalyst, Na2CO3 (0.6 mmol) as the 
base and PPh3 (0.03 mmol) as the ligand in toluene (1 mL) at 140 °C for 24 h gave the 
benzylation product 2a in 91% isolated yield (Table 1, entry 1). The reaction also produced 
2a in 75% NMR yield in the absence of PPh3 (entry 2). While the presence of PPh3 as a ligand 
was not crucial for the reaction to proceed, PPh3 was added because the product yields were 
consistently higher than the yields in the absence of PPh3. Other perfluoroalkyl or aryl iodides, 
such as n-C6F13I, C6F5I, and CF3CH2I, or C6Br6 were not effective (entries 3-6). The reaction 
was also dependent on the base used in the reaction. Among the bases screened, carbonates 
were found to be effective. The nature of the cation portion is also important (entries 7-11). A 
1.2 equivalent of iC3F7I (0.36 mmol, 1.2 equivalents to the amide 1a) did not affect the 
product yield (entries 1 vs 12). 
 
Figure 2. The effect of directing groups 
 
Raction conditions: amide (0.3 mmol), Ni(OTf)2 (10 mol%), PPh3 (10mol%), Na2CO3 (0.6 
mmol), iC3F7I (0.36 mmol) in toluene (1 mL) at 140 °C for 24 h. Isolated yield. 
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To examine the effect of 5-substitutent at a quinolone moiety, the screening of directing 
groups were conducted (Figure 2). The reaction of non-substituent at 5-position gave the 
mixture of benzylation product 2b in 54% yield and heptafluoroisopropylation at 5-position 3 
in 33% yield. The use of chlorine group instead of methoxy group increase the benzylation 
product 2c in 94% yield. We choose an 8-amino-5-chloro-quinoline moiety as a suitable 
directing group. 
 
Table 1. Optimization of reaction conditionsa 
 
a Raction conditions: 1a (0.3 mmol), Ni(OTf)2 (10 mol%), PPh3 (10mol%), Na2CO3 (0.6 
mmol), oxidant (0.6 mmol) in toluene (1 mL) at 140 °C for 24 h. b NMR yields. The Number 
in parentheses is the isolated yield. c iC3F7I (0.36 mmol) was used. 
 
With the optimized reaction conditions in hand, the reaction of various benzamides in 
toluene as the solvent was examined (Table 2). A wide variety of functional groups on 
benzamides are tolerated in the reaction. The less hindered C-H bonds were exclusively 
activated to give benzylation products, 4-8, 11, and 15 in the reaction of meta-substituted 
aromatic amides. In the case of a meta-fluoro substrate and a benzamide, di-benzylation 
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products 12 and 13 were obtained in high yields by using 3 equivalents of iC3F7I. In all cases, 
no coupling between the ortho C-H bonds in benzamides and C(sp2)-H bonds in toluene was 
observed.  
 
Table 2. The Ni(II)-catalyzed ortho-benzylation of benzamides in toluenea 
 
a Reactions were conducted on a 0.3 mmol scale. Reported yields are isolated yields. b Run 
at 160 °C. c iC3F7I (0.9 mmol) was used. 
d Reaction was conducted on a 0.15 mmol scale and 
15 mol% catalyst was used. 
 
In order to develop a more useful reaction in organic synthesis, we examined the reaction 
with functionalized toluene derivatives in unreactive solvent. When 5 equivalents of toluene 
in 0.7 mL of tert-buthylbenzene as the solvent were used under standard reaction condition, 
2c was obtained in 62% yield. The yield increased to 84% isolated yield when 10 equivalents 
of toluene were used. The results for the reaction of 1c with various toluene derivatives in 
tert-buthylbenzene as a solvent were shown in Table 3. Various functional groups, even 
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bromides, iodides and protected amine are tolerated under the current catalytic system. The 
presence of substituents at the ortho position had no effect on the efficiency of the reaction, as 
in 24, 25, 26, 29 and 31. 
 
Table 3. The scope of toluene derivatives in oxidative coupling with benzamidesa 
 
a Reactions were conducted on a 0.3 mmol scale. Reported yields are isolated yields. b 
Toluene derivatives (1.0 mL) were used as the solvent. 
 
To gain insights into the reaction mechanism, deuterium-labeling experiments were 
performed. When the deuterated benzamide 1c-d7 was reacted under standard reaction 
conditions for 4 h to recover the 1c-d7, 2c was obtained in 52% isolated yield, along with 41% 
of 1c-d7 being recovered, in which H/D exchange was observed between only at the ortho 
C-H bond and the NH bond. The D-content at the ortho C-H bond was decreased to 0.48D (eq 
2). Even without a iC3F7I, the H/D exchange was also observed in recovered stirting amide. 
These results clearly indicate that activation of aromatic C-H bond in benzamides is reversible 
under the reaction conditions, and iC3F7I is not involved in activation of aromatic C-H bond 
step. 
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When toluene-d8 was used instead of toluene, the reaction was slower than the reaction in 
toluene. Furthermore, no H atom was detected in the benzyl moiety in the product and no 
deuterium atom was incorporated into the recovered 1c, indicating the cleavage of benzylic 
C-H bond is irreversible step (eq 3).  
 
To collect additional information regarding the reaction mechanism, the reaction of 1c in a 
1:1 mixture of toluene and toluene-d8 was carried out (eq 4). In the 
1H-NMR spectrum of the 
product, 1.52H was observed in the benzylic position, indicating that the reaction in toluene is 
3.2 times faster when toluene-d8 is used (1.52/0.48).  
 
The most important issue to be addressed is what the real benzylation reagent is and how it 
is generated. A reaction of iC3F7I and toluene at 140 °C for 24 h resulted in no reaction 
(Scheme 1). But the in the presence of Na2CO3 gave the benzyl iodide in 21% NMR yield. 
The addition of Ni(OTf)2 and Na2CO3 furnished benzyl iodide in 39% NMR yield. Although 
benzyl iodide was formed only in 39% yield, catalytic C-H benzylation proceeded smoothly 
as shown in Table 2. These results suggest that benzyl iodide is formed to some extent under 
the reaction conditions, but that it does not contribute to the benzylation as the major path. To 
gain the more information about formation of benzyl iodide, the addition of TEMPO as a 
radical scavenger was examined. The inhibition effect of TEMPO indicated the benzyl radical 
or perfluoroalkyl radical were intermediate for this reaction. 
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Scheme 1. Generation of Benzyl Iodide 
 
 
On the basis of these results and previous reports,5 a plausible reaction mechanism is 
proposed in Scheme 2. The coordination of amide A to the nickel(II) center gives the 
nickel(II) complex B with the generation of HX, which is trapped by Na2CO3. The C-H bonds 
in complex B then undergo reversible cleavage via a concerted metalation deprotonation 
(CMD) mechanism to give nickelacycle C. The reaction of the complex C with a benzyl 
radical, which is generated by the base-promoted SET of Rf-I 
6 followed by the abstraction of 
a hydrogen from toluene, generates a benzyl radical and Rf-H.
7 The reaction of the complex C 
with the benzyl radical affords the Ni(III) species D, from which the reductive elimination 
and protonation occurs to give the final product with the generation of Ni(I) complex. The 
reaction of Ni(I) with Rf-I regenerates the Ni(II) complex with the generation of an Rf 
radical,8 which undergoes H-atom abstraction from toluene gives the benzyl radical and Rf-H. 
In fact, the formation of Rf-H was confirmed by 
19F NMR spectra of the reaction mixtures. A 
mechanism involving the oxidative addition of benzyl iodide to complex C cannot be 
excluded as the alternative mechanism, since we also observed the formation of benzyl iodide. 
However, this mechanism is not the major route for the present benzylation because the 
benzylation of C-H bonds proceeded smoothly even when the generation of benzyl iodides 
was not efficient.  
Another alternative mechanism involves the oxidative addition of Rf-I to complex C to 
give complex G, which reacts with toluene to afford the complex H. The step from the 
complex G to H would be expected to proceed via a radical mechanism because the oxidative 
addition of iC3F7I to transition metal complexes
9 and the abstraction of a H-atom radical by a 
iC3F7 radical are known.
10 
As shown in Table 1, nC6F13I was less reactive, although 
iC3H7I showed a high activity. It is 
known that secondary perfluoroalkyl radical undergoes the abstraction of H-atom faster than a 
primary perfluoroalkyl radical.10 If perfluoroalkyl anion is involved in the reaction, 
perfluoroalkene would be generated by -fluoro elimination.11 However, no perfluoroalkene 
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was detected. Furthermore, the addition of TEMPO completely quenched the reaction. These 
results suggest that the reaction involves the formation of a iC3F7 radical and benzyl radical. 
 
Scheme 2. Reaction mechanism 
 
After published this reaction, Fu and co-workers performed computational studies of this 
reaction mechanism (Scheme 3).12 The left catalytic cycle is our proposed mechanism. The 
reaction of nickel(II) and an amide gives a metallacycle C. A metallacycle C reacts with a 
benzyl radical to give the product. In contrast to our mechanism, DFT calculations indicate 
that an iodine atom transfer between alkyl iodide and complex C occurs, to give alkyl radical 
and Ni(III) intermediate I. The reaction of complex I and a benzyl radical gives the Ni(IV) 
complex H, which undergoes reductive elimination and protonation to give the final product. 
This catalytic cycle, including the iodine atom transfer and the formation of a Ni(IV) 
intermediate H, is more feasible based on DFT calculations. 
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Scheme 3. Reaction mechanism supported by computational studies 
 
 
3.3  Conclusions  
In summary, we report on a unique strategy that enables oxidative coupling between 
C(sp2)-H and C(sp3)-H bonds via a Ni(II)-catalyzed reaction of benzamides with toluene 
derivatives. The presence of iC3H7I is essential for the reaction to proceed. The role of 
iC3H7 
radical is to generate a benzyl radical via the abstraction of a H-atom from toluene derivatives, 
and high functional group compatibility was achieved by using a iC3H7I as a mild oxidant. 
This reaction system is applicable to oxidative coupling of two C(sp3)-H bonds. The reaction 
of aliphatic amide and toluene in the presence of iC3H7I, 1-AdCOOH as a ligand and 
Pd(OAc)2 gave the -benzylation product in good yield (eq 5).13 The addition of caroboxylic 
acid is necessary to increase the product yields. The reaction in the presence of nickel-catalyst 
resulted in no reaction. 
 
The reaction of aromatic amide containing an 8-amino-5-Chloroquinoline and iodine in the 
presence of nickel(II)-catalyst gave the ortho-iodination product (eq 6).14 This reaction 
represents the first example of direct iodination of C-H bonds with nickel-catalyst. In contrast, 
the reaction of aliphatic amide and iodine didn’t furnish the corresponding iodination products 
but the -lactams (eq 7).14 The synthesis of -lactams via cleavage of C(sp3)-H bonds with 
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nickel-catalyst was reported by using TEMPO as a oxidant.15 The reaction with 5-methoxy 
directing group were ineffective, indicating that the role of chloro group at 5 position is not 
only to prevent the substitution reaction at 5-position but also to facilitate the reaction.  
 
 
3.4  Experimental Section 
General Information. 
1H NMR and 13C NMR spectra were recorded on a JEOL ECS-400 spectrometer in CDCl3 
with tetramethylsilane as the internal standard. Data are reported as follows: chemical shift in 
ppm, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, and m = 
multiplet), coupling constant (Hz), and integration. Infrared spectra (IR) were obtained using 
a JASCO FT/IR-4000; absorptions are reported in reciprocal centimeters with the following 
relative intensities: s (strong), m (medium), or w (weak). Mass spectra were obtained using 
Shimadzu GCMS-QP 2014 and Shimadzu GCMS-QP 5000 instruments instrument with 
ionization voltages of 70 eV. High resolution mass spectra (HRMS) were obtained on a JEOL 
JMS-700 instrument. Analytical gas chromatography (GC) was carried out on Shimadzu 
GC-14B, Shimadzu GC-2014 and Shimadzu GC-8A gas chromatographs, equipped with a 
flame ionization detector. Melting points were determined using a Stanford Research Systems 
apparatus. Column chromatography was performed with SiO2 (Silicycle SiliaFlash F60 
(230-400 mesh)). Some compounds were purified by LC-908 HPLC (GPC).  
 
Materials.  
Na2CO3 (CAS 497-19-8) was purchased from Nacalai Tesque, Inc.  Heptafluoroisopropyl 
iodide (CAS 677-69-0) and 8-Aminoquinoline (CAS 578-66-5), were purchased from Tokyo 
Kasei Kogyo Co., Ltd. Ni(OTf)2 ( CAS 60871-84-3) was prepared by chapter 1 procedure.
 
Toluene, super dehydrated (CAS 68-12-2) and PPh3 (CAS 603-35-0) was purchased from 
Wako Pure Chemicals. 5-methoxyquinolin-8-amine (CAS 30465-68-0) was prepared by 
following procedure.16 
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Synthesis of the Starting Amides. 
All amides containing an 8-aminoquinoline were prepared by the reaction of the 
corresponding acid chlorides and 8-aminoquinoline. All starting amides were synthesize 
following general procedure. All spectrum data of starting amides are cited in original 
paper.17 
 
General Procedure for the Preparation of 8-amino-5-chroloquinoline. 
 
Glycerol (57 mL, 782.5 mmol, 2.7 equiv) was added to an oven-dried 300 mL of three-necked 
flask and heated at 160 °C for 1 h, then cooled to 110 °C. 5-Chloro-2-nitroaniline (50 g, 290 
mmol, 1 equiv) and NaI (850 mg, 6 mmol, 0.02 equiv) were added, and the mixture was 
heated to 150 °C with vigorous stirring. Conc. H2SO4 (35.5 mL, 666.5 mmol, 2.3 equiv) was 
added dropwise, and the reaction was heated at 150 °C for 1 h, and then the reaction was 
cooled to rt. The reaction was diluted with 200 mL of water and 200 mL of DCM, and filtered 
through a celite pad. The filtrate was extracted with DCM(3x). The combined organic layer 
was washed with brine and dried by anhydrous Na2SO4, and concentrated in vacuo to give 
5-chloro-8-nitroquinoline (36.4 g, 175 mmol, 60%) which was used for next step without 
purification. 
5-Chloro-8-nitroquinoline (13.8 g, 66 mmol) was dissolved in 180 mL of acetic acid, and the 
iron powder (25 g, 455 mmol) was added to the solution. The mixture was heated to 65 °C for 
2 h under nitrogen. The reaction was filtered through a celite pad, and washed with ethyl 
acetate. The filtrate was concentrated in vacuo. The resulting brown gum was dissolved in 
200 mL of DCM, and basified by 4N NaOH aq. until pH. 10, and the solution was filtered 
through a celite pad, and filtrate was extracted with DCM (3x). The combined organic layer 
was washed with brine and dried by anhydrous Na2SO4, and concentrated in vacuo to give 
5-chloroquinolin-8-amine (10.2 g, 57 mmol, 87%). 
 
General Procedure for the Preparation of Starting Amide. 
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To an oven-dried 100 mL three-necked flask, 3-methoxybenzoic acid (1.5 g, 10 mmol), DMF 
(5 drops) and DCM (20 mL) were added under a N2 atmosphere. Oxalyl chloride (1.0 mL, 12 
mmol, 1.2 equiv.) was added dropwise at 0 °C resulting in vigorous bubbling. The mixture 
was stirred for 3 h at room temperature, and the solvent was then removed in vacuo. The 
resulting acid chloride was used immediately without further purification. To a solution of 
acid chloride in DCM(30 mL), the solution of 8-amino-5-chroloquinoline (2.1 g, 12 mmol, 
1.2 equiv.), Et3N (2.5 mL, 24 mmol, 2 equiv.) in DCM (15 mL) were added dropwise to the 
solution at 0 °C, and the solution was then warmed to room temperature. After stirring 
overnight, the reaction system was quenched with sat. aq. NaHCO3 (30 mL) and the organic 
layer was separated. The aqueous layer was extracted with DCM (2 x 15 mL). The combined 
organic layers were washed with 1 M HCl aq. (30 mL) and brine (30 mL), dried over MgSO4, 
filtered and evaporated in vacuo. The resulting crude amide was purified by column 
chromatography on silica gel (eluant: hexane/DCM = 3/1) to afford the desired amide as a 
white solid (2.3 g, 74%). 
 
General Procedure for Direct Benzylation: Ni-Catalyzed Dehydrogenative Cross 
Coupling of Amides 1c with Toluene 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide  
1c (89 mg, 0.3 mmol), heptafluoroisopropyl iodide (107 mg, 0.36 mmol), Ni(OTf)2 (10.6 mg, 
0.03 mmol), PPh3 (7.8 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene (1 mL) were 
added in a glove box. The mixture was stirred for 24 h at 140 °C followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (eluent: hexane/EtOAc= 20/1) to afford the 
desired alkylated product 2c (108 mg, 94%) as a light yellow solid. 
 
General Procedure for Direct Benzylation: Ni-Catalyzed Dehydrogenative Cross 
Coupling of Amides 1c with arene 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide  
1c (89 mg, 0.3 mmol), heptafluoroisopropyl iodide (107 mg, 0.36 mmol), Ni(OTf)2 (10.6 mg, 
0.03 mmol), PPh3 (7.8 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol), toluene (276 mg, 3.0 
mmol) and tert-buthylbenzene (0.7 mL) were added in a glove box. The mixture was stirred 
for 24 h at 140 °C followed by cooling. The resulting mixture was filtered through a celite pad 
and concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(eluent: hexane/EtOAc= 20/1) to afford the desired alkylated product 2c (97 mg, 84%) as a 
light yellow solid. 
 
Spectroscopic Data for Products  
2-benzyl-N-(5-methoxyquinolin-8-yl)-6-methylbenzamide (2a). 
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Rf 0.17 (hexane/EtOAc = 5/1). Light Yellow Solid. Mp = 149 °C. 
1H NMR (CDCl3, 399.78 
MHz) 2.45 (s, 3H), 4.02 (s, 3H), 4.10 (s, 2H), 6.89 (d, J = 8.4 Hz, 1H), 7.00-7.18 (m, 7H), 
7.25 (t, J = 8.0 Hz, 1H), 7.41 (dd, J =  8.0, 4.0 Hz, 1H), 8.58 (dd, J = 8.4, 1.6 Hz, 1H), 8.67 
(dd, J = 4.0, 1.6 Hz, 1H), 8.88 (d, J = 8.4 Hz, 1H), 9.59 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz) 19.53, 39.08, 55.81, 104.20, 116.96, 120.37, 120.66, 125.87, 127.49, 127.67, 128.18, 
128.25, 128.97, 129.04, 131.19, 134.71, 137.85, 138.08, 139.08, 140.43, 148.52, 150.56, 
168.16; IR (neat) 3351 w, 1664 m, 1594 w, 1521 s, 1490 s, 1396 m, 1325 w, 1260 m, 1148 m, 
1090 m, 903 m; MS m/z (relative intensity, %) 383 (13), 382 (M+, 45), 292 (11), 210 (11), 209 
(77), 208 (100), 194 (37), 174 (35), 166 (13), 165 (31), 159 (18), 119 (22), 91 (12); HRMS 
Calcd for C25H22N2O2: 382.1681; Found: 382.1684. 
 
2-Benzyl-6-methyl-N-(quinolin-8-yl)benzamide (2b). 
 
Rf 0.23 (hexane/EtOAc = 5/1). 
1H NMR (CDCl3, 399.78 MHz) 2.45 (s, 3H), 4.10 (s, 2H), 
7.00 (t, J = 8.0 Hz, 1H), 7.05-7.11 (m, 3H), 7.13-7.17 (m, 3H), 7.26 (t, J = 7.6 Hz, 1H), 7.40 
(dd, J = 8.0, 4.0 Hz, 1H), 7.53-7.61 (m, 2H), 8.14 (dd, J = 8.0, 1.6 Hz, 1H), 8.65 (dd, J = 4.0, 
1.6 Hz, 1H), 8.96 (dd, J= 8.0, 1.6 Hz, 1H), 9.82 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
19.51, 39.10, 116.67, 121.55, 121.90, 125.88, 127.30, 127.56, 127.86, 128.25 (overlapping 
peaks), 129.01, 129.09, 134.24, 134.66, 136.18, 137.83, 137.92, 138.39, 140.32, 
148.10,168.60; HRMS Calcd for C24H20N2O: 352.1576; Found: 352.1574. 
 
2-benzyl-6-methyl-N-(5-(perfluoropropan-2-yl)quinolin-8-yl)benzamide (3). 
 
Rf 0.46 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 88 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.44(s, 3H), 4.09 (s, 2H), 6.95 (t, J = 7.2 Hz, 1H), 7.04-7.18 (m, 6H), 7.29 (t, J = 7.6 Hz, 1H), 
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7.51 (dd, J = 7.6, 4.0 Hz, 1H), 7.87 (d, J = 8.8 Hz, 1H), 8.68 (dd, J = 4.0, 1.2 Hz, 1H), 8.77 (d, 
J = 8.4 Hz, 1H), 9.00 (dd, J = 7.6 Hz, 1H), 10.04 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 
19.48, 39.18, 114.54, 115.44 (d, J = 19.1 Hz), 119.55 (d, J = 27.8 Hz), 122.32 (d, J = 27.6 Hz), 
122.46, 125.90, 126.66, 127.79, 128.24, 128.38, 128.92, 129.35, 1134.19 (d, J = 21.0 Hz); 
134.64, 137.49, 137.53, 137.79, 138.40, 140.15, 148.11, 169.02; IR (neat) 3336 w, 1712 s, 
1517 m, 1359 m, 1266 m, 1220 s, 1096 m, 975 m, 888 m; MS m/z (relative intensity, %) 520 
(M+, 11), 210 (13), 209 (85), 208 (100), 194 (29), 166 (11), 165 (28), 119 (19), 91 (10); 
HRMS Calcd for C27H19F7N2O: 520.1386; Found: 520.1390. 
 
2-benzyl-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (2c and 9). 
 
Rf 0.43 (hexane/EtOAc = 5/1). Light Yellow Solid. Mp = 122 °C. 
1H NMR (CDCl3, 399.78 
MHz) 2.43 (s, 3H), 4.09 (s, 2H), 6.98 (t, J = 7.2 Hz, 1H), 7.05-7.17 (m, 6H), 7.28 ( t, J = 7.6 
Hz, 1H), 7.54 (dd, J = 8.4, 4.0 Hz, 1H), 7.66 (d, J = 8.8 Hz, 1H), 8.56 (dd, J = 8.0, 1.6 Hz, 1H), 
8.68 (dd, J = 4.0, 1.6 Hz, 1H), 8.90 (d, J = 8.4 Hz, 1H), 9.73 (brs, 1H); 13C NMR (CDCl3, 
100.53 MHz) 19.51, 39.17, 116.64, 122.27, 124.70, 125.87, 125.90, 127.71, 127.26, 128.26, 
128.33, 128.93, 129.23, 1331.32, 133.45, 134.69, 137.71, 137.79, 138.88, 140.26, 148.53, 
168.62; IR (neat) 3342 w, 1673 m, 1626 w, 1595 w, 1518 s, 1425 s, 1422 s, 1264 m, 1158 m; 
MS m/z (relative intensity, %) 386 (M+, 17), 210 (15), 209 (100), 208 (93), 194 (35), 166 (13), 
165 (32); HRMS Calcd for C24H19ClN2O: 386.1186; Found: 386.1189. 
 
2-benzyl-N-(5-chloroquinolin-8-yl)-5-methylbenzamide (4). 
 
Rf 0.40 (hexane/EtOAc = 5/1). White Solid. Mp = 112 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.40 (s, 3H), 4.25 (s, 2H), 7.04-7.08 (m, 1H), 7.13-7.24 (m, 6H), 7.46 (s, 1H), 7.55 (dd, J = 
8.4, 4.0 Hz, 1H), 7.65 (d, J = 8.8 Hz, 1H), 8.57 (dd, J = 8.0, 1.6 Hz, 1H), 8.55 (dd, J = 4.0, 1.6 
Hz, 1H), 8.85 (d, J = 8.8 Hz, 1H), 10.02 (brs); 13C NMR (CDCl3, 100.53 MHz) 20.98, 38.44, 
116.60, 122.28, 124.52, 125.87, 127.23, 127.77, 128.30, 129.01, 131.02, 131.21, 133.44, 
133.85, 136.23, 136.52, 138.96, 140.84, 1487.56, 168.36; IR (neat) 3349 w, 1675 m, 1515 s, 
1475 s, 1383 m, 1319 m, 1207 w, 950 m; MS m/z (relative intensity, %) 386 (M+, 17), 209 
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(49), 208 (100), 194 (28), 178 (10), 165 (29); HRMS Calcd for C24H19ClN2O: 386.1186; 
Found: 386.1187 
 
2-benzyl-N-(5-chloroquinolin-8-yl)-5-methoxybenzamide (5). 
 
Rf 0.26 (hexane/EtOAc = 5/1). White Solid. Mp = 102 °C. 
1H NMR (CDCl3, 399.78 MHz) 
3.85(s、3H), 4.23 (s, 2H), 6.96 (dd, J = 8.0, 2.8 Hz, 1H), 7.04-7.08 (m, 1H), 7.13-7.20 (m, 6H), 
7.54 (dd, J =8.8, 4.8 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 8.56 (dd, J = 8.4, 1.6 Hz, 1H), 8.73 (dd, 
J = 4.0, 1.6 Hz, 1H), 8.83 (d, J = 8.4 Hz, 1H), 10.03 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz) 38.03, 55.47, 112.66, 116.02, 116.53, 122.30, 124.61, 125.86, 127.15, 128.29, 128.93, 
131.37, 132.26, 133.34, 133.73, 137.46, 138.96, 140.96, 148.61, 157.89, 167.87; IR (neat) 
3347 w, 1675 m, 1605 w, 1516 s, 1475 s, 1319 m, 1219 m, 1038 m, 948 m; MS m/z (relative 
intensity, %) 402 (M+, 18), 225 (36), 224 (100), 194 (10), 181 (12), 165 (12); HRMS Calcd 
for C24H19ClN2O2: 402.1135; Found: 402.1133. 
 
2-benzyl-5-chloro-N-(5-chloroquinolin-8-yl)benzamide (6). 
 
Rf 0.40 (hexane/EtOAc = 5/1). White Solid. Mp = 162 °C. 
1H NMR (CDCl3, 399.78 MHz) 
4.25 (s, 2H),  7.05 (q, J = 4.0 Hz, 1H), 7.16-7.21 (m, 5H), 7.38 (dd, J = 8.4, 2.4 Hz, 1H), 7.56 
(dd, J = 8.4, 4.4 Hz, 1H), 7.62-7.64 (m, 2H), 8.57 (dd, J = 8.8, 1.2 Hz, 1H), 8.75 ( 4.4, 1.2 Hz, 
1H), 8.81 (d, J = 7.6 Hz, 1H), 10.00 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 38.26, 116.63, 
122.39, 124.93, 125.87, 126.17, 127.10, 127.14, 128.43, 129.01, 130.45, 132.23, 132.46, 
133.38, 133.47, 137.96, 138.17, 138.92, 139.97, 148.74, 166.60; IR (neat) 3340 w, 1676 m, 
1516 s, 1475 s, 1384 m, 13119 m, 1254 w, 941 m, 837 m; MS m/z (relative intensity, %) 408 
(27), 407 (10), 406 (M+, 33), 230 (34), 229 (22), 228 (100), 195 (10), 194 (69), 193 (83), 180 
(20), 179 (24), 178 (60), 166 (19), 165 (90), 164 (20), 163 (20); HRMS Calcd for 
C23H16Cl2N2O: 406.0640; Found: 406.0642. 
 
2-benzyl-N-(5-chloroquinolin-8-yl)-5-(trifluoromethyl)benzamide (7). 
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Rf 0.37 (hexane/EtOAc = 5/1). White Solid. Mp = 176 °C. 
1H NMR (CDCl3, 399.78 MHz) 
4.33(s, 2H),7.06-7.12 (m, 1H), 7.17-7.12 (m, 4H), 7.39 (d, J = 8.4, 1H), 7.57 (dd, J = 8.8, 4.0 
Hz, 1H), 7.64-7.67 (m, 2H), 7.90 (s, 1H), 8.58 (d, J = 8.8 Hz, 1H), 8.76 (d, J = 4.0 Hz, 1H), 
8.82 (d, J = 8.8 Hz, 1H), 10.04 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 38.78, 116.70, 
122.37 (q, J = 270 Hz), 122.42, 124.14 (d, J = 3.8 Hz), 125.08, 125.87, 126.36, 127.03, 
127.08, 128.53,129.05 (q, J = 65.8 Hz), 129.08, 131.55, 133.38, 137.17, 138.89, 139.39, 
143.70, 148.78, 166.64; IR (neat) 3341 w, 1678 m, 1518 s, 1477 s, 1385 m, 133 s, 1253 m, 
1171 m, 1123 s, 944 m; MS m/z (relative intensity, %) 442 (10), 440 (M+, 31), 379 (12), 263 
(30), 262 (100), 194 (32), 180 (16), 179 (10), 178 (51), 166 (11), 165 (47), 164 (11), 163 (11); 
HRMS Calcd for C24H16ClF3N2O: 440.0903; Found: 440.0901. 
 
5-acetyl-2-benzyl-N-(5-chloroquinolin-8-yl)benzamide (8). 
 
Rf 0.31 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 155 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.63 (s, 3H), 4.34 (s, 2H), 7.07-7.10 (m, 2H), 7.15-7.18 (m, 4H), 7.37 (d, J = 8.0 Hz, 1H), 
7.56 (dd, J = 8.0, 4.0 Hz, 1H), 7.65 (d, J = 8.8 Hz, 1H), 7.98 (dd, J = 8.0, 2.0 Hz, 1H), 8.24 (d, 
J = 1.6 Hz, 1H), 8.57 (dd, J = 8.4, 1.6 Hz, 1H), 8.75 (d, J = 4.4, 1.6 Hz, 1H), 8.83 (d, J = 8.4 
Hz, 1H), 10.07 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 26.62, 38.93, 116.64, 122.39, 
124.94, 125.87, 126.28, 127.09, 128.48, 129.09, 130.36, 131.36, 133.37, 133.50, 135.30, 
136.98, 138.91, 139.53, 145.10, 148.73, 167.20, 196.95; IR (neat) 3342 w, 1677 s, 1598 w, 
1517 s, 1476 s, 1385 m, 1319 m, 1255 m, 942 m; MS m/z (relative intensity, %) 416 (17), 415 
(14), 414 (M+, 47), 237 (29), 236 (100), 221 (40), 195 (24), 194 (35), 193 (11), 180 (16), 179 
(17), 178 (48), 165 (37); HRMS Calcd for C25H19ClN2O: 414.1135; Found: 414.1138. 
 
4-benzyl-3-((5-chloroquinolin-8-yl)carbamoyl)-2-methylphenyl acetate (10). 
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Rf 0.11 (hexane/EtOAc = 5/1). White Solid. Mp = 169 °C. 
1H NMR (CDCl3, 399.78 MHz) 
12.25 (s, 3H), 2.34 (s, 3H), 4.06 (s, 2H), 6.68-7.14 (m, 7H), 7.54 (dd, J = 8.0, 4.0 Hz, 1H), 
7.65 (d, J = 8.4 Hz, 1H), 8.56 (d, J = 8.0 Hz, 1H), 8.71 (dd, J = 4.0, 1.2 Hz, 1H), 8.89 (d, J = 
8.0 Hz, 1H), 9.78 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 13.31, 20.83, 38.82, 116.65, 
122.34, 122.92, 124.91, 125.83, 126.03, 127.05 (overlapping peaks), 128.31, 128.70, 128.99, 
133.24, 133.30, 135.60, 138.88, 139.04, 139.77, 147.73, 148.66, 167.49, 169.35; IR (neat) 
3340 w, 1675 m, 1590 w, 1514 s, 1476 s, 1384 m, 1319 m, 1218 w, 939 m; MS m/z (relative 
intensity, %) 444 (M+, 16), 267 (26), 266 (17), 226 (11), 225 (71), 224 (100), 223 (10), 210 
(24), 181 (19), 179 (10), 178 (12), 165 (11), 152 (10); HRMS Calcd for C26H21ClN2O3: 
444.1241; Found: 444.1245. 
 
2-benzyl-N-(5-chloroquinolin-8-yl)-4,5-dimethoxybenzamide (11). 
 
Rf 0.60 (hexane/EtOAc = 1/1). Yellow Solid. Mp = 60 °C. 
1H NMR (CDCl3, 399.78 MHz) 
3.85 (s, 3h), 3.94 (s, 3H), 4.29 (s, 2H), 6.73 (s, 1H), 7.11-7.23 (m, 6H), 7.54 (dd, J = 8.0, 4.0 
Hz, 1H), 7.63 (d, J = 8.8 Hz, 1H), 8.56 (d, J = 8.8 Hz, 1H), 8.71 (d, J = 4.0, 1H), 8.82 (d, J = 
8.4 Hz, 1H), 10.07 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 38.48, 55.88, 56.09, 110.65, 
113.69, 116.40, 122.22, 124.36, 125.82, 125.94, 127.14, 128.33, 128.60, 128.77, 132.54, 
133.29, 133.83, 138.74, 140.82, 147.19, 148.54, 150.53, 167.66; IR (neat) 3348 w, 1671 m, 
1604 w, 1511 s, 1476 s, 1382 m, 1318 m, 1262 s, 1210 s, 1034 m, 397 m; MS m/z (relative 
intensity, %) 432 (M+, 12), 256 (11), 255 (70), 254 (100), 224 (20), 165 (10); HRMS Calcd 
for C25H21ClN2O3: 432.1241; Found: 432.1239. 
 
2,6-dibenzyl-N-(5-chloroquinolin-8-yl)-3-fluorobenzamide (12). 
 
Rf 0.37 (hexane/EtOAc = 5/1). White Solid. Mp = 102 °C. 
1H NMR (CDCl3, 399.78 MHz) 
4.05 (s, 2H), 4.11 (s, 2H), 6.92-6.95 (m, 1H), 6.98-7.03 (m, 3H), 7.08-7.16 (m, 8H), 7.49 (dd, 
J = 8.8, 4.4 Hz, 1H), 7.63 (d, J = 8.4 Hz, 1H), 8.52-8.55 (m, 2H), 8.84 (dd, J = 8.0, 2.4 Hz, 
1H), 9.56 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 32.53, 38.60, 116.28, 116.51, 122.18, 
124.88, 125.05, 125.22, 125.68, 125.91, 126.07, 127.01, 128.18, 128.35, 128.43, 128.91, 
129.97 (d, J = 8.6 Hz), 133.06 (d, J = 3.8 Hz), 133.76 (d, J = 3.8 Hz), 138.69, 139.21, 139.26, 
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139.85, 148.41, 159.69 (d, J = 245 Hz), 166.79 (d, J = 2.8 Hz); IR (neat) 3333 w, 1676 m, 
1515 s, 1475 s, 1384 m, 1319 m, 1265 m, 935 m, 724 s; MS m/z (relative intensity, %) 482 
(13), 481 (12), 480 (M+, 36), 317 (16), 303 (19), 302 (68), 301 (13), 226 (17), 225 (100), 224 
(57), 212 (20), 197 (10), 196 (23), 183 (18), 179 (10), 178 (16), 91 (22); HRMS Calcd for 
C30H22ClFN2O: 480.1405; Found: 480.1407. 
 
2,6-dibenzyl-N-(5-chloroquinolin-8-yl)benzamide (13). 
 
Rf 0.43 (hexane/EtOAc = 5/1).White Solid. Mp = 171 °C. 
1H NMR (CDCl3, 399.78 MHz) 
4.09 (s, 4H), 6.98 (t, J = 7.6 Hz, 1H), 7.06-7.15 (m, 10H), 7.27 (t, J = 7.6 Hz, 1H), 7.45 (dd, J 
= 8.0, 4.0 Hz, 1H), 7.61 (d, J = 8.8 Hz, 1H), 8.49 (dd, J = 8.4, 1.6 Hz, 1H), 8.57 (dd, J = 4.0, 
1.2 Hz, 1H), 8.86 (d, J = 8.0 Hz, 1H), 9.63 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 39.13, 
116.44, 122.14, 124.62, 125.67, 125.92, 127.02, 128.13, 128.25, 128.94, 129.31, 133.04, 
133.30, 137.55, 137.90, 138.75, 140.06, 148.37, 168.27; IR (neat) 3339 w, 1674 m, 1514 s, 
1384 m, 1319 m, 1260 w, 939 m; MS m/z (relative intensity, %) 462 (M+, 18), 285 (29), 284 
(74), 283 (11), 208 (17), 207 (100), 206 (30), 179 (18), 178 (31), 165 (15), 91 (28); HRMS 
Calcd for C30H23ClN2O: 462.1499; Found: 462.1504. 
 
2-benzyl-N-(5-chloroquinolin-8-yl)-1-naphthamide (14). 
 
Rf 0.34 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 192 °C. 
1H NMR (CDCl3, 399.78 MHz) 
4.26 (s, 2H), 7.05 (t, J = 7.2 Hz, 1H), 7.14 (t, J = 7.6 Hz, 1H), 7.22 (d, J = 7.2 Hz, 2H), 7.37 (d, 
J = 7.8 Hz, 1H), 7.47-7.51 (m, 3H), 7.69 (d, J = 8.4 Hz, 1H), 7.83-7.87 (m, 2H), 8.00 (dd, J = 
8.4, 4.0 Hz, 1H), 8.55 (dd, J = 8.8, 4.4 Hz, 1H), 8.61 (dd, J = 4.4, 1.6 Hz, 1H), 9.05 ( d, J = 8.0 
Hz, 1H), 10.05 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 39.42, 116.76, 122.31, 124.91, 
125.90, 125.98, 126.10, 127.17, 127.20, 1127.96, 128.04, 128.39, 129.00, 129.58, 130.15, 
131.99, 133.28, 133.54, 134.18, 135.36, 138.87, 140.14, 148.57, 168.21; IR (neat) 3339 w, 
1674 m, 1515 s, 1476 s, 1386 w, 1318 m, 1215 w, 937 w; MS m/z (relative intensity, %) 422 
(M+, 10), 246 (18), 245 (100), 244 (93), 227 (17), 226 (10), 216 (11), 215 (34), 202 (14); 
HRMS Calcd for C27H19ClN2O: 422.1186; Found: 422.1185. 
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(8R,9S,13S,14S)-2-benzyl-N-(5-chloroquinolin-8-yl)-13-methyl-17-oxo-7,8,9,11,12,13,14,1
5,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3-carboxamide (15). 
 
Rf 0.31 (hexane/EtOAc = 2/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 0.92 (s, 3H), 
1.44-1.68 (m, 6H), 1.95-2.55 (m, 7H), 2.97 (dd, J = 9.6, 3.6 Hz, 2H), 4.26 (q, J = 15.6 Hz, 2H), 
7.06 (t, J = 6.8 Hz, 1H), 7.13-7.22 (m, 5H), 7.40 (s, 1H), 7.54 (dd, J = 8.8, 4.0, 1H), 7.63 (dd,J 
= 8.8 Hz, 1H), 8.56 (dd, J = 8.4, 1.6 Hz, 1H), 8.73 (dd, J = 4.4, 1.6 Hz, 1H), 8.83 (d, J = 8.0 
Hz, 1H), 10.01 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 13.81, 21.55, 25.57, 26.32, 28.95, 
31.46, 35.80, 37.95, 38.74, 44.44, 47.89, 50.41, 116.43, 122.26, 124.41, 125.85, 127.19, 
127.86, 128.26, 128.30, 128.90, 133.31, 133.92, 134.25, 134.79, 136.78, 139.01, 140.92, 
142.26, 148.55, 168.19, 220.73; IR (neat) 3351 w, 2930 w, 1737 m, 1674 m, 1517 s, 1476 m, 
1383 m, 1319 m, 938 w; MS m/z (relative intensity, %) 548 (M+, 14), 372 (12), 371 (53), 370 
(100), 368 (14), 207 (26); HRMS Calcd for C35H33ClN2O2: 548.2231; Found: 548.2228. 
 
2-benzyl-N-(5-chloroquinolin-8-yl)cyclohex-1-enecarboxamide (16). 
 
Rf 0.09 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 1.63-1.76 (m, 
4H), 2.01-2.04 (m, 2H), 2.51-2.52 (m, 2H), 3.64 (s, 2H), 7.16-7.21 (m, 1H), 7.24-7.31 (m, 
4H), 7.54 (dd, J = 8.0, 4.0 Hz, 1H), 7.60 (d, J = 8.4 Hz, 1H), 8.54 (dd, J = 8.0, 1.6 Hz, 1H), 
8.76 dd, J = 4.4, 1.6 Hz, 1H), 8.81 (d, J = 8.4 Hz, 1H), 9.93 (brs, 1H); 13C NMR (CDCl3, 
100.53 MHz) 22.21, 22.23, 27.33, 28.77, 40.69, 116.52, 122.24, 124.23, 125.87, 126.01, 
127.21, 128.33, 128.85, 131.26, 133.36, 133.76, 138.51, 138.93, 139.38, 148.47, 170.00; IR 
(neat) 3356 w, 2931 w, 1672 m, 1516 s, 1477 s, 1384 m, 1319 m, 939 w; MS m/z (relative 
intensity, %) 376 (M+, 12), 199 (55), 198 (100), 178 (30), 157 (25), 129 (10), 91 (17); HRMS 
Calcd for C23H21ClN2O: 376.1342; Found: 376.1341. 
 
methyl 4-(2-((5-chloroquinolin-8-yl)carbamoyl)-3-methylbenzyl)benzoate (17). 
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Rf 0.14 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 173 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.43 (s, 3H), 3.79 (s, 3H), 4.12 (s, 2H), 7.10-7.20 (m, 4H), 7.31 (t, J = 8.0 Hz, 1H), 7.50 (dd, J  
=8.8, 4.4 Hz, 1H), 7.63-7.66 (m, 3H), 8.54 (dd, J = 8.4, 1.6 Hz, 1H), 8.62 (dd, J = 4.0, 1.6 Hz, 
1H), 8.85 (d, J = 8.8 Hz, 1H), 9.58 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz)  19.44, 39.38, 
51.81, 116.53, 122.19, 124.78, 125.79, 127.08, 127.69, 127.88, 128.70, 128.84, 129.32, 
129.54, 133.23, 133.28, 134.86, 136.86, 137.81, 138.66, 145.73, 148.50, 166.66, 168.38; IR 
(neat) 3341 w, 1718 m, 1676 m, 1514 s, 1476 s, 1319 m, 1278 m, 1108 m, 938 m, 753 m; MS 
m/z (relative intensity, %) 446 (14), 445 (12), 444 (37), 268 (16), 267 (88), 266 (100), 235 
(13), 223 (14), 208 (57), 207 (67), 193 (13), 192 (19), 179 (27), 178 (30), 165 (30); HRMS 
Calcd for C26H21ClN2O3: 444.1241; Found: 444.1240. 
 
N-(5-chloroquinolin-8-yl)-2-methyl-6-(4-(trifluoromethyl)benzyl)benzamide (18). 
 
Rf 0.26 (hexane/EtOAc = 5/1). White Solid. Mp = 119 °C. 
1H NMR (CDCl3, 399.78 MHz) 
3.43 ( s, 3H), 4.13 (s, 2H), 7.13 (d, J = 7.6 Hz, 1H), 7.19-7.26 (m, 5H), 7.33 (d, J = 8.0 Hz, 
1H), 7.53 (dd, J = 8.4, 4.0 Hz, 1H), 7.65 (d, J = 8.4 Hz, 1H), 8.56 (dd, J = 8.8, 2.0 Hz, 1H), 
8.62 (dd, J = 4.0, 1.6 Hz, 1H), 8.87 (d, J = 8.8 Hz, 1H), 9.59 (bes, 1H); 13C NMR (CDCl3, 
100.53 MHz) 19.47, 39.18, 116.55, 122.37, 124.03 (q, J = 271 Hz), 124.91, 125.12 (d, J = 3.8 
Hz), 125.87, 127.10, 127.89, 128.15 (q, J = 32.4 Hz), 128.82, 129.06, 129.40, 133.18, 133.40, 
135.02, 136.65, 137.82, 138.61, 144.44, 148.57, 168.37; IR (neat) 3342 w, 1678 m, 1516 s, 
1477 s, 1385 m, 1323 s, 1162 m, 1121 m, 1066 m; MS m/z (relative intensity, %) 454 (M+, 
21), 278 (16), 277 (100), 276 (86), 262 (18), 208 (11), 165 (20); HRMS Calcd for 
C25H18ClF3N2O: 454.1060; Found: 454.1057. 
 
2-(4-chlorobenzyl)-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (19). 
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Rf 0.31 (hexane/EtOAc = 5/1). White Solid. Mp = 136 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.43 (s, 3H),  4.03 (s, 2H), 6.96 (dt, J = 8.4, 2.0 Hz, 2H), 7.02 (d, J = 8.4 Hz, 2H), 7.10 (d, J 
= 7.6 Hz, 1H), 7.18 (d, J = 8.0 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.54 (dd, J = 8.0, 4.0 Hz, 1H), 
7.65 (d, J = 8..8 Hz, 1H), 8.56 (dd, J = 8.4, 2.0 Hz, 1H), 8.66 (dd, J = 4.0, 1.6 Hz, 1H), 8.86 (d, 
J = 8.8 Hz, 1H), 9.60 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.45, 38.66, 116.49, 122.37, 
124.81, 125.84, 127.07, 127.77, 128.31, 128.61, 129.30, 130.11, 131.70, 133.25, 133.32, 
134.91, 137.15, 137.75, 138.73, 138.83, 148.65, 168.43; IR (neat) 3341 w, 1676 m, 1514 s, 
1476 s, 1384 m, 1319 m, 938 m, 786 m; MS m/z (relative intensity, %) 422 (16), 420 (M+, 22), 
245 (24), 244 (41), 243 (71), 242 (100), 209 (10), 208 (59), 207 (86), 179 (20), 178 (25), 165 
(41); HRMS Calcd for C24H18Cl2N2O: 420.0796; Found: 420.0793. 
 
N-(5-chloroquinolin-8-yl)-2-methyl-6-(4-methylbenzyl)benzamide (20). 
 
Rf 0.34 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 139 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.08 (s, 3H), 2.43 (s, 3H), 4.04 (s, 2H), 6.84 (d, J = 7.6 Hz, 1H), 7.00 (d, J = 8.0 Hz, 1H), 7.08 
(d, J = 8.8 Hz, 1H), 7.14 (d, J = 8.8 Hz, 1H), 7.27 (t, J = 8.0 Hz, 1H), 7.52 (dd, J = 8.0, 4.0 Hz, 
1H), 7.65 (d, J = 8.0 Hz, 1H), 8.55 (dd, J = 8.8, 1.2 Hz, 1H), 8.67 (dd, J = 4.0, 1.2 Hz, 1H), 
8.90 (d, J = 8.0 Hz, 1H), 9.68 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.45, 20.79, 38.79, 
116.57, 122.18, 124.60, 125.82, 127.15, 127.66, 128.21, 128.76, 128.92, 129.16, 133.25, 
133.51, 134.61, 135.30, 137.21, 137.68, 138.07, 138.82, 148.43, 168.64; IR (neat) 3343 w, 
1677 m, 1513 s, 1476 s, 1383 m, 1319 m, 938 m, 786 m; MS m/z (relative intensity, %) 400 
(M+, 12), 224 (11), 223 (76), 222 (100), 208 (32), 179 (12), 178 (11), 165 (14); HRMS Calcd 
for C25H21ClN2O: 400.1342; Found: 400.1341. 
 
N-(5-chloroquinolin-8-yl)-2-(4-methoxybenzyl)-6-methylbenzamide (21). 
 86 
 
 
Rf 0.20 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 2.42 (s, 3H), 
3.56 (s, 3H), 4.02 (s, 2H), 6.56 (d, J = 8.4 Hz, 1H), 7.02 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 7.6 
Hz, 1H), 7.14 (d, J = 7.6 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.53 (dd, J = 8.4, 4.0 Hz, 1H), 7.65 
(d, J = 8.8 Hz, 1H); 8.56 (dd, J = 8.8, 1.2 Hz, 1H), 8.67 (dd, J = 4.0, 1.2 Hz, 1H), 8.90 (d, J = 
8.4 Hz, 1H), 9065 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.44, 38.39, 54.91, 113.56, 
116.53, 122.23, 124.60, 125.81, 127.13, 127.64, 128.25, 129.17, 129.78, 132.39, 133.20, 
133.51, 134.67, 137.65, 138.21, 138.83, 148.49, 157.68, 168.66; IR (neat) 3343 w, 1677 m, 
1512 s, 1477 s, 1384 m, 1319 m, 1247 m, 1037 w, 939 m; MS m/z (relative intensity, %) 416 
(M+, 9), 239 (47), 238 (100), 224 (14); HRMS Calcd for C25H21ClN2O2: 416.1292; Found: 
416.1293. 
 
N -(5-chloroquinolin-8-yl)-2-methyl-6-(3-methylbenzyl)benzamide (22). 
 
Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 2.01 (s, 3H), 
2.43 (s, 3H), 4.04 (s, 2H), 6.73 (d, J = 6.8 Hz, 1H), 6.91-6.97 (m, 3H), 7.10 (d, J = 7.2 Hz, 
1H), 7.14 (d, J = 8.0 Hz, 1H), 7.27 (t, J = 7.6 Hz, 1H), 7.51 (dd, J = 8.0, 4.0 Hz, 1H), 7.64 (d, 
J = 8.4 Hz, 1H), 8.54 (dd, J = 8.4, 1.6 Hz, 1H), 8.65 (dd, J = 4.4, 1.6 Hz, 1H), 8.91 (d, J = 8.4 
Hz, 1H), 9.67 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.44, 21.05, 39.17, 116.49, 122.22, 
124.60, 125.81, 125.90, 126.59, 127.10, 127.73, 128.12, 128.25, 129.66, 133.16, 133.51, 
134.61, 137.73, 137.93, 138.90, 140.15, 148.46, 168.61; IR (neat) 3343 w, 1677 m, 1513 s, 
1476 s, 1383 m, 1319 m, 938 m; MS m/z (relative intensity, %) 400 (M+, 17), 224 (15), 223 
(95), 222 (100), 208 (37), 179 (16), 178 (13), 165 (18); HRMS Calcd for C25H21ClN2O: 
400.1342; Found: 400.1341. 
 
2-(3-acetamidobenzyl)-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (23). 
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Rf 0.23 (hexane/EtOAc = 1/1). White Solid. Mp = 212 °C. 
1H NMR (CDCl3, 399.78 MHz) 
1.97 (s, 3H), 2.41 (s, 3H), 4.00 (s, 2H), 6.82 (d, J = 8.0, 1H), 6.95-6.99 (m, 2H), 7.08 (d, J = 
8.4 Hz, 1H), 7.14 (d, J = 6.8 Hz, 1H), 7.24-7.33 (m, 2H), 7.51 (dd, J = 8.0, 4.0 Hz, 1H), 7.62 
(d, J = 8.0 Hz, 1H), 8.53 (dd, J = 8.4, 1.6 Hz, 1H), 8.65 (dd, J = 4.0, 1.6 Hz, 1H), 8.87 (d, J = 
8.0 Hz, 1H), 9.651 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.40, 24.30, 39.16, 116.45, 
117.45, 119.83, 122.39, 124.48, 124.75, 125.80, 126.99, 127.80, 128.42, 128.89, 129.28, 
133.11, 133.38, 134.65, 137.41, 137.59, 137.96, 138.81, 140.94, 148.66, 168.11, 168.66; IR 
(neat) 3361w, 3291w, 1676m, 1657m, 1517 s, 1478 s, 1369 m, 1306 m, 1263 m, 941 m; MS 
m/z (relative intensity, %) 443 (M+, 16), 225 (16), 224 (100), 223 (84), 180 (11), 178 (13); 
HRMS Calcd for C26H22ClN3O: 443.1401; Found: 443.1404. 
 
N -(5-chloroquinolin-8-yl)-2-(2-iodobenzyl)-6-methylbenzamide (24). 
 
Rf 0.34 (hexane/EtOAc = 5/1). Light Yellow Solid. Mp = 148 °C. 
1H NMR (CDCl3, 399.78 
MHz) 2.46 (s, 3H), 4.21 (s, 2H), 6.79-6.87 (m, 2H), 7.15-7.27 (m, 4H), 7.54 (dd, J = 8.0, 4.0 
Hz, 1H), 7.65 (d, J = 8.0, 1H), 7.69 (d, J = 8.0 Hz, 1H), 8.56 (dd, J = 8.0, 1.6 Hz, 1H), 8.71 
(dd, J = 4.0, 1.6 Hz, 1H), 8.91 (d, J = 8.4 Hz, 1H); 9.91 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz) 19.55, 43.94, 101.36, 116.79, 122.30, 124.78, 125.92, 127.04, 127.19, 128.00, 128.36, 
128.52, 129.27, 130.70, 133.39, 133.46, 134.73, 136.39, 137.80, 138.93, 139.38, 142.80, 
148.58, 168.46; IR (neat) 3340 w, 1676 m, 1514 s, 1476 s, 1384 m, 1319 m, 939 m, 750 m; 
MS m/z (relative intensity, %) 514 (10), 512 (28), 335 (36), 209 (18), 208 (100), 207 (96), 193 
(10), 179 (14), 178 (25), 165 (26); HRMS Calcd for C24H18ClN2OI: 512.0152; Found: 
512.0149. 
 
N -(5-chloroquinolin-8-yl)-2-methyl-6-(2-methylbenzyl)benzamide (25). 
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Rf 0.40 (hexane/EtOAc = 5/1). Colorless Oil. 
1H NMR (CDCl3, 399.78 MHz) 2.36 (s, 3H), 
2.60 (s, 3H), 4.09 (s, 2H), 6.85 (d, J = 7.6 Hz, 1H), 6.97-7.02 (m, 2H), 7.06-7.07 (m, 2H), 
7.15 (d, J = 7.2 Hz, 1H), 7.23 (t, J = 7.6 Hz, 1H), 7.52 (dd, J = 8.4, 4.0 Hz, 1H), 7.64 (d, J = 
8.8 Hz, 1H), 8.54 (dd, J = 8.4, 1.6 Hz, 1H), 8.71 (dd, J = 4.4, 1.6 Hz, 1H), 8.90 (d, J = 8.4 Hz, 
1H), 9.81 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.47, 19.64, 36.39, 116.57, 122.27, 
124.70, 125.86, 125.94, 126.30, 126.87, 127.10, 128.12, 129.18, 129.94, 130.06, 133.24, 
133.49, 134.60, 136.57, 137.16, 137.74, 138.02, 148.60, 168.63; IR (neat) 3345w, 1678 m, 
1515 s, 1476 s, 1384 m, 1319 m, 939 m; MS m/z (relative intensity, %) 400 (M+, 17), 224 (15), 
223 (98), 222 (100), 208 (37), 179 (13), 178 (14), 165 (16); HRMS Calcd for C25H21ClN2O: 
400.1342; Found: 400.1340. 
 
N-(5-chloroquinolin-8-yl)-2-(2-methoxybenzyl)-6-methylbenzamide (26). 
 
Rf 0.23 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 138 °C. Yellow Solid. Mp = 138 °C. 
1H 
NMR (CDCl3, 399.78 MHz) 2.43 (s, 3H), 3.57, (s, 3H), 4.09 (s, 2H), 6.63 (d, J = 7.6 Hz, 1H), 
6.77 (td, J = 7.2, 0.8 Hz, 1H), 7.02-7.12 (m, 4H), 7.23 (t, J = 7.6 Hz, 1H), 7.49 (dd, J = 8.4, 
4.4 Hz, 1H), 7.63 (d, J = 8.8 Hz, 1H), 8.52 (dd, J = 8.4, 1.6 Hz, 1H), 8.67 (dd, J = 4.0, 2.0 Hz, 
1H), 8.93 (d, J = 8.8 Hz, 1H), 9.82 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.47, 32.88, 
55.03, 110.03, 116.51, 120.30, 122.20, 124.47, 125.78, 127.09, 127.32, 127.94, 128.58, 
128.98, 130.52, 133.14, 133.66, 134.44, 137.65, 137.68, 138.92, 148.48, 157.04, 168.75; IR 
(neat) 3344 w, 1677 m, 1590 w, 1514 s, 1476 s, 1383 m, 1319 m, 1245 m, 939 m, 753 m; MS 
m/z (relative intensity, %) 416 (M+, 15), 240 (15), 239 (88), 238 (100), 224 (21), 223 (1), 208 
(10), 195 (11); HRMS Calcd for C25H21ClN2O2: 416.1292; Found: 416.1288. 
 
N-(5-chloroquinolin-8-yl)-2-(3,5-dimethylbenzyl)-6-methylbenzamide (27). 
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Rf 0.43 (hexane/EtOAc = 5/1). White Solid. Mp = 143 °C. 
1H NMR (CDCl3, 399.78 MHz) 
1.97 (s, 6H), 2.42 (s, 3H), 3.99 (s, 2H), 6.47 (s, 1H), 6.70 (s, 2H), 7.14 (t, J = 9.2 Hz, 2H), 
7.28 (t, J = 8.0 Hz, 1H), 7.52 (dd, J = 8.0, 4.0 Hz, 1H), 7.65 (d, J = 8.0 Hz, 1H), 8.55 ( dd, J = 
8.4, 1.6 Hz, 1H), 8.65 (dd, J = 4.4, 1.6 Hz, 1H), 8.91 (d, J = 8.4 Hz, 1H), 9.61 (brs, 1H); 13C 
NMR (CDCl3, 100.53 MHz) 19.42, 20.94, 39.18, 116.45, 122.20, 124.53, 125.79, 126.69, 
127.11, 127.42, 127.78, 128.20, 129.13, 133.18, 133.53, 134.56, 137.60, 137.75, 138.07, 
138.84, 141.08, 148.31, 168.67; IR (neat) 3343 w, 2+77 m, 1513 s, 1476 s, 1382 m, 1319 m, 
938 m, 754 m; MS m/z (relative intensity, %) 414 (M+, 16), 238 (14), 237 (82), 222 (34), 221 
(11), 179 (20), 178 (12); HRMS Calcd for C26H23ClN2O: 414.1499; Found: 414.1498. 
 
N -(5-chloroquinolin-8-yl)-2-methyl-6-(naphthalen-1-ylmethyl)benzamide (28). 
 
Rf 0.26 (hexane/EtOAc = 5/1). White Solid. Mp = 79 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.47 (s, 3H), 4.55 (s, 2H), 6.88 (d, J = 6.8 Hz, 1H), 7.14-7.21 (m, 2H), 7.28-7.36 (m, 4H), 
7.52 (dd, J = 8.8, 4.0 Hz, 1H), 7.59-7.62 (m, 2H), 7.67-7.69 (m, 1H), 7.94-7.67 (m, 1H), 8.53 
(dd, J = 8.4, 1.6 Hz, 1H), 8.69 (dd, J = 4.0, 1.6 Hz, 1H), 8.88 (d, J = 8.4 Hz, 1H), 9.85 (brs, 
1H); 13C NMR (CDCl3, 100.53 MHz) 19.52, 35.99, 116.69, 122.25, 124.16, 124.74, 125.39 
(overlapping peaks), 125.85, 125.92, 127.06, 127.10, 127.16, 127.64, 128.33 (overlapping 
peaks), 129.23, 131.94, 133.31, 133.40, 133.74, 134.65, 135.77, 137.38, 137.59, 138.86, 
148.56, 168.72; IR (neat) 3342 w, 1676 m, 1514 s, 1476 s, 1384 m, 1319 m, 939 w, 786 m; 
MS m/z (relative intensity, %) 436 (16), 259 (54), 258 (100), 244 (17), 215 (30), 178 (15); 
HRMS Calcd for C28H21ClN2O: 436.1342; Found: 436.1340 
 
2-(2-bromo-5-fluorobenzyl)-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (29). 
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Rf 0.40 (hexane/EtOAc = 5/1). White Solid. Mp = 125 °C.  
1H NMR (CDCl3, 399.78 MHz) 
2.46 (s, 3H), 4.18 (s, 2H),  6.66 (td, J = 8.0, 2.8 Hz, 1H), 6.89 (dd, J = 9.6, 2.8 Hz, 1H), 6.97 
(d, J = 7.6 Hz, 1H), 7.21 (d, J = 8.0 Hz, 1H), 7.28-7.32 (m, 2H), 7.53 (dd, J = 8.4, 4.4 Hz, 1H), 
7.64 (d, J = 8.0 Hz, 1H), 8.56 (dd, J = 8.4, 1.6 Hz, 1H), 8.71 (dd, J = 4.0, 1.6 Hz, 1H), 8.88 (d, 
J = 8.4 Hz, 1H), 9.81 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.54, 39.21, 115.95 (d, J = 
21.9 Hz), 116.67, 118.11 (d, J = 22.9 Hz), 118.78 (d, J = 0.29 Hz), 122.34, 124.85, 125.87, 
127.15, 127.33, 128.89, 129.42, 133.32, 133.61 (d, J = 0.85 Hz), 134.98, 134.46, 137.91, 
138.96, 148.61, 161.99 (d, J = 245.1 Hz), 168.24; IR (neat) 3339 w, 1674 m, 1514 s, 1475 s, 
1384 m, 1319 m, 1218 m, 1029 w, 938 m, 751 s; MS m/z (relative intensity, %) 484 (20), 482 
(M+, 15), 307 (40), 305 (41), 305 (41), 226 (44), 225 (100), 197 (10), 196 (11), 183 (41), 178 
(11); HRMS Calcd for C24H17BrClFN2O: 482.0197; Found: 482.0193. 
 
2-(3-bromo-5-fluorobenzyl)-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (30). 
 
Rf 0.40 (hexane/EtOAc = 5/1). Yellow Solid. Mp = 160 °C. 
1H NMR (CDCl3, 399.78 MHz) 
2.44 (s, 3H), 4.01 (s, 2H), 6.71 (d, J = 8.0 Hz, 1H), 6.77 (d, J = 9.6 Hz, 1H), 7.02 (s, 1H), 7.11 
(d, J = 7.2 Hz, 1H), 7.20 (d, J = 7.6 Hz, 1H), 7.32 (t, J = 7.6 Hz, 1H), 7.53 (dd, J = 8.0, 4.0 Hz, 
1H), 7.65 (d, J = 8.8 Hz, 1H), 8.55 (d, J = 8.0 Hz, 1H), 8.68 (d, J = 4.0 Hz, 1H), 8.86 (d, J = 
8.4 Hz, 1H), 9.60 (brs, 1H); 13C NMR (CDCl3, 100.53 MHz) 19.45, 38.84, 114.74 (d, J = 21.0 
Hz,), 116.56, 116.57 (d, J = 23.8 Hz), 122.23 (d, J = 10.5 Hz), 122.34, 124.95, 125.90, 127.11, 
127.67 (d, J = 2.9 Hz), 127.83, 129.00, 129.44, 133.15, 133.28, 135.03, 136.11, 137.82, 
138.82, 144.43 (d, J = 7.7 Hz), 148.59, 162.41 (d, J = 248.8 Hz), 168.18; IR (neat) 3338 w, 
1674 m, 1578 m, 1514 s, 1476 s, 1439 m, 1384 m, 1319 m, 1259 w, 938 w, 729 s; MS m/z 
(relative intensity, %) 486 (12), 485 (12), 484 (45), 483 (10), 482 (M+, 33), 308 (15), 307 (97), 
306 (89), 305 (99), 304 (77), 227 (33), 226 (58), 225 (41), 199 (19), 197 (29), 196 (26), 184 
(18), 183 (100), 181 (11), 180 (14), 179 (25), 178 (39), 164 (15), 163 (14); HRMS Calcd for 
C24H17BrClFN2O: 482.0197; Found: 482.0199. 
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2-(3-chloro-4-methylbenzyl)-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (31a) and 
2-(2-chloro-4-methylbenzyl)-N-(5-chloroquinolin-8-yl)-6-methylbenzamide (31b). 
 
Rf 0.40 (hexane/EtOAc = 5/1). White Solid. Mp = 179 °C. 
1H NMR (CDCl3, 399.78 MHz) 
1.99 (○s, 3H), 2.15 (△s, 3H), 2.42 (○s, 3H), 2.44 (△s, 3H), 4.00 (○s, 2H), 4.17 (△s, 2H), 6.79 
(○d, J = 7.6 Hz, 1H), 6.87-6.89 (○+△ m), 6.94 (△d, J = 7.6 Hz, 1H), 7.00-7.06 (○+△ m), 
7.10-7.18 (○+△ m), 7.27-7.31 (○+△ m), 7.50-7.54 (○+△ m), 7.64 (○+△ d, J = 8.8 Hz, 1H), 
8.53-8.56 (○+△ m), 8.66 (○dd, J = 4.4, 1.6 Hz, 1H), 8.71 (△dd, J = 4.0, 1.6 Hz, 1H), 8.87 (○d, 
J = 8.4 Hz, 1H), 8.91 (△d, J = 8.4 Hz, 1H), 9.59 (○brs, 1H), 9.84 (△brs, 1H); 13C NMR 
(CDCl3, 100.53 MHz) 19.27, 19.41, 19.48, 20.57, 36.09, 38.63, 116.49, 116.65, 122.18, 
122.24, 124.67, 125.80, 125.85, 127.13, 127.56, 127.78, 128.36, 128.57, 129.17, 129.26, 
130.27, 131.11, 133.21, 133.29, 133.30, 133.50, 133.80, 134.06, 134.56, 134.61, 134.79, 
136.56, 137.19, 137.59, 137.71, 137.76, 138.74, 138.90, 139.58, 148.43, 148.52; IR (neat) 
3341 w, 1676 m, 1514 s, 1476 s, 1383 m, 1319 m, 1049 w, 938 m; MS m/z (relative 
intensity, %) 436 (16), 434 (M+, 24), 259 (27), 258 (82), 256 (100), 242 (12),  222 (58), 221 
(58), 179 (37), 178 (26); HRMS Calcd for C25H20Cl2N2O: 434.0953; Found: 434.0954. 
 
N-(5-methoxyquinolin-8-yl)-3-methyl-4-phenylbutanamide (33). 
 
Rf 0.31 (hexane/EtOAc = 3/1). White Solid. Mp = 66 °C. 1H NMR (CDCl3, 399.78 MHz)  
1.04 (d, J = 6.0 Hz, 3H), 2.34 (dd, J = 14.0, 7.2 Hz, 1H), 2.43-2.66 (m, 3H), 2.78 (dd, J = 13.6, 
6.0 Hz, 1H), 3.98 (s, 3H), 6.83 (d, J = 8.8 Hz, 1H), 7.11-7.35 (m, 5H), 7.44 (q, J = 4.3 Hz, 1H), 
8.57 (dd, J = 8.5, 1.6 Hz, 1H), 8.71 (d, J = 8.7 Hz, 1H), 8.81 (dd, J = 4.0, 1.2 Hz, 1H), 9.54 
(brs, 1H); 13C NMR (CDCl3, 100.53 MHz)19.56, 32.68, 43.05, 44.95, 55.72, 104.28, 
116.50, 120.36, 120.66, 125.92, 127.89, 128.21, 129.29, 131.22, 138.98, 140.35, 148.54, 
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150.11, 170.60; IR (neat) 3362 w, 3011 w, 2958 w, 1734 w, 1672 w, 1596 w, 1525 m, 1493 
m; MS m/z (relative intensity, %) 334 (M+, 30), 216 (70), 201 (12), 175 (14), 174 (100), 159 
(77), 91 (16); HRMS Calcd for C21H22N2O2: 334.1681; Found: 334.1684. 
 
N-(5-chloroquinolin-8-yl)-2-iodo-6-methylbenzamide (34). 
 
Rf 0.43 (hexane/EtOAc = 5/1). White Solid. Mp = 210 °C. 
1H NMR (CDCl3, 399.78 MHz)  
2.46 (s, 3H), 7.05 (t, J = 8.0 Hz, 1H), 7.25 (d, J = 7.2 Hz, 1H), 7.57 (dd, J = 8.4, 4.0 Hz, 1H), 
7.69 (d, J = 8.4 Hz, 1H), 7.73 (d, J = 8.0 Hz, 1H), 8.59 (dd, J = 8.4, 1.6 Hz, 1H), 8.81 (dd, J = 
4.0, 1.6 Hz, 1H), 8.91 (d, J = 8.4 Hz, 1H), 9.88 (brs, 1H); 13C NMR (CDCl3, 100.53 
MHz)20.13, 92.85, 116.94, 122.43, 125.08, 126.02, 127.19, 130.08, 130.67, 133.37, 133.41, 
136.61, 136.79, 139.07, 142.92, 148.83, 168.13; IR (neat) 3330 w, 1725 w, 1672 m, 1581 m, 
1517 s, 1476 s, 1381 m, 1266 m; MS m/z (relative intensity, %) 424 (10), 422 (M+, 30), 245 
(100), 90 (18); HRMS Calcd for C17H12ClIN2O: 421.9683; Found: 421.9687. 
 
1-(5-chloroquinolin-8-yl)-3,3-dimethylazetidin-2-one (36). 
 
Rf 0.26 (hexane/EtOAc = 5/1). White Solid. Mp = 155 °C. 
1H NMR (CDCl3, 399.78 MHz)  
1.45 (s, 6H), 4.33 (s, 2H), 7.49 (dd, J = 8.4, 4.0 Hz, 1H), 7.56 (d, J = 8.8 Hz, 1H), 8.45 (d, J = 
8.4 Hz, 1H), 8.53 (dd, J = 8.8, 6.0 Hz, 1H), 8.84 (dd, J = 4.0, 1.6 Hz, 1H); 13C NMR (CDCl3, 
100.53 MHz)21.44, 51.62, 60.79, 119.08, 121.89, 124.99, 126.58, 126.75, 132.75, 134.48, 
140.82, 148.80, 173.71; IR (neat) 2966 w, 1739 s, 1502 m, 1466 m, 1399 m, 1350 m, 1140 m; 
MS m/z (relative intensity, %) 260 (M+, 21), 232 (18), 217 (12), 206 (32), 205 (13), 204 (100), 
189 (17), 165 (11), 163 (33); HRMS Calcd for C14H13ClN2O: 260.0716; Found: 260.0716. 
 
 
Deuterium Labeling Experiments (eq 2). 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide 
1c-d7 (90 mg, 0.3 mmol), heptafluoroisopropyl iodide (107 mg, 0.36 mmol), Ni(OTf)2 (10.6 
mg, 0.03 mmol), PPh3 (7.8 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene (1 mL) 
were added in a glove box. The mixture was stirred for 4 h at 140 °C followed by cooling. 
The resulting mixture was filtered through a celite pad and concentrated in vacuo. The ratio of 
deuterium was determined by 1H-NMR. 
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Deuterium Labeling Experiments (eq 3). 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide 1c 
(89 mg, 0.3 mmol), heptafluoroisopropyl iodide (107 mg, 0.36 mmol), Ni(OTf)2 (10.6 mg, 
0.03 mmol), PPh3 (7.8 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene-d8 (1 mL) 
were added in a glove box. The mixture was stirred for 24 h at 140 °C followed by cooling. 
The resulting mixture was filtered through a celite pad and concentrated in vacuo. The ratio of 
deuterium was determined by 1H-NMR. 
 
Deuterium Labeling Experiments (eq 4). 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide 1c 
(89 mg, 0.3 mmol), heptafluoroisopropyl iodide (107 mg, 0.36 mmol), Ni(OTf)2 (10.6 mg, 
0.03 mmol), PPh3 (7.8 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene (0.5 mL) / 
toluene-d8 (0.5 mL)  were added in a glove box. The mixture was stirred for 4 h at 140 °C 
followed by cooling. The resulting mixture was filtered through a celite pad and concentrated 
in vacuo. The ratio of deuterium was determined by 1H-NMR. 
 
Observation of C3F7H. 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide 1c 
(89 mg, 0.3 mmol), heptafluoroisopropyl iodide (177 mg, 0.60 mmol), Ni(OTf)2 (10.6 mg, 
0.03 mmol), PPh3 (7.8 mg, 0.03 mmol), Na2CO3 (64 mg, 0.6 mmol) and toluene (1 mL) were 
added in a glove box. The mixture was stirred for 4 h at 140 °C. The resulting mixture was 
cooled at -78 °C, and transferred to sealed NMR tube. The formation of C3F7H was 
determined by 19F-NMR. 
 
General Procedure for Direct Benzylation: Pd-Catalyzed Dehydrogenative Cross 
Coupling of Amides 32 with Toluene (eq 5).  
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)butyramide 32 (75 mg, 
0.3 mmol), heptafluoroisopropyl iodide (178 mg, 0.60 mmol), Pd(OAc)2 (6.7 mg, 0.03 mmol), 
1-AdCOOH (10.8 mg, 0.06 mmol), K2CO3 (124 mg, 0.9 mmol) and toluene (1 mL) were 
added in a glove box. The mixture was stirred for 48 h at 140 °C followed by cooling. The 
resulting mixture was filtered through a celite pad and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (eluent: hexane/EtOAc= 2/1) to afford the 
desired alkylated product 33 (78 mg, 77%) as a white solid. 
 
General Procedure for Direct Iodination of Aromatic C-H Bonds (eq 6). 
To an oven-dried 5 mL screw-capped vial, N-(5-chloroquinolin-8-yl)-2-methylbenzamide  
(45 mg, 0.15 mmol), iodine (76 mg, 0.3 mmol), Ni(OTf)2 (5.3 mg, 0.015 mmol), Na2CO3 (32 
mg, 0.3 mmol) and toluene (0.7 mL) were added in a glove box. The mixture was stirred for 
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24 h at 140 °C followed by cooling. The resulting mixture was filtered through a celite pad 
and concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(eluent: hexane/EtOAc= 20/1) to afford the desired alkylated product 2c (48 mg, 76%) as a 
white solid. 
 
General Procedure for the formation of -Lactams (eq 7). 
To a 5 mL two necked flask equipped with condenser, N-(5-chloroquinolin-8-yl)pivalamide 
(39 mg, 0.15 mmol), iodine (76 mg, 0.3 mmol), Ni(OTf)2 (5.3 mg, 0.015 mmol), Ag2CO3 (10 
mg, 0.0375 mmol), Na2CO3 (32 mg, 0.3 mmol) and DMF (0.5 mL) were added in a glove box. 
The mixture was stirred for 24 h at 140 °C followed by cooling. The resulting mixture was 
filtered through a celite pad and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (eluent: hexane/EtOAc= 20/1) to afford the desired -lactam (35 
mg, 91%) as a white solid. 
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Conclusion 
 
Although the Ni-catalyzed functionalization of C-H bonds has been limited to acidic C-H 
bonds, such as azole derivatives, perfluorobenzene and activated pyridine derivatives, these 
studies revealed that a combination of a nickel(II)-catalyst and an N,N-bidentate directing 
group permit inert C-H bonds to be functionalized. 
Chapter 1 discusses the nickel(II)-catalyzed direct alkylation of C(sp2)-H bonds 
containing an 8-aminoquinline moiety as a bidentate directing group with an alkyl halide. The 
driving force for C-H bond cleavage with a low active nickel-catalyst is the formation of 
metallacycle intermediate stabilized by an N,N-bidentate directing group. Deuterium labeling 
experiments indicated that the cleavage of the C-H bond is not likely the rate determining step. 
This reaction proceeded via a Ni(II)/Ni(IV) cycle, which is unusual in Ni-catalyzed cross 
coupling reactions. 
Chapter 2 deals with the direct arylation of aliphatic amides with aryl halides via the 
cleavage of C(sp3)-H bonds by utilizing a combination of a nickel(II)-catalyst and an 
N,N-bidentate directing group. The C-H bond cleavage step proceeded rapidly and reversibly, 
even when a more inert C(sp3)-H bond was used. Diaryliodonium salts instead of aryl halides 
could be used for arylation reagents. 
Chapter 3 is concerned with the nickel(II)-catalyzed oxidative coupling of C(sp2)-H bonds 
benzamides and benzylic C-H bonds in toluene derivatives using the hetafluoroisopropyl 
iodide as a mild oxidant. This reaction involves the catalytic cleavage of two different C-H 
bonds, C(sp2)-H and benzylic C-H bonds. A high functional group compatibility was achieved 
when iC3H7I was used as a mild oxidant. 
In this study, a combination of a nickel(II)-catalyst and an N,N-bidentate directing group 
has the potential to allow various functional groups to be introduced in benzene ring, such as 
aryl, alkyl, methyl and iodo groups, and benzyl moieties via oxidative coupling. Not only 
C(sp2)-H bonds but also more inert C(sp3)-H bonds could be functionalized by using this 
chelation system. Aryl groups were introduced by using aryl halides and diaryiodonium salts 
as arylation reagents, and -lactams were prepared via the cleavage of C(sp3)-H bonds.  
 
 
 
 
 
 
 
 
 
 97 
 
Scheme 1. Summary of this thesis 
 
 
Key to these successes derives from the nature of the N,N-bidentate directing group. The 
N,N-bidentate directing group efficiently and strongly coordinates to the nickel(II) complex 
by the formation of a N-Ni covalent bond with the amide N-H, and the subsequent C-H bond 
activation step was facilitated by the formation of a stabilized metallacycle. In chapter 1 and 2, 
a mechanism is proposed for the Ni(II)/Ni(IV) cycle. A high valent Ni(IV) intermediate 
generated after the reaction with the aryl or alkyl halide was probably stabilized by the C, N, 
N pincer type ligand or a non-innocent ligand which is derived from the 8-amonoquinoline 
moiety. 
These studies can be expected to provide new methodology for use in the functionalization 
of C-H bonds and to the development of a new field of high valent Ni(IV) chemistry. In fact, 
more than 30 papers concerning C-H bond functionalization reactions utilizing a 
nickel(II)-catalyst and an N,N-bidentate directing group have been reported since we 
published the first report of the Ni(II)-catalyzed direct alkylation of aromatic C-H bonds 
containing a N,N-bidentate directing group in 2013. 
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